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 Abstract 
Infectious pancreatic necrosis virus (IPNV) is the aetiological agent of infectious 
pancreatic necrosis (IPN), a disease associated with serious economic loss in Atlantic 
salmon (Salmo salar). The interaction between IPNV and the host is poorly characterised. 
IPNV has been detected within macrophages in natural and experimental infections. The 
macrophage is an important component of the host immune system, participating in 
innate and adaptive immune responses. The overarching objective of this project was to 
study aspects of the interaction between IPNV and innate immune responses in the 
Atlantic salmon macrophage.  
 Methods were developed for the isolation and in vitro culture of Atlantic salmon 
macrophages. These cells were isolated from head kidney using percoll gradients and 
subsequently cultured in 24 well plates using Leibovitz L-15 medium containing 
penicillin, streptomycin and foetal calf serum. This procedure enabled the in vitro culture 
of macrophages for 9 days post isolation. Real time RT-PCR assays were developed to 
quantitate the expression of IPNV, Interferon (IFN), Mx, and Elongation factor 1 (ELF-1) 
in IPNV-infected macrophages and uninfected controls. ELF-1 is utilised as a control 
gene for relative quantitation in RT-PCR studies. The RT-PCR assays utilised target-
specific primers, and MGB probes. Assay efficiencies varied from 0.85 to 0.99, these 
were suitable for quantitative RT-PCR analyses.  
 IPNV was demonstrated to replicate in macrophages cultured in vitro as assessed 
by quantitative RT-PCR. IPNV levels in macrophages were greatest at the early stages of 
infection. Virus was detected in infected macrophages throughout the nine day period of 
investigation. Quantitative RT-PCR analyses of the expression of the immune response 
 genes IFN and Mx suggested that IPNV blocks IFN production, as opposed to blocking 
IFN signalling.   
 The ability of three immunostimulants, Lipopolysaccharide (LPS), macrophage 
activating factor (MAF), and glucan to up regulate immune responses in IPNV-infected 
macrophages was also investigated. None of these immunostimulants were able to 
enhance expression of IFN and Mx, suggesting that these substances may not represent 
useful therapeutic means of mitigating IPN in Atlantic salmon.  
 
 
 
 
 
 
 
 
 i 
List of Abbreviations 
 
2ME : 2 mercaptoethanol 
ANOVA : analysis of variance 
CHSE-214 : Chinook salmon embryo (cell line) 
CFS : guinbuna crucian carp cell line 
Con A : concanavalin A 
cDNA : complementary deoxyribonucleic acid 
CPE : cytopathic effect 
Ct : threshold cycle 
DEPC : diethylpyrocarbonate 
DNA : deoxyribonucleic acid 
dsRNA : double stranded RNA 
ELISA : enzyme-linked immunosorbent assay 
ELF-1 : elongation factor 1 
EMEM : minimal essential medium with Earle’s salts 
FCS : foetal calf serum 
IFN : interferon 
IL : interleukin 
IPNV : infectious pancreatic necrosis virus 
i.p. : intraperitoneal 
kDa : kilodalton 
l : litre 
L-15 : Leibovitz-15 
LPS : lipopolysaccharide 
M : molar 
MAF : macrophage activating factor 
mRNA : messenger RNA 
mM : millimolar 
min : minute 
 ii 
MOI : multiplicity of infection 
NBT : nitroblue tetrazolium 
NEAA : non-essential amino acids 
PBS : phosphate buffered saline 
PCR : polymerase chain reaction 
PMA : phorbol myristate acetate 
Poly I:C : Polyinosinic-polycytidylic acid 
qRT-PCR : quantitative reverse-transcription PCR 
RNA : ribonucleic acid 
RT : reverse transcription 
RT-PCR : reverse-transcription PCR 
RTG : rainbow trout gonad cells 
SD : standard deviation 
TBS : Tris buffered saline 
TCID50 : 50% tissue culture infective dose 
TLR : toll like receptor 
TNF-α : tumour necrosis factor alpha 
 
 
 
 
 
 
 
 
 
 
 
 
 iii 
Table of contents 
Chapter 1 - Literature review ------------------------------------------------------ 1 
1.1 Infectious Pancreatic Necrosis Virus------------------------------------------------------------ 1 
1.1.1 Structure --------------------------------------------------------------------------------------------------------- 1 
1.2 Antigenic composition ----------------------------------------------------------------------------- 2 
1.3 Clinical signs of IPNV-induced disease --------------------------------------------------------- 3 
1.3.1 External signs--------------------------------------------------------------------------------------------------- 4 
1.3.2 Internal signs---------------------------------------------------------------------------------------------------- 4 
1.4 Host and geographic range------------------------------------------------------------------------ 5 
1.5 Vectors of IPNV------------------------------------------------------------------------------------- 7 
1.6 Transmission----------------------------------------------------------------------------------------- 7 
1.6.1 Horizontal transmission--------------------------------------------------------------------------------------- 8 
1.6.2 Vertical transmission ------------------------------------------------------------------------------------------ 9 
1.7 Entry of virus into fish ----------------------------------------------------------------------------- 9 
1.8 Carrier status---------------------------------------------------------------------------------------10 
1.8.1 Sites of IPNV persistence within host -------------------------------------------------------------------- 11 
1.8.2 Defective interfering particles ----------------------------------------------------------------------------- 11 
1.9 IPN and post-smolt mortalities------------------------------------------------------------------13 
1.10 Influence of environmental stressors on the occurrence of IPN -------------------------13 
1.11 Effect of IPNV on global aquaculture --------------------------------------------------------15 
1.12 Control of IPN ------------------------------------------------------------------------------------16 
1.12.1 Chemotherapy----------------------------------------------------------------------------------------------- 16 
 iv 
1.12.2 Vaccination -------------------------------------------------------------------------------------------------- 17 
1.12.2.1 Recombinant vaccines ------------------------------------------------------------------------------- 18 
1.12.2.2 Live attenuated vaccines ---------------------------------------------------------------------------- 19 
1.12.2.3 Inactivated vaccines---------------------------------------------------------------------------------- 19 
1.12.2.4 DNA vaccines----------------------------------------------------------------------------------------- 20 
1.12.3 Immunostimulants------------------------------------------------------------------------------------------ 20 
1.13 Husbandry-----------------------------------------------------------------------------------------21 
1.14 Genetic resistance --------------------------------------------------------------------------------22 
1.15 Current techniques for the detection and identification of aquatic IPNV -------------22 
1.16 Host defence mechanisms against IPNV -----------------------------------------------------24 
1.16.1 Innate immunity -------------------------------------------------------------------------------------------- 25 
1.16.1.1 Cellular ------------------------------------------------------------------------------------------------- 25 
1.16.1.2 Humoral ------------------------------------------------------------------------------------------------ 26 
1.16.2 Adaptive immunity----------------------------------------------------------------------------------------- 28 
1.16.2.1 Cellular ------------------------------------------------------------------------------------------------- 28 
1.16.2.2 Humoral ------------------------------------------------------------------------------------------------ 28 
1.17 Summary and Aims------------------------------------------------------------------------------29 
Chapter 2 - General Materials and Methods ---------------------------------- 31 
2.1 Virology----------------------------------------------------------------------------------------------31 
2.1.1 Cell culture ---------------------------------------------------------------------------------------------------- 31 
2.1.2 Virus culture -------------------------------------------------------------------------------------------------- 31 
2.1.3 Estimation of virus titre ------------------------------------------------------------------------------------- 32 
2.2 Isolation and culture of macrophages----------------------------------------------------------33 
2.2.1 Fish ------------------------------------------------------------------------------------------------------------- 33 
2.2.2 Sampling------------------------------------------------------------------------------------------------------- 33 
 v 
2.2.3 Isolation of macrophages on 34-51% discontinous gradient------------------------------------------ 33 
2.2.4 Isolation of macrophages on 51% percoll---------------------------------------------------------------- 34 
2.2.5 Culture of macrophages------------------------------------------------------------------------------------- 36 
2.2.6 Estimation of macrophage cell numbers in vitro ------------------------------------------------------- 36 
2.2.7 IPNV infection of macrophages in vitro ----------------------------------------------------------------- 36 
2.2.8 Extracellular IPNV titre------------------------------------------------------------------------------------- 37 
Chapter 3 - Development of a protocol for the in vitro culture of Atlantic 
salmon macrophages --------------------------------------------------------------- 38 
3.1 Introduction-----------------------------------------------------------------------------------------38 
3.2 Materials and Methods ---------------------------------------------------------------------------38 
3.2.1 Isolation of macrophages on 34 - 51% discontinuous percoll gradient or 51% percoll. --------- 38 
3.2.2 Statistical analysis of the cells produced by the 34-51% percoll gradient and those on 51% 
percoll----------------------------------------------------------------------------------------------------------------- 39 
3.2.3 Staining of adherent cells obtained from 34-51% and 51% percoll gradients --------------------- 39 
3.2.4 In vitro virus infection in isolated macrophages -------------------------------------------------------- 40 
3.2.5 Extraction of RNA from in vitro macrophage monolayer--------------------------------------------- 40 
3.2.6 Viability of in vitro macrophage cultures ---------------------------------------------------------------- 41 
3.3 Results -----------------------------------------------------------------------------------------------42 
3.3.1 In vitro culture of macrophages and extraction of RNA from cells grown in a 96 well plate--- 42 
3.3.2 Comparison of cells isolated from 34-51% percoll gradient and 51% percoll--------------------- 44 
3.3.3 In vitro culture of macrophages and extraction of RNA from cell monolayers grown in 24 well 
plates ------------------------------------------------------------------------------------------------------------------ 48 
3.4 Discussion -------------------------------------------------------------------------------------------52 
3.4.1 Macrophage isolation conditions -------------------------------------------------------------------------- 52 
3.4.2 In vitro culture of macrophages and extraction of RNA ---------------------------------------------- 54 
 vi 
3.5 Conclusion-------------------------------------------------------------------------------------------56 
Chapter 4 - Optimization of qRT-PCR assays for the quantitation of the 
expression of immune response genes in Atlantic salmon macrophages - 57 
4.1 Introduction-----------------------------------------------------------------------------------------57 
4.2 Materials and Methods ---------------------------------------------------------------------------58 
4.2.1 Isolation of macrophages from head kidney------------------------------------------------------------- 58 
4.2.2 IPNV infection of Atlantic salmon macrophages in vitro --------------------------------------------- 58 
4.2.3 Two-step RT-PCR ------------------------------------------------------------------------------------------- 59 
4.2.3.1 First strand cDNA synthesis ------------------------------------------------------------------------- 59 
4.2.3.2 IFN, Mx, IPNV and ELF-1 q RT-PCR------------------------------------------------------------- 60 
4.3 Reverse transcription of total RNA extracted from macrophages incorporating the 
optimised cycling conditions.-------------------------------------------------------------------------62 
4.4 Standard curve production ----------------------------------------------------------------------62 
4.5 Results -----------------------------------------------------------------------------------------------63 
4.5.1 Optimization of the reverse transcription of RNA extracted from Atlantic salmon macrophages.
------------------------------------------------------------------------------------------------------------------------- 63 
4.5.2 Sensitivity of real time RT-PCR assays ------------------------------------------------------------------ 67 
4.6 Discussion -------------------------------------------------------------------------------------------73 
4.6.1 Optimization of first strand cDNA synthesis------------------------------------------------------------ 73 
4.6.2 Selection of the housekeeping gene for use in relative quantitation by real-time qRT-PCR---- 74 
4.6.3 Real-time quantitative PCR for IFN, Mx, IPNV and ELF-1 ----------------------------------------- 75 
4.6.4 Selection of method for quantification in real-time RT-PCR----------------------------------------- 77 
4.6.5 Explanation of components of Pfaffl calculation ------------------------------------------------------- 82 
4.7 Conclusion-------------------------------------------------------------------------------------------82 
 vii 
Chapter 5 - Innate immune responses in Atlantic salmon macrophages 
infected with IPNV: induction and effect of immunostimulants----------- 83 
5.1 Introduction-----------------------------------------------------------------------------------------83 
5.2 Materials and Methods ---------------------------------------------------------------------------85 
5.2.1 Production of IFN-preparations from Atlantic salmon macrophages ------------------------------- 85 
5.2.2 Efficacy of IFN-preparations in stimulation of Mx response----------------------------------------- 86 
5.2.3 Luciferase assay ---------------------------------------------------------------------------------------------- 86 
5.2.4 Production of MAF containing supernatants by salmon leucocytes--------------------------------- 87 
5.2.5 Measurement of MAF activity----------------------------------------------------------------------------- 88 
5.2.6 Lipopolysaccharide (LPS) and glucan-------------------------------------------------------------------- 89 
5.2.7 Isolation of macrophages to obtain macrophage monolayers for in vitro experiments----------- 89 
5.2.8 In vitro virus infection in isolated macrophages -------------------------------------------------------- 89 
5.2.9 Real time q RT-PCR of extracted RNA------------------------------------------------------------------ 92 
5.2.10 Statistical analysis of gene expression in macrophages---------------------------------------------- 92 
5.2.11 Detection of extracellular IPNV ------------------------------------------------------------------------- 93 
5.3 Results -----------------------------------------------------------------------------------------------93 
5.3.1 IPNV levels in infected macrophages -------------------------------------------------------------------- 93 
5.3.2 Preparation of IFN-preparations--------------------------------------------------------------------------- 97 
5.3.3 Assessment of MAF activity in supernatants------------------------------------------------------------ 99 
5.3.4 Expression of innate immune genes by Atlantic salmon macrophages in response to IFN 
treatment-------------------------------------------------------------------------------------------------------------- 99 
5.3.5 Expression of innate immune genes by Atlantic salmon macrophages in response to treatment 
with immunostimulants. ------------------------------------------------------------------------------------------103 
5.3.6 IPNV levels in IFN-treated macrophages---------------------------------------------------------------106 
5.3.7 IPNV levels in immunostimulant-treated macrophages. ---------------------------------------------109 
5.3.8 Determination of IPNV levels in the culture media of infected macrophages--------------------112 
 viii 
5.4 Discussion ----------------------------------------------------------------------------------------- 112 
5.4.1 IPNV levels in infected macrophages in vitro ---------------------------------------------------------112 
5.4.2 Effect of IPNV infection on the innate immune response of macrophages in vitro -------------113 
5.4.3 Does IPNV induce an Mx response, and how does this compare to that induced by IFN?-----114 
5.4.4 Does IFN reduce IPNV levels in Atlantic salmon macrophages? ----------------------------------117 
5.4.5 Do immunostimulants induce IFN and Mx responses in macrophages and do immunostimulant-
treated macrophages clear IPNV?-------------------------------------------------------------------------------121 
5.4.5.1 Glucan --------------------------------------------------------------------------------------------------122 
5.4.5.2 MAF-----------------------------------------------------------------------------------------------------124 
5.4.5.3 LPS ------------------------------------------------------------------------------------------------------126 
5.5 Conclusion----------------------------------------------------------------------------------------- 130 
5.5.1 IFN as a treatment for IPNV ------------------------------------------------------------------------------130 
5.5.2 Immunostimulants as potential treatments for IPN----------------------------------------------------131 
5.5.3 The effect of IPNV on the antiviral response within Atlantic salmon head kidney macrophages
------------------------------------------------------------------------------------------------------------------------131 
Chapter 6 - Comparison of the effects of IPNV and Poly I:C treatment 
to demonstrate the type I IFN suppressing properties of IPNV in 
Atlantic salmon head kidney macrophages. ---------------------------------- 133 
6.1 Introduction--------------------------------------------------------------------------------------- 133 
6.2 Materials and Methods ------------------------------------------------------------------------- 134 
6.2.1 Isolation of macrophages from head kidney------------------------------------------------------------134 
6.2.2 In vitro virus infection in isolated macrophages -------------------------------------------------------134 
6.2.3 RNA extraction and quantitative real-time RT-PCR--------------------------------------------------135 
6.2.4 Statistical analysis of real time RT-PCR gene expression -------------------------------------------136 
6.2.5 Detection of extracellular IPNV--------------------------------------------------------------------------136 
6.3 Results --------------------------------------------------------------------------------------------- 136 
 ix 
6.3.1 Expression of antiviral genes -----------------------------------------------------------------------------136 
6.3.2 IPNV-levels in infected macrophages -------------------------------------------------------------------141 
6.3.3 Determination of IPNV levels in the culture media of infected macrophages--------------------141 
6.4 Discussion ----------------------------------------------------------------------------------------- 143 
6.4.1 Type I IFN response of Atlantic salmon head kidney macrophages to IPNV infection --------143 
6.4.2 Intracellular levels of IPNV following infection in Atlantic salmon macrophages --------------157 
6.5 Conclusion----------------------------------------------------------------------------------------- 157 
Chapter 7 - General discussion-------------------------------------------------- 159 
7.1 Discussion ----------------------------------------------------------------------------------------- 159 
7.1.1 Macrophage culture and real time RT-PCR assay development ------------------------------------159 
7.1.2 Innate immune responses in IPNV-infected Atlantic salmon head kidney macrophages. ------160 
7.1.3 IPNV levels in Atlantic salmon head kidney macrophages------------------------------------------161 
7.1.4 Suppression of type I IFN response in Atlantic salmon macrophages by IPNV -----------------163 
7.1.5 Relevance of findings to the current status of IPN in Scotland -------------------------------------165 
7.2 Future work--------------------------------------------------------------------------------------- 167 
 x 
Table of Figures 
Figure 1: Isolation of macrophages on a 51% percoll gradient gave rise to 3 main layers. 
Layer 1; L-15 medium containing cell debris (a). Layer two; the L-15 medium-51% 
percoll interface containing macrophages (b). Layer three; 51% percoll with pelleted 
red blood cells (c). .................................................................................................... 35 
Figure 2: Number of viable adherent head kidney macrophages maintained in vitro over 
time in a 96 well plate. Cells were derived from Atlantic salmon head kidney and 
isolated on 34-51% percoll gradients. The cells were seeded in wells at a 
concentration of 2 x 10-7 ml-1, then washed after 3 hours to remove non-adherent 
cells. Cultures were incubated overnight at 15°C, before being infected with IPNV 
at an MOI of 1, 24 hours after initial seeding. Negative control macrophages were 
inoculated with L-15 medium. Counts of viable macrophages were taken for 9 days 
after virus inoculation. Data represent mean counts (N=3) ± SD............................. 43 
Figure 3: Mann and Whitney Statistical test preformed on macrophage counts obtained 
from cell suspensions derived from Atlantic salmon head kidneys. Comparisons 
were made concerning the numbers of macrophages obtained from 34-51% percoll 
gradients and those on 51% percoll (N=18). Differences were considered 
statistically significant when P <0.05. ...................................................................... 45 
Figure 4: Adherent cell populations obtained following isolation on 34-51% percoll 
gradients. Aliquots of cell suspension at the 34-51% percoll interface were allowed 
to adhere to glass slides for 3 hours.  Unattached cells were removed by washing and 
the remaining adhered cells were stained. Cells were identified as being either 
macrophages (M) or Lymphocytes (L). Photographs were taken using an Olympus 
BX51 inverted microscope under oil immersion at x 100 magnification................. 46 
Figure 5: Adherent cell populations obtained following isolation on 51% percoll. 
Aliquots of cell suspension at the 51%-medium interface were allowed to adhere to 
glass slides for 3 hours.  Unattached cells were removed by washing and the 
 xi 
remaining adhered cells were stained.  Cells were identified as being either 
macrophages (M), or Lymphocytes (L). Photographs were taken using an Olympus 
BX51 inverted microscope under oil immersion at x 100 magnification................. 47 
Figure 6: Number of viable adherent head kidney macrophages maintained in vitro over 
time in a 24 well plate. Cells were derived from Atlantic salmon head kidney and 
isolated on 51% percoll. The cells were seeded in wells at a concentration of 2 x 10-7 
ml-1, then washed after 3 hours to remove non-adherent cells. Cultures were 
incubated overnight at 15°C, before being infected with IPNV at an MOI of 1, 24 
hours after initial seeding. Negative control macrophages were inoculated with L-15 
medium. Counts of viable macrophages were taken for 9 days after virus 
inoculation. Data represent mean counts (log 10); (N=3) ± SD. .............................. 49 
Figure 7: Yield of RNA extracted from adherent head kidney macrophages maintained in 
vitro over time in a 24 well plate. Cells were derived from Atlantic salmon head 
kidney and isolated on 51% percoll. Prior to extraction, the macrophages had been 
infected with IPNV at an MOI of 1, 24 hours after initial seeding. Negative control 
macrophages were inoculated with L-15 medium. RNA was extracted from 
macrophage monolayers for 9 days after virus inoculation; extractions followed the 
TRIzol manufacturer’s protocol. Data represent mean concentration (N=3) ± SD.. 50 
Figure 8: Yield of RNA extracted from adherent head kidney macrophages maintained in 
vitro over time in a 24 well plate. Cells were derived from Atlantic salmon head 
kidney and isolated on 51% percoll. Prior to extraction, the macrophages had been 
infected with IPNV at an MOI of 1, 24 hours after initial seeding. Negative control 
macrophages were inoculated with L-15 medium. RNA was extracted from 
macrophage monolayers for 9 days after virus infection. Extractions were performed 
using a modified version of the TRIzol manufacturer’s protocol, which included the 
an overnight precipitation step at -20°C and the use of a co-precipitant. Data 
represent mean concentration (N=3) ± SD. .............................................................. 51 
 xii 
Figure 9: Real time RT-PCR amplification using ELF-1 specific primers and ELF-1 
probe to amplify a cDNA template derived from Poly I:C stimulated macrophages. 
The following variables in the reverse transcription step were investigated: reaction 
temperatures, 42°C, 46.4°C and 52°C;  reaction duration 20, 30, 40, 50, and 60 
minutes. The sample showing the earliest Ct value corresponded to reverse 
transcription condition 60 minutes at 46.4°C (a). No template controls and RT-
minus controls were incorporated into amplification runs (b).................................. 64 
Figure 10: Real time RT-PCR amplification using Mx specific primers and Mx probe to 
amplify a cDNA template derived from Poly I:C stimulated macrophages. The 
following variables in the reverse transcription step were investigated: reaction 
temperatures, 42°C, 46.4°C and 52°C;  reaction duration 20, 30, 40, 50, and 60 
minutes. The sample showing the earliest ct value corresponded to reverse 
transcription condition 60 minutes at 46.4°C (a). No template controls and RT-
minus controls were incorporated into amplification runs (b).................................. 65 
Figure 11: Real time RT-PCR amplification using ELF-1 specific primers and ELF-1 
probe to amplify a ten-fold dilution series of a cDNA template derived from Poly 
I:C stimulated macrophages. Amplifications were performed in triplicate. Target 
dilutions tested were 100 (a), 101 (b), 102 (c), 103 (d), 104 (e), No template controls 
and RT-minus controls were incorporated into amplification runs (f). .................... 68 
Figure 12: Standard curve obtained from amplification using ELF-1 specific primers and 
ELF-1 probe produced using the Rotor-Gene software. Amplification efficiencies 
were calculated according to the equation: E = 10[-1/slope]..................................... 68 
Figure 13: Real time RT-PCR amplification using Mx-specific primers and Mx probe to 
amplify a ten-fold dilution series of a cDNA template derived from Poly I:C 
stimulated macrophages. Amplifications were performed in triplicate. Target 
dilutions tested were 100 (a), 101 (b), 102 (c), 103 (d), 104 (e), No template controls 
and RT-minus controls were incorporated into amplification runs (f). .................... 69 
 xiii 
Figure 14: Standard curve obtained from amplification using Mx-specific primers and 
Mx-specific probe produced using the Rotor-Gene software. Amplification 
efficiencies were calculated according to the equation: E = 10[-1/slope]. ................ 69 
Figure 15: Real time RT-PCR amplification using IPNV-specific primers and IPNV 
probe to amplify a ten fold dilution series of cDNA derived from IPNV-infected 
macrophages. Amplifications were performed in triplicate. Target dilutions tested 
were 100 (a), 101 (b), 102 (c), 103 (d), 104 (e), 105 (f), No template controls and RT-
minus controls were incorporated into amplification runs (g).................................. 70 
Figure 16: Standard curve obtained from amplification using IPNV-specific primers and 
probes produced using the Rotor-Gene software. Amplification efficiencies were 
calculated according to the equation: E = 10[-1/slope]. ............................................ 70 
Figure 17: Real time RT-PCR amplification using IFN-specific primers and IFN probe to 
amplify a ten fold dilution series of a cDNA derived from Poly I:C stimulated 
macrophages. Amplifications were performed in triplicate. Target dilutions tested 
were 100 (a), 101 (b), 102 (c), 103 (d), No template controls and RT-minus controls 
were incorporated into amplification runs (e)........................................................... 71 
Figure 18: Standard curve obtained from amplification using IFN-specific primers and 
probes produced using the Rotor-Gene software. Amplification efficiencies were 
calculated according to the equation: E = 10[-1/slope]. ............................................ 71 
Figure 19: Flow diagram for the selection of a quantitative mathematical method 
(www.wzw.tum.de/gene-quantification) .................................................................. 79 
Figure 20: Pfaffl calculation for the relative expression in real time PCR (from Pfaffl et 
al., 2002). .................................................................................................................. 81 
Figure 21: IPNV levels in infected Atlantic salmon macrophages and uninfected controls. 
The figure shows a RT-PCR amplification plot performed with ELF-1 and IPNV-
specific primers and probe of  macrophage cDNA. The cDNA samples were taken 
 xiv 
from IPNV-infected macrophages and controls at 0 hours (a) and 24 hours (b) post 
infection. IPNV levels were quantified relative to expression of the housekeeping 
gene ELF-1 (c) using the method described by Pfaffl for relative quantification. The 
difference in IPNV Ct values between the time 0 and 24h samples (a and b) is 
clearly evident, whereas the Ct values for ELF-1 from these time points remains 
relatively constant (c). No template controls and RT- controls were incorporated into 
amplification runs (d)................................................................................................ 94 
Figure 22: IPNV levels in infected Atlantic salmon macrophages and uninfected controls. 
The figure shows an RT-PCR amplification plot performed with ELF-1 and IPNV-
specific primers and probe of macrophage cDNA. The cDNA samples were taken 
from IPNV-infected macrophages and controls at 5 days post infection. IPNV levels 
(a) were quantified relative to expression of the housekeeping gene ELF-1 (b) using 
the method described by Pfaffl. No template controls and RT- controls were 
incorporated into amplification runs (d). .................................................................. 95 
Figure 23: Two way ANOVA results for relative IPNV:ELF-1 expressed in IPNV 
inoculated Atlantic salmon head kidney macrophages and negative controls over 
time. Differences were considered statistically significant when P <0.05. .............. 95 
Figure 24: Levels of IPNV in Atlantic salmon head kidney macrophages and uninfected 
controls detected by qRT-PCR. IPNV levels were studied over a period of 9 days 
post-infection, and were quantified in relation to expression of the housekeeping 
gene ELF-1 using method described by Pfaffl. ........................................................ 96 
Figure 25: Induction of the Mx-promoter reporter gene activity by IFN containing 
supernatants in RTG-P1 cells. Histogram bars represent mean luciferase activity 
expressed in RLU (N = 3) ± SD. * indicates that the RLU value of an IFN 
preparation was significantly greater than that exhibited by the negative control (P < 
0.05). ......................................................................................................................... 98 
 xv 
Figure 26: One way ANOVA results for Luciferase activity expressed in RTG-P1 cells 
stimulated with IFN supernatant compared to negative controls. Differences were 
considered statistically significant when P <0.05. .................................................... 98 
Figure 27: IFN expression in Atlantic salmon head kidney macrophages determined by 
qRT-PCR. The following experimental groups were studied: (a) IPNV-infected; (b) 
IFN-stimulated and IPNV-infected; (c) IFN stimulated and (d) untreated 
macrophages.  Expression of IFN was investigated over a period of nine days post-
infection and was estimated in relation to expression of the housekeeping gene ELF-
1. Data represent mean IFN:ELF-1 ratio (N = 3) ± SD. ......................................... 101 
Figure 28: Two way ANOVA results for relative IFN:ELF-1 expression in (a) IPNV-
infected; (b) IFN-stimulated and IPNV-infected; (c) IFN stimulated and (d) 
untreated Atlantic salmon head kidney macrophages over time. Differences were 
considered statistically significant when P<0.05. ................................................... 101 
Figure 29: Mx expression in Atlantic salmon head kidney macrophages determined by 
qRT-PCR. The following experimental groups were studied: (a) IPNV-infected; (b) 
IFN-stimulated and IPNV-infected; (c) IFN stimulated and (d) untreated 
macrophages. Expression of Mx was investigated over a period of nine days post-
infection and was estimated in relation to expression of the housekeeping gene ELF-
1. Data represent mean Mx:ELF-1 ratio (N = 3) ± SD. .......................................... 102 
Figure 30: Two way ANOVA results for relative Mx:ELF-1 expression in (a) IPNV-
infected; (b) IFN-stimulated and IPNV-infected; (c) IFN stimulated and (d) 
untreated Atlantic salmon head kidney macrophages over time. Differences were 
considered statistically significant when P<0.05. ................................................... 102 
Figure 31: IFN expression in Atlantic salmon head kidney macrophages determined by 
qRT-PCR. The following experimental groups were studied: (a) IPNV-infected; (b) 
MAF-stimulated and IPNV-infected; (c) MAF stimulated (d) glucan-stimulated and 
IPNV-infected; (e) glucan stimulated (f) LPS-stimulated and IPNV-infected; (g) 
LPS stimulated; (h) Untreated macrophages. Expression of IFN was investigated 
 xvi 
over a period of nine days post-infection and was estimated in relation to expression 
of the housekeeping gene ELF-1. Data represent mean IFN:ELF-1 ratio (N = 3) ± 
SD. .......................................................................................................................... 104 
Figure 32: Two way ANOVA results for relative IFN:ELF-1 expression in (a) IPNV-
infected; (b) MAF-stimulated and IPNV-infected; (c) MAF stimulated (d) glucan-
stimulated and IPNV-infected; (e) glucan stimulated (f) LPS-stimulated and IPNV-
infected; (g) LPS stimulated; (h) Untreated Atlantic salmon head kidney 
macrophages over time. Differences were considered statistically significant when 
P<0.05. .................................................................................................................... 104 
Figure 33: Mx expression in Atlantic salmon head kidney macrophages determined by 
qRT-PCR. The following experimental groups were studied: (a) IPNV-infected; (b) 
MAF-stimulated and IPNV-infected; (c) MAF stimulated (d) glucan-stimulated and 
IPNV-infected; (e) glucan stimulated (f) LPS-stimulated and IPNV-infected; (g) 
LPS stimulated; (h) Untreated macrophages. Expression of Mx was investigated 
over a period of nine days post-infection and was estimated in relation to expression 
of the housekeeping gene ELF-1. Data represent mean Mx:ELF-1 ratio (N = 3) ± 
SD. .......................................................................................................................... 105 
Figure 34: Two way ANOVA results for relative Mx:ELF-1 expression in (a) IPNV-
infected; (b) MAF-stimulated and IPNV-infected; (c) MAF stimulated (d) glucan-
stimulated and IPNV-infected; (e) glucan stimulated (f) LPS-stimulated and IPNV-
infected; (g) LPS stimulated; (h) Untreated Atlantic salmon head kidney 
macrophages over time. Differences were considered statistically significant when 
P<0.05. .................................................................................................................... 105 
Figure 35: IPNV expression in Atlantic salmon head kidney macrophages determined by 
qRT-PCR. The following experimental groups were studied: (a) IPNV-infected; (b) 
IFN-stimulated and IPNV-infected; (c) IFN stimulated and (d) untreated 
macrophages.  Expression of IPNV was investigated over a period of nine days post-
 xvii 
infection and was estimated in relation to expression of the housekeeping gene ELF-
1. Data represent mean IPNV:ELF-1 ratio (N = 3) ± SD. ...................................... 108 
Figure 36: Two way ANOVA results for relative IPNV:ELF-1 expression in (a) IPNV-
infected; (b) IFN-stimulated and IPNV-infected; (c) IFN stimulated and (d) 
untreated Atlantic salmon head kidney macrophages over time. Differences were 
considered statistically significant when P<0.05. ................................................... 108 
Figure 37: IPNV expression in Atlantic salmon head kidney macrophages determined by 
qRT-PCR. The following experimental groups were studied: (a) IPNV-infected; (b) 
MAF-stimulated and IPNV-infected; (c) MAF stimulated (d) glucan-stimulated and 
IPNV-infected; (e) glucan stimulated (f) LPS-stimulated and IPNV-infected; (g) 
LPS stimulated; (h) untreated macrophages. Expression of IPNV was investigated 
over a period of nine days post-infection and was estimated in relation to expression 
of the housekeeping gene ELF-1. Data represent mean IPNV:ELF-1 ratio (N = 3) ± 
SD. .......................................................................................................................... 111 
Figure 38: Two way ANOVA results for relative IPNV:ELF-1 expression in (a) IPNV-
infected; (b) MAF-stimulated and IPNV-infected; (c) MAF stimulated (d) glucan-
stimulated and IPNV-infected; (e) glucan stimulated (f) LPS-stimulated and IPNV-
infected; (g) LPS stimulated; (h) untreated Atlantic salmon head kidney 
macrophages over time. Differences were considered statistically significant when 
P<0.05. .................................................................................................................... 111 
Figure 39: IFN expression in Atlantic salmon head kidney macrophages in response to 
infection with IPNV or treatment with Poly I:C.  Mock-treated macrophages (L-15 
alone) served as a negative controls. IFN levels were quantified in relation to 
expression of the housekeeping gene ELF-1 using the method described by Pfaffl. 
Data points represent mean IFN:ELF-1 ratios (N = 3) ± SD.................................. 139 
Figure 40: Two way ANOVA results for relative IFN:ELF-1 expressed in (a) IPNV 
infected; (b) Poly I:C stimulated; (c) untreated Atlantic salmon head kidney 
 xviii 
macrophages over time. Differences were considered statistically significant when 
P<0.05. .................................................................................................................... 139 
Figure 41: Mx expression in Atlantic salmon head kidney macrophages in response to 
infection with IPNV or treatment with Poly I:C. Mock-treated macrophages (L-15 
alone served as negative controls). Mx levels were quantified in relation to 
expression of the housekeeping gene ELF-1 using the method described by Pfaffl. 
Data points represent mean Mx:ELF-1 ratios (N = 3) ± SD................................... 140 
Figure 42: Two way ANOVA results for relative Mx:ELF-1 expressed in (a) IPNV 
infected; (b) Poly I:C stimulated; (c) untreated Atlantic salmon head kidney 
macrophages over time. Differences were considered statistically significant when 
P<0.05. .................................................................................................................... 140 
Figure 43: IPNV levels in infected Atlantic salmon head kidney macrophages. Untreated 
macrophages were used as a negative control. IPNV levels were quantified relative 
to expression of the housekeeping gene ELF-1 using the method described by Pfaffl. 
Data points represent mean IPNV:ELF-1 ratios (N = 3) ± SD. .............................. 142 
Figure 44: Two way ANOVA results for relative IPNV:ELF-1 expressed in (a) IPNV 
infected; (b) Poly I:C stimulated; (c) untreated Atlantic salmon head kidney 
macrophages over time. Differences were considered statistically significant when 
P<0.05. .................................................................................................................... 142 
Figure 45: Type I IFN induction, signalling and action. Left panel: dsRNA, a 
characteristic by-product of virus replication, leads to activation of the transcription 
factors NF-қ B, IRF-3. The cooperative action of these factors is required for full 
activation of the IFN-ß promoter. Right panel: Newly synthesised IFN-ß binds to the 
type I receptor and activates the expression of numerous ISGs via the JAK/STAT 
pathway which leads to production of intracellular antiviral proteins such Mx 
protein (from Haller, 2006)..................................................................................... 146 
 
 xix 
List of Tables 
Table 1: Data collected from cell counts of viable adherent head kidney macrophages 
maintained in vitro over time in a 96 well plate after IPNV inoculation. Data 
represent mean counts (N=3) ± SD........................................................................... 44 
Table 2: Data collected from cell counts of viable adherent head kidney macrophages 
maintained in vitro over time in a 24 well plate after IPNV inoculation. Data 
represent mean counts (N=3) ± SD........................................................................... 50 
Table 3: Primer and probe nucleotide sequences used in real-time qRT-PCR................. 61 
Table 4: Ct values corresponding to the real time RT-PCR amplification using both ELF-
1 and Mx specific primers along with ELF-1 and Mx specific probes to amplify a 
cDNA template derived from Poly I:C stimulated macrophages. ............................ 66 
Table 5: Amplification efficiencies and R values for the primers and probes used in this 
study.......................................................................................................................... 72 
Table 6: Characteristics of various relative quantitation methods.................................... 78 
Table 7: Examples of gene products from different human viruses which have been 
described to be involved in the inhibition of the IFN-mediated antiviral responses of 
the host (from Garcia-Sastre 2002)......................................................................... 149 
Chapter 1: Literature review 
 
1 
Chapter 1 - Literature review 
1.1    Infectious Pancreatic Necrosis Virus 
Infectious pancreatic necrosis virus (IPNV) is the etiological agent of a highly infectious 
disease of wild and cultured fin fish (Hill and Way, 1995). IPNV is the type species of the 
genus Aquabirnavirus of the family birnaviridae (Dobos et al., 1979). Aquatic birnaviruses 
generally have a wide host range and both clinical disease and carrier states have been 
reported in a variety of salmonids as well as non-salmonid fish world-wide (Wolf, 1988; 
Hill and Way, 1995). The classification of aquatic birnaviruses have been divided into two 
serogroups A and B based on serological analyses (Hill and Way, 1995). Nine different 
serotypes have been distinguished so far in serogroup A, whereas serogroup B contains 
only one serotype (Hill and Way, 1995; Song, 2005).  
1.1.1  Structure 
IPNV is an unenveloped icosahedral virus containing two segments of dsRNA (Dobos, 
1995), which encode five proteins designated VP1 to VP5 (Weber et al., 2001). Genome 
segment A of 3097bp, contains a large open reading frame (ORF) encoding a 106 kDa 
polyprotein which is cleaved to produce two structural polypeptides, pVP2 and VP3, and 
one non-structural polypeptide, NS (or VP4) (Ducan et al., 1987). pVP2 is a precursor of 
the major capsid protein VP2 (Blake et al., 2001), which is further cleaved to yield VP2 
during virus maturation. VP3 is thought to be an internal virion protein (Blake et al., 
2001), whereas VP2, being the outermost protein, is involved in attachment to cells 
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(Sadasiv, 1995). Genome segment A contains an additional small open reading frame 
(ORF) which overlaps the amino terminal of the polyprotein ORF and is translated in a 
different reading frame; this ORF encodes a 17-kDa arginine rich minor polypeptide 
(Magyar et al., 1998) designated VP5 (Weber et al., 2001). The smaller genome segment 
B (2784 bp) is monocistronic and encodes VP1 (94 kDa), the putative virion-associated 
RNA-dependent RNA polymerase (Blake et al., 2001). VP1 is present in the virion in two 
forms, as a free polypeptide (VP1) and as a genome linked protein (VPg). (Calvert et al., 
1991).  
1.2    Antigenic composition 
It has been demonstrated that IPNV serotype varies between broad geographical areas 
(Melby et al., 1994). Whilst the vast majority of isolates have been found to be 
antigenically-related to the original reference serotypes (VR299, Sp and Ab) of IPNV, 
(Hill and Way, 1995) found there to be a high degree of antigenic diversity amongst 
isolates with some relating only relatively weakly with the three traditional serotypes. A 
standardized serological classification scheme was proposed by (Hill and Way, 1995) for 
serotyping IPNV and the other aquatic birnaviruses, through which they divided the 
birnaviruses into serogroups A and B. Serogroup B consists of a single serotype (B1), 
whilst serogroup A has been divided into nine serotypes A1-A9. Serological 
characterization of this group of viruses is important both for epizootiological reasons as 
well as the development of vaccines (Reno, 1999). According to (Frost and Ness, 1997), in 
the northern part of Europe, aquatic birnaviruses that cause clinical infectious pancreatic 
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necrosis (IPN) in Atlantic salmon show a surprisingly homogeneous nature, all belonging 
to the Sp serotype of serogroup A. From the European serotypes Sp is usually highly 
virulent whereas Ab displays a low virulence (Dorson, 1988).   
1.3    Clinical signs of IPNV-induced disease 
In salmonid hatchery populations, a sudden and usually progressive increase in mortalities, 
particularly in faster growing individuals, is often the first sign of an outbreak (Hill, 1982). 
Mortality can be variable, ranging from negligible to almost 100% in extreme cases 
(Taksdal, 1999). IPN commonly results in mortality that is inversely proportional to the 
age of the fish, being typically highest in the youngest fish and relatively rare in older fish, 
in which infections are often asymptomatic (Wolf, 1988). Clinical signs typically appear 
on day 3 to 5 (fry) or on day 8 to 10 (fingerlings) after exposure to the virus. Peak 
mortalities usually occur between days 12 to 18 (Noga, 2000), however Atlantic salmon 
smolts can suffer from the disease shortly after transfer to seawater (Bowden et al., 2002). 
The time course of clinical disease varies with fish age, species, temperature and other 
conditions (Wolf, 1988). Larger, faster growing young fish, as a rule, are the first to die 
from IPN (Hill, 1982, Post, 1987). Mortality develops rapidly at about 10-14°C, is 
protracted at lower temperatures, and can be reduced at higher temperatures (Ahne et al., 
1989).    
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1.3.1  External signs  
In a fish farm which has never previously been affected by an outbreak of IPN the 
fundamental sign of the disease is the occurrence of high mortality in young fry during the 
first two months after coming onto feed (Roberts and Shepherd, 1997). Infected fish show 
a gradual loss of equilibrium with a tendency to swim on their sides or in spirals in a 
corkscrew fashion (Dorson, 1988). Prior to death, fish may become lethargic with violent 
flexing of the body, suggesting abdominal distress (Candan, 2002; Roberts and Shepherd 
1997). IPNV-infected fish frequently exhibit an overall darkening of the body (Post, 1987 
Wolf, 1988; Roberts and Shepherd, 1997) and swelling of the ventral region (Dorson, 
1988; Wolf 1988). Haemorrhages are sometimes present in ventral areas, including the 
ventral fins (Wolf, 1988; Ahne et al., 1989). Many victims trail long, thin, whitish, castlike 
excretions from the vent (Wolf, 1988). According to Roberts and Shepherd (1997), after 
early mortalities in an outbreak showing the acute disease, the picture changes to a chronic 
from where the mortalities are lower and fish take longer to die. In this form, the fish 
appear quite black and show severe exophthalmia. They are very anaemic due to the 
severe internal bleeding and this particularly evident in the gills.  
1.3.2  Internal signs 
As suggested by its name IPNV-infection produces marked pancreatic necrosis (Dorson, 
1988), however histopathological changes may also occur in adjacent adipose tissue, in 
renal hematopoietic tissue, in the gut and in the liver (Wolf, 1988). IPN virus replicates 
largely within pancreatic acini and causes pyknosis and karyorrhexis with a moderate 
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inflammatory infiltrate (Ahne et al., 1989; Ferguson, 1989). Microscopically, there is focal 
coagulative necrosis of the acinar and islet cells of the pancreas and of the haemopoietic 
cells of the kidney (Reno, 1999). Prominent gut enteritis with sloughing of the mucosa has 
been reported as a common characteristic (Ahne et al., 1989; Ferguson, 1989; Smail et al., 
1995). Smail et al., (1995) report that this produces a catarrhal exudate which they suggest 
inhibits digestion and leads to malabsorption of the gut contents and the normal passage of 
food through the gut. The development of a catarrhal exudate is also reported by Noga, 
(2000), which may help to explain why the digestive tracts of infected fry are almost 
always devoid of food (Wolf, 1988). Prior to 1940, the disease was called acute catarrhal 
enteritis because of the typical opalescent mucus plug characteristically found in the 
intestine of obvious cases of the disease (Post, 1987). In chronic form, affected fish are 
very anaemic due to severe internal bleeding and this is shown especially in the gills and 
liver; the swim bladder and kidney may be enlarged or the entire abdomen filled with 
fluid, which produces the swollen dropsical external appearance (Roberts and Shepherd, 
1997).  
1.4    Host and geographic range 
The first isolation of IPNV was made from brook trout (Salvelnius fontinalis) in 1957 in 
the United States. This prototype isolate was deposited with the American Type Culture 
Collection (ATCC) in 1963 and given the reference number VR299. For several years 
thereafter all isolates which were neutralized by antiserum against the VR299 reference 
virus were referred to as IPNV strains (Hill and Way, 1995). For several years after it was 
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first discovered, IPNV was known only from North America and only as a pathogen that 
produced disease and mortality in trout fry, however the movement of fish and especially 
eggs, in the international market is thought to be one of the main reasons for the 
dissemination of the virus worldwide (Reno, 1999). With improvements in virus detection 
methods, it is apparent that IPNV is quite ubiquitous (Sadasiv, 1995). There are however 
some countries that are reported to be free of IPNV, these being Australia (Wolf, 1988; 
Reno, 1999; Taksdal, 1999), Iceland (Reno, 1999; Taksdal, 1999), Sweden (Ariel and 
Olesen, 2002; Murray et al., 2003) and New Zealand (Wolf, 1988 and Taksdal, 1999). The 
most susceptible species of fish appear to be rainbow trout (0ncorhynchus mykiss), brook 
trout, brown trout (Salmo trutta) and Atlantic salmon (Kent and Poppe, 1988; Wolf, 1988; 
Moya et al., 2000). While freshwater salmonids are the group most commonly afflicted 
with clinical IPN (Noga, 2000). IPNV has been isolated from many non salmonid species 
of fishes and shellfish (Stoskopf, 1993; Sadasiv, 1995). In most cases, these isolates have 
not been proven to be pathogenic for the host species (Stoskopf, 1993; Sadasiv, 1995; 
Cutrin et al., 2000), although they have been pathogenic to trout. Thus at present, 
according to Noga (2000) these aquatic species are most clinically important in acting as 
nonsusceptible viral reservoirs. Ahne et al., (1989) have demonstrated one such example 
of this by showing that carnivorous fish such as pike (Esox lucius) can become infected 
with IPNV by feeding on infected food fish, and as they develop IPNV infection cycles, 
which in turn leads to carrier status.  
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1.5    Vectors of IPNV 
Mcallister and Owens (1992) demonstrated that wild piscivorous birds, resident in 
salmonid fish hatcheries can be contaminated with IPN virus under natural conditions and 
can potentially serve as mechanical vectors for the dissemination of the virus. Mortensen, 
(1993) studied the passage of IPNV through a marine food chain, including uptake and 
release of the virus by bivalve molluscs, further transmission to prawns, and from prawns 
to trout. Mortensen’s findings showed that IPNV could be detected in the faeces of 
contaminated scallops, and the virus was then able to be transmitted to prawns that 
ingested either dead scallops, infected faeces or pseudofaeces. These results suggest that 
viral transmission may occur between aquatic invertebrates and fish. Smail et al., 1993(a) 
have demonstrated the ability of IPN to survive in commercial fish silage for periods of 
many days, especially at low temperatures. It was the opinion of Smail et al., 1993(b) 
reported that if fish silage is not treated to inactivate IPNV, it could lead to the spread of 
IPNV via application to pasture and permit subsequent return of the virus to fresh water 
sources via the water cycle.  
1.6    Transmission 
IPN only occurs through interaction between susceptible fish and virus. Salmonid immune 
defence systems are either not present or are overcome (Sadasiv, 1995). Each cell infected 
with virus can produce up to 1000 new infectious particles within a few hours, depending 
on the temperature and cell type (Dobos, 1995). IPNV has been shown to be able to 
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transfer both vertically from parent fish to offspring and horizontally via water (Lopez-
Lastra et al., 1994). Anderson (1982) has suggested that information about the 
mechanisms and patterns of pathogen transmission from infected to susceptible 
individuals can be used to develop methods for the prevention and control of infectious 
disease outbreaks. 
1.6.1  Horizontal transmission  
IPN is a contagious disease (Taksdal et al., 1998). IPNV shed in infected faeces will 
possibly contaminate surrounding areas and lead to horizontal transmission (Wolf, 1988). 
Faecal pseudocasts are considered as major sources of the virus by Noga (2000) who 
states that during epidemics, IPNV is readily transmitted horizontally by contact and 
ingestion of infected tissue. Studies conducted by Bebak et al., (1998) demonstrated that 
rainbow trout infected with IPNV can begin excreting virus within two days after 
infection, and infected fish that are shedding the virus can infect others in the population 
within another two days. They found that it was possible for 75% of the population to 
become infected in less than a week after initial shedding of the virus began. Mcallister 
and Bebak, (1997) sampled the discharge and downstream distribution of IPNV from three 
fish hatcheries and found the virus could be detected for at least 19.3km below the point of 
effluent discharge. However based on IPNV prevalence within the surrounding streams it 
would appear that chronic low level exposure to IPNV in the stream water did not appear 
to pose a significant risk to resident salmonid and non-salmonid fish. It was concluded that 
population density is associated with transmission and the probability of infection or an 
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epizootic, and that the population density within the sample streams was below the 
threshold needed for infection.  
1.6.2  Vertical transmission 
IPNV persists in clinically diseased fish as well as in asymptomatic carriers which shed 
high levels of virus via infected reproductive fluids (Wolf, 1988; Lopez-Lastra, 1994; 
Sadasiv, 1995). IPNV can replicate in hosts for long periods without causing clinical 
disease, for this reason broodstock carriage has been considered a likely source of the 
virus for the lethal infection of progeny fish (Sadasiv, 1995). The hardened eggs of 
rainbow trout and artic charr (Salvelinus alpinus) were shown by (Ahne and Negele, 1985) 
to provide a surface for IPNV to adhere to because of the lobed and porous nature of their 
surface, which is in contrast to the chorion of eggs before hardening. Thus, the surface of 
the hardened eggs may provide anchorage for the virus and protect it from flowing water.  
1.7    Entry of virus into fish 
In horizontal transmission, it is likely that the digestive tract is the prime site of infection 
but the gills may also be important because the fry and fingerlings are easily infected by 
bath or immersion (Wolf, 1988). According to Ferguson (1989) the natural route for initial 
infection in the commercial hatchery is likely to be via water and therefore at the gill 
surface, infection may also take place via ingestion of virus contaminated faeces. In 
studies concerned with entry and sequential distribution of IPNV in turbot (Scophthalmus 
maximus) Novoa et al., (1995) noticed that after an immersion challenge the virus was 
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detected in skin mucus and intestine, therefore suggesting that these could be interpreted 
as portals of entry. However, virus could not be recovered from internal organs contesting 
this theory and suggesting that the skin and mucus act as potential barriers to infection. 
Swanson and Gillespie (1982) presented the first documentation of a viremia in IPNV 
infected fish, with the virus being detected in both the serum and the mononuclear cell 
fractions of the blood. Research has been performed to study the distribution and spread of 
the IPNV within infected fish (Swanson and Gillespie, 1982). After intraperitoneal (i.p.) 
infection of rainbow trout the virus replicated quickly in the pancreas and was also 
detected in the kidney and liver. Nova et al., (1995) studied the entry and sequential 
distribution of an aquatic birnavirus in turbot, and found the evolution of the viral titre in 
fish infected by i.p. injection showed that the kidney is a preferential replication site for 
birnavirus, since the highest titres were obtained in this organ.  
1.8    Carrier status 
The term carrier applies to survivors of IPNV infection that have no disease although high 
titres of virus can be isolated from their viscera (Reno, 1999). Whilst these fish no longer 
exhibit signs of the disease, they continue to shed the virus in their faeces, urine and 
reproductive fluids (Wolf, 1988; Lopez-Lastra et al., 1994). Many fish viral pathogens 
produce a persistent carrier state in the host; however little is known about the 
mechanisms involved in viral carrier states in fish and how the viruses evade the hosts 
defences (Ellis, 2001).  
Chapter 1: Literature review 
 
11 
1.8.1    Sites of IPNV persistence within host 
It is the opinion of Johansen and Sommer (1995) that because the kidney, which is a 
haematopoietic organ in fish, is most often the organ in which tests successfully detect 
IPNV carriers, this would suggest that one or more types of leucocytes may harbour 
IPNV. Swanson and Gillespie (1982) intraperitoneally injected rainbow trout with IPNV 
and reported that the virus was transported by phagocytic cells to the kidney. Johansen and 
Sommer (1995) suggested that adherent salmon head kidney leucocytes have a major role 
in maintaining the IPNV carrier state in Atlantic salmon. IPNV was shown to persist in 
salmon head kidney macrophages for 9 days after in vitro infection without causing 
cytopathic effect (CPE); (Collet et al., 2007). There are many other reports of detection of 
IPNV from carrier fish in leucocytes (Johansen and Sommer, 1995; Cutrin et al., 2005; 
Munro et al., 2004; Garcia et al., 2006), however whilst IPNV has been reported to be 
associated with leucocytes there is doubt wether the virus actually replicates in these cells 
(Nova, Figueras, Secombes 1996; Munro et al., 2006). Yu et al., (1982) reported that 
whilst rainbow trout leucocytes harbour IPNV, they do not contribute in large measure to 
the high titres of IPNV found in haematopoietic organs, and concluded that in these organs 
and at other sites, the bulk of IPNV replication may occur in other cell types.  
1.8.2  Defective interfering particles 
The production of defective interfering (DI) particles is a common consequence of virus 
infection of animals, particularly by RNA viruses (Cann, 2001). Structural analyses of DI 
viral genomes revealed that the majority of them are deletion mutants which originate 
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from the genome of parental viruses (Lancaster et al., 1998). According to Cann (2001), 
the presence of DI particles can profoundly influence the course and the outcome of a 
virus infection, and may result in a persistent infection by a virus that normally causes 
acute infection and is rapidly cleared from the body. DI particles may play a major role in 
determining the persistence of the carrier state for IPNV (Hill, 1982). Infectious 
hematopoietic necrosis virus (IHNV), a rhabovirus that produces an acute, lethal infection 
in rainbow trout is similar to IPNV in that fish surviving infections continue to harbour 
virus at subclinical levels. Subclinical persistence of virus in the tissues of IHNV survivors 
was first confirmed by Drolet et al., (1995), in the form of truncated IHNV particles 
resembling rhabdovirus DI particles. Drolet et al., (1995) suggested that these DI particles 
act as mediators of virus persistence, therefore providing a model for the maintenance of 
IHNV in salmon and trout populations. Kim et al., (1999) conducted studies to determine 
if the truncated particles present in the tissues of survivor fish could interfere with viral 
replication. They were able to show that when explant tissue cultures were infected with 
purified IHNV, the liver tissues from survivor fish produced up to 10-fold less virus than 
control fish liver tissues. They were also able to demonstrate that only the supernatant 
media from cultured explants of survivor fish revealed truncated particles, whereas the 
control tissue supernatants contained normal virus particles. Hedrick and Fryer (1982) 
compared the persistence of IPNV in carrier brook trout and persistently infected cell lines 
and suggested that DI IPNV appeared to function in maintaining persistent infection. From 
the similarity between the interference observed in vitro and in vivo, Hedrick and Fryer 
(1982) suggested that DI virus production may also occur in carrier trout tissues. However 
it is the opinion of Kim et al., (1999) that although most viruses are thought to produce DI 
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particles in tissue culture cells and some of these DI particles have been shown to 
modulate infections in animals, much of the proposed impact of these particles in natural 
infections has been speculative.  
1.9    IPN and post-smolt mortalities 
According to Taksdal et al., (1995) a remarkable shift in the disease pattern of IPNV has 
occurred. In recent years, this disease has been associated with mortality in Atlantic 
salmon post-smolts about 8 weeks after seawater transfer (Smail et al., 1992; Jarp et al., 
1992; Labus et al., 2001; Bowden et al., 2002). Post-smolt mortality is especially 
prevalent in Norway and the Shetland Islands (Bowden et al., 2002). Post-smolt mortality 
has caused great losses in recent years in Norwegian fish farms (Jarp et al., 1995; Eggset 
et al., 1997). In 1991, post-smolt mortality was at a high of 17% compared to normal 
mortalities of 3-5% of the previous years. Smail et al., (1992) were the first to show that 
IPNV of the Sp serotype was associated with mortality of post-smolts in Scotland. There 
have also been reports of smolt losses in the Faroe Islands (Smail et al., 1992). It has been 
suggested environmental and management factors may contribute to these mortalities 
(Smail et al., 1992; Jarp et al., 1995).  
1.10    Influence of environmental stressors on the occurrence of IPN 
According to Jarp et al., (1996) it is likely that the IPNV is carried with the smolt to the 
sea site; however the causal mechanisms triggering outbreaks of IPN after seawater 
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transfer are not known. Jarp et al., (1995) demonstrated that an increased risk of IPN is 
associated with the age and location of seawater sites in Norway, with the risk of disease 
being significantly higher in new sites compared with older sites. It was suggested that 
IPNV might be transmitted to smolts, after being introduced to sea ongrowing sites, by a 
marine vector (Smail et al., 1992). However, Jarp et al., (1995) performed an 
epidemiological survey of IPN in post-smolts in Norway and demonstrated that clinical 
disease was associated with the combination of smolts, at the same seawater site from 
more than two hatcheries. Poor seawater adaptation at seawater transfer has been 
suggested to cause reduced resistance and especially increased susceptibility to IPN 
(Taksdal, 1999); however, studies by Jarp et al., (1996) showed no relationship between 
the hypo-osmoregulatory capacity of Atlantic salmon, and the risk of clinical IPN after 
seawater transfer. According to Christie (1997), clinical IPN in Atlantic salmon occurs 
only under conditions of virus exposure, accompanied by additional stress factors 
including rise in temperature and or co-infections with other viruses. Jarp et al., (1995) 
suggested that the stress that the smolts are subjected to through transportation to seawater 
sites may result in an increased susceptibility to infection, which may explain high 
mortality in the first months after seawater transfer. According to Smail et al., (1995), it is 
likely that disease is precipitated by a combination of environmental and behavioural 
factors, especially strong competition for food, acting in competition with viral infection.  
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1.11    Effect of IPNV on global aquaculture 
Disease outbreaks remain a considerable obstacle to aquaculture production and 
development (Ariel and Olesen, 2002). Viral diseases cause very significant losses in 
aquaculture (Ellis, 2001), with IPNV being considered to be one of the most important 
diseases of farmed salmonids (Sadasiv, 1995). Atlantic salmon is economically the most 
important fish species farmed in Norway (Havarstein et al., 1990). IPN causes large 
economic losses in Norwegian fish farming (Biering and Bergh, 1996). It is believed that 
more than 50% of the farmed Atlantic salmon in Norway are IPNV carriers (Havarstein et 
al., 1990). In Norway, the incidence of clinical IPN in Atlantic salmon farms was 39% in 
1991, and it had increased to 61% in 1995. The total loss from IPN in Atlantic salmon set 
to sea in Norwegian fish farms in 1995 was estimated to be 5%, giving economic losses 
about 60 million USD yearly (Christie, 1997). Smail et al., (1992) report an increased 
association of IPNV serotype Sp with cage sites and the failure of post-smolts to thrive in 
Scotland. Murray et al., (2003), used data from an official monitoring program to study 
the emergence of IPNV in Scottish fish farms from 1996 to 2001. Their results showed an 
10% annual increase of IPNV in saltwater, a 2-3% annual increase in freshwater sites with 
a much faster annual increase of 6.5% in Shetlands freshwater sites. Murray et al., (2003) 
concluded that given IPNV prevalence of approximately 10% per year, effective control 
would have to be re-established very soon before it becomes ubiquitous in most areas, as 
for example in Shetland were the high IPNV levels stood out for both freshwater and 
seawater sites.  
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1.12    Control of IPN 
1.12.1  Chemotherapy 
No truly effective chemotherapeutics are available for the treatment of IPN (Stoskopf, 
1993). Savan and Dobos (1980), used virazole to treat IPNV experimentally challenged 
rainbow trout, and found that treatment had only a slight positive effect. They suggested 
that repeated daily exposure of the fry to the virazole rather than the single exposure 
would have produced more promising results. However, Savan and Dobos (1980) stressed 
that in a hatchery situation, the cost involved in repeated exposure to virazole would be 
economically prohibitive, and as a result most hatchery owners would be reluctant to 
initiate any antiviral treatment until existence of the viral disease became apparent. Jashes 
et al., (1996) used a plaque evaluation assay to asses a group of compounds that had a 
broad spectrum antiviral activity for both single- and double- stranded RNA viruses. From 
their tests 5-ethynyl-1-β-D-ribofuranosylimidazole-4-carboxamide (EICAR) and 4-
hydroxy-3-β-D-ribofuranosylpyrazole-5-carboxamide (pyrazofurin) both achieved 
inhibition of IPNV at concentrations that were 50-100 times lower than the concentration 
required to inhibit DNA synthesis in growing cells. Moya et al., (2000) developed these 
findings to test the in vivo antiviral effect of EICAR, by experimentally infecting coho 
salmon (Onchorhynchus kisutch) and rainbow trout fry with IPNV. The results showed 
that treatment with EICAR resulted in a reduction in the viral load of infected fish; 
however, this did not prevent them from being carriers. Therefore, it was concluded that 
treatment of EICAR could be effective for increasing salmon and trout production as it 
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reduces viral load and mortality, however as the transmission of IPNV is both horizontal 
and vertical, this treatment is ineffective for broodstock.  
1.12.2  Vaccination 
Vaccines have long proven their efficacy for the control of virus diseases, but in the 
aquaculture industry, they are in a relatively early phase of development. The high cost of 
new product development combined with the relatively small size of the industry and the 
low value of individual animals have largely contributed to this situation (Heppell and 
Davis, 2000). It is the opinion of Park and Jeong (1996), that once IPNV is established, it 
is very difficult to eradicate from infected fish, and the development of a safe, efficient 
and inexpensive vaccine against IPNV infection is greatly needed. According to Biering et 
al., (2005) vaccines against infectious pancreatic necrosis (IPN) have been sold for many 
years in Norway and are now also available in Chile. Most of the research on these 
vaccines has been performed by pharmaceutical companies, and not much information is 
available as scientific publications. It has also been difficult to establish reproducible IPN 
challenge models suitable for vaccine testing and this probably explains the lack of 
scientific publications. There have also been a number of reasons offered as to why IPN 
vaccine development has proved so difficult. Wolf (1988) states that age of the fish that 
are susceptible to the disease and their lack of a developed immune system could be a 
factor in the lack of success in producing an effective vaccine against IPNV. It is the 
opinion of Noga (2000) that the large amount of serological variation among various 
strains and apparent lack of cross-protection has hindered development of a practical 
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vaccine. According to Dorson (1988), as a result of the epidemiological characteristics of 
IPN an vaccine should: 
 
i) Protect the fish early in its life, 
ii) Allow a rapid onset of protection, 
iii) Be delivered easily i.e. orally, or best via immersion before fry start first feeding, 
iv) Protect against a wide variety of antigenically different strains in view of a world wide 
use.  
1.12.2.1    Recombinant vaccines 
Nagy and Dobos (1987) produced monoclonal antibodies against IPNV and reported that 
all the neutralising monoclonal antibodies developed were VP2 specific, which led them to 
believe that VP2 contains the major neutralising epitopes of IPNV. Frost and Ness (1997) 
have described an IPN vaccine component developed from recombinant VP2 added to an 
existing multivariant injectable vaccine, against furunculosis, vibriosis and cold water 
vibriosis (Norvax protect-IPN; (NP-IPN)). Frost and Ness (1997) demonstrated that 
although the vaccine suppressed viral replication post-challenge, it did not produce any 
measurable humoral immune response. As trying to experimentally induce mortality or 
IPN pathology can be problematic (Sadasiv, 1995), due to the lack of a good challenge 
model the effect of this recombinant component can only be determined through the 
antibody response as demonstrated by Frost and Ness (1997). However, Biering (1997) 
used this same recombinant vaccine to immunize Atlantic halibut (Hippoglossus 
hippoglossus) prior to challenge with IPNV and was unable to show that it had a positive 
effect on the humoral immune system.  
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1.12.2.2    Live attenuated vaccines  
According to Christie (1997), a live attenuated vaccine would be the most effective and 
inexpensive solution for IPN control, however finding a stable non-pathogenic strain of 
the virus has proven very difficult. Dorson et al., (1978) produced a non pathogenic 
variant from a wild IPN virus strain after several passages in rainbow trout gonad (RTG)-2 
cells. This strain was used for infection of rainbow trout fry but was unable to provide any 
protection against an IPNV serotype Sp. The instability of attenuated vaccines has been 
highlighted as a potential drawback, (Wolf, 1988; Christie, 1997) with fears of live 
vaccines reverting to virulence (Dorson, 1988). These associated problems make the 
licensing of a live viral vaccines difficult (Bootland et al., 1990). 
1.12.2.3    Inactivated vaccines  
Dixon and Hill (1983) demonstrated that formalin and ß-propiolactone (BPL) could be 
used to inactivate IPNV for vaccine use. Injection is not considered to be a convenient 
method of administration in aquaculture, when large numbers of vaccine doses are 
required and when fish that require vaccination are small and thus difficult to handle. 
Bootland et al., (1995) conducted an experiment to see if the immunization of adult fish 
with an inactivated IPNV vaccine would prevent the development of a carrier state, 
therefore resulting in IPNV free progeny. Bootland et al., (1995) immunized adult brook 
trout broodstock 5 months prior to sexual maturity with an injection of inactivated IPNV 
in Freund’s complete adjuvant. However, the inactivated IPNV vaccine failed to prevent 
the fish from becoming IPNV carriers and IPNV was detected in the faeces, blood 
components, organs and reproductive products of the immunized male and female fish. It 
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was therefore concluded that this vaccine preparation was unlikely to prevent vertical 
transmission. 
1.12.2.4    DNA vaccines  
Antiviral DNA vaccines carrying a gene for a major antigenic viral protein have received 
considerable attention as a new approach to vaccine development, especially when 
traditional vaccines have failed (Kim et al., 2000). DNA vaccines compared to traditional 
antigen vaccines have several practical and immunological advantages that make them 
very attractive for the aquaculture industry (Heppell and Davis, 2000). Kim et al., (2000) 
report that for fish viruses, DNA vaccines have been developed for IHNV and viral 
hemorrhagic septicaemia virus (VHSV), with laboratory trials indicating that these 
vaccines are more effective in protecting fish in challenge experiments than inactivated 
and subunit vaccines. Mikalsen et al., (2004) reported that a DNA vaccine containing the 
whole large open reading frame (ORF) of segment A of the IPN virus provided a high 
level of protect in Atlantic salmon against a subsequent challenge of IPN.  
1.12.3  Immunostimulants  
Bricknell and Dalmo (2005) have stated that the theoretical benefit of immunostimulants 
is considerable, particularly given the current progress towards developing an efficacious 
IPNV vaccine. Immunostimulants have the potential to elevate the innate immune defence 
mechanisms of fish prior to the exposure to a pathogen, or improve survival following 
exposure to a specific pathogen. Sakai (1999) reviewed the use of fish immunostimulants; 
however, none of them have any documented effects towards IPN. Most of the studies that 
have been reported in literature have focused on the protection against bacterial pathogens 
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and/or non specific immune parameters such as phagocytic, complement or lysozyme 
activities, whilst studies on increased protection against viral infection are scarce. As a 
result, little is known about the antiviral effects of immunostimulants in fish (Salinas et al., 
2004). However, the findings of Damsgard et al., (1998) may provide an obstacle to the 
delivery of immunostimulants through therapeutic diets to treat IPN.  They reported that 
feed intake and growth were significantly lower in IPNV infected fish than uninfected 
fish, with some infected fish displaying a complete loss in appetite. 
1.13    Husbandry 
It is widely accepted that if IPNV has never been detected on a farm, every precaution 
should taken to prevent its introduction, including only stocking with inspected and 
certified IPNV free stocks (Blake et al., 1995; Sadasiv, 1995). According to Alonso et al., 
(1999), until vaccine technology improves, the only effective way to control virus 
infections in aquaculture is to prevent exposure to the virus. One example of this can be 
seen in Denmark, where IPN is considered to be endemic like most of Europe, except for a 
number of approved IPN-free rainbow trout broodstock farms. Most of these farms have 
been maintained as closed units since 1969 and have thus been able to uphold an IPN free 
status and have supplied IPN free material to the international market for decades (Ariel 
and Olesen, 2002). However according to Reno (1999), this type of vigilance is difficult to 
achieve, for economic or technical reasons. In practice, particularly in commercial 
operations where IPN cannot be avoided, economic loss is minimized by anticipating the 
extent of mortality and incubating proportionately more eggs (Wolf, 1988). It is the 
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opinion of Stoskopf (1993), that the incidence of acute IPN and consequent mortality can 
be reduced if factors that promote physiological stress are controlled. These included 
reducing population density, following optimal feeding protocols and maintaining proper 
hatchery hygiene.            
1.14    Genetic resistance 
Systematic breeding for increased innate resistance constitutes a potential strategy for 
control of infectious diseases in all segments of animal and plant production. According to 
Midtlyng et al., (2002), because of the high reproduction rate and the opportunity to score 
families by use of challenge tests, fish have a much higher potential for improving 
resistance to infectious diseases through selective breeding than most other food producing 
animals. Some salmonid species are recognized as IPN resistant, e.g. coho salmon 
(Dorson, 1988). 
1.15    Current techniques for the detection and identification of aquatic 
IPNV 
Diagnostic procedures are important for IPN control. It is important that infectious agents 
are rapidly identified and differentiated, because rapid detection of an outbreak may help 
to prevent further spread of the disease (Espinoza and Kusnar, 2002). The diagnosis of 
IPN has historically been predicted on clinical signs of the disease, isolation and 
identification of the aetiological agent by cell culture methods and confirmation using 
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serological methods (Reno, 1999). However, according to (Ahne et al., 1989) clinical 
signs and histopathological changes associated with IPN are variable and cannot be used 
for presumptive or definitive diagnosis or to distinguish IPN from other fish viral diseases. 
In most cases, classification of these viruses as strains of IPNV are made on the basis of 
neutralization with antisera against reference strains of IPNV (Hill and Way, 1995). 
Immunofluorescence adsorption test (IFAT) is also used after conventional virus isolation 
on cell cultures, this method although time consuming, works very well in acute cases, but 
it is difficult to detect virus in subclinically or latently infected fish Barlic-Maganja et al., 
(2002). According to Alonso et al., (1999), because of the occurrence of co-infections of 
IPNV with, for example IHNV, more sensitive detection methods for each virus are 
needed to avoid false negative results, as the growth of one virus may be inhibited by the 
other, and standard diagnostic assays might not reveal the second virus. Therefore, it is 
widely agreed that there is a need for a sensitive, rapid diagnostic technique (Lopez-Lastra 
et al., 1994; Hill and Way, 1995; Alonso et al., 1999; Taksdal et al., 2001; Espinoza and 
Kuznar, 2002). IPNV may be detected with molecular methods such as reverse- 
transcription PCR (RT-PCR). At present, the major disadvantage of molecular methods of 
virus detection is the cost, but the efficiency and rapidity compared with virus isolation 
and differentiation by cell culture methods, where 14-20 days are required for a negative 
diagnosis, offer a considerable advantage and offset the higher costs of molecular tests 
(Barlic-Maganja et al., 2002). Blake et al., (1995) developed a RT-PCR assay which was 
found to be capable of routinely detecting aquatic birnaviruses directly in fish tissue 
samples at a level of accuracy and sensitivity comparable to those of virus isolation in cell 
culture. Taksdal et al., (2001), used RT-PCR to test Atlantic salmon for the presence of 
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IPNV in survivors of a viral bath challenge. Their results showed that RT-PCR detected a 
higher number of IPNV positive samples than standardised cell culture method detection. 
This was a significant finding as it was one of the first reported methods that was more 
sensitive than virus culture for the detection of IPNV. It is believed that methods that can 
detect IPNV in covertly infected fish may be beneficial in the surveillance and prevention 
of spread of the infection (Taksdal et al., 2001). According to Barlic-Maganja et al., 
(2002) when RT-PCR positive results are obtained additional confirmation by culture 
based diagnostic methods is necessary and the latter will remain as the gold standard 
method for virus detection meantime. Therefore, it could be argued that molecular tests are 
inappropriate for final diagnosis of IPNV but are useful in conjunction with routine 
diagnostic procedures of virus isolation, especially when quick detection of viral agents 
could identify an outbreak and help to prevent further spread of disease. Therefore, 
according Einer-Jensen et al., (2002) cell culture assays are still considered to be the 
“Gold Standard”. 
1.16    Host defence mechanisms against IPNV 
There is a belief that an increased knowledge about antiviral defence mechanisms of fish 
may contribute to the understanding of the development of virus diseases in aquaculture 
(Nygaard et al., 2000), and more specifically help to explain the susceptibility of Atlantic 
salmon to IPNV (Jensen and Robertsen, 2002). 
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1.16.1  Innate immunity  
1.16.1.1     Cellular  
According to Rønnesth et al., (2006) the non-specific cellular immune activities are 
central in combating virus infections in fish. Cells with very similar properties to 
mammalian natural killer (NK) cells have been observed in fish (Ferguson, 1989). These 
natural cytotoxic cells (NCC) have cytotoxic effects on many tissue culture cells, 
especially when the latter are infected with IPN virus (Moody et al., 1985). According to 
(Ferguson, 1989) NCCs which are present in the blood, lymphoid tissues and mucosal 
sites, spontaneously kill cells via an apoptotic and necrotic mechanism. A variety of 
leucocyte types are involved in non-specific cellular defences of fish, and include 
monocytes/macrophages, granulocytes and non-specific cytotoxic cells (Moody et al., 
1985). Macrophages play a significant role in non-specific resistance to virus infection, 
due in part to the non-permissiveness of these cells for the replication of many viruses  
(Nova et al., 1996). Another important phagocytic leucocyte is the neutrophilic 
granulocyte. In teleosts, three types of granulocytes, namely neutrophils, eosinophils and 
basophils, have been identified (Rønnesth et al., 2006). Atlantic salmon parr and post 
smolts were challenged with IPNV and Rønnesth et al., (2006) reported that there was a 
reduced level of neutrophils in the head kidney of infected parr and post-smolts than 
observed in non-infected fish. From their results, they suggested that neutrophils may take 
part in virus clearance or are affected by IPNV weeks post challenge. These results 
complemented other studies that report that IPNV effects the levels of neutrophils in IPNV 
infected Atlantic salmon (Pettersen et al., 2003; Pettersen et al., 2005). The cellular 
components of the non-specific immune system include phagocytic cells (neutrophils and 
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macrophages) and natural killer cells which interact with lymphocytes and other cells of 
the immune system through cytokines. Cytokines are polypeptides or glycoproteins which 
act as modulators in the immune system (Sakai, 1999). The production of T cell-derived 
cytokines able to influence phagocyte functions is a key aspect of cell-mediated responses 
(Mulero and Meseguer, 1998). In mammals, a diverse array of cytokines secreted by 
leucocytes is able to affect phagocyte activities (Mulero and Meseguer, 1998). There is 
evidence that fish, like mammals, have a network of signalling cytokines that control and 
coordinate the innate and acquired immune response (Magnadóttir, 2006). The cytokines 
that have been identified in fish are reviewed by Manning and Nakanashi (1996), which 
include Interleukin 1 (IL-1), Interleukin 2 (IL-2), Interleukin 3 (IL-3), Interleukin 4 (IL-4), 
Interleukin 6 (IL-6), Interferons (IFNs) and Macrophage activating factors (MAFs), 
Tumour Necrosis Factor (TNF), Transforming Growth Factor ß1 (TGF ß1), Chemotactic 
Factor (GF) and Macrophage Migration Inhibition Factor (MIF). IFNs are the most 
extensively studied cytokines regarding IPN, and their relevance will be discussed in the 
next section.  
1.16.1.2    Humoral         
The serum, mucus, and eggs of fish contain a variety of substances that non-specifically 
inhibit the growth of infectious microorganisms. They are specific in that they react with 
just one chemical group or configuration, but they have been called “non-specific” 
because they do not influence the growth of only one microorganism (Ahne and Negele, 
1985). Another component of resistance to IPN is interferon, a broad ranging protective 
molecule generated by lymphocytes and other cells (Reno, 1999). Cells infected with a 
virus are stimulated to produce and secrete IFN, which in turn induces a complex pattern 
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of physiological changes, including the establishment of an antiviral state in as yet 
uninfected cells (Collet and Secombes, 2001).  It is now appreciated that IFNs consist of 
two families, the type I or IFN-α/ß family that consists of many, structurally related 
members, and type II or IFN-γ, consisting of a single, unrelated protein (Levy et al., 
2001). Type I IFNs induce the production of antiviral proteins in various body cells 
whereas Type II IFNs, in addition to this, activates macrophages for enhanced killing of 
bacterial, fungal and viral pathogens (Robertsen, 1999). Viruses induce interferon gene 
expression and then the up-regulation of various downstream interferon responsive genes 
(Boudinot et al., 2006; Bergan et al., 2006). Some of these genes such as 2-5 A synthetase, 
RNA-dependant protein kinase, RNase I, and MxA, have antiviral activity (Boudinot et 
al., 2006). It has been known for some time that interferon synthesis can be triggered in 
fish, either in vivo or in cell culture, following infection by pathogenic viruses (Hill, 
1982). The limited number of functional studies that have been performed with the cloned 
fish IFNs show that they have the characteristic properties of type I IFNs (Robertsen 
2005). Type I IFNs have been cloned from zebra fish (Brachydanio rerio); (Altmann et al., 
2003), Atlantic salmon (Robertsen et al., 2003), channel catfish (Ictalarus punctatus); 
(Long et al., 2004), whilst Mx genes have been detected and cloned in rainbow trout 
(Trobridge et al., 1997), Atlantic salmon (Robertsen et al., 2003) and Japanese flounder 
(Paralichthys olivaceus); (Lee et al., 2000). Mx is one of several IFN-inducible proteins 
that have been shown to inhibit the replication of different types of viral infection. Mx 
proteins are members of a family of IFN-inducible genes expressed when cells undergo 
virus infection (Leong et al., 1998). The study of Mx-genes in cultured fish species is of 
importance not only as components of antiviral defense, but also as molecular markers for 
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type I IFN induction (Robersten et al., 1997). There is controversy as to whether IPNV 
induces IFN responses in fish cells (Collet et al., 2007) which has led to suggestions of a 
complex virus/host interation (Lockhart et al., 2006).  
1.16.2  Adaptive immunity 
1.16.2.1    Cellular           
Cell-mediated killing is an important defence mechanism in the control of virus-infected 
cells (Nakanisihi et al., 2002; Somamoto et al., 2000). Virus-specific cell mediated 
cytotoxicity was demonstrated in fish for the first time by Somamoto et al., (2000) using 
clonal guibuna crucian carp (Carassius auratus langsdorfiiand) a syngenic cell line (CFS). 
Peripheral blood leucocytes, from crucian carp immunized with IPNV infected CFS cells 
lysed IPNV infected CFS cells (immunogen) more completely than CFS cells infected 
with different virus (non-immunogen). These results suggest that fish exhibit specific 
cytotoxicity against virus-infected cells, resembling the specific cytotoxicites of higher 
vertebrates. This appears to be the only study in the literature on specific cell-mediated 
immune responses to IPN in fish.  
1.16.2.2    Humoral  
According to Frost et al., (1998) the importance of antibodies in a protective immune 
response against IPNV is unknown.  Bootland et al., (1991) reported that a strong antibody 
response was produced in 1 year old brook trout injected with IPNV, however this 
response failed to prevent a chronic infection which subsequently led to a carrier state 
within the survivors of the infection. Similarly Bootland et al., (1995) attempted to 
immunize adult brook trout with inactivated IPNV, which induced a strong humoral 
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immune response with IPNV-neutralising antibodies. However, this failed to prevent the 
fish from becoming infected following challenge with IPNV. Biering (1997) performed an 
experiment in which Atlantic halibut were bath challenged with IPNV which subsequently 
led to a strong humoral immune response in the form of IPNV-specific serum antibodies. 
Whilst no mortality occurred as a result of virus exposure, no connection was observed 
between the high humoral immune response and virus elimination.  Whilst the importance 
of IPNV-specific antibodies is unknown literature clearly indicates that they are a specific 
immune response.  
1.17    Summary and Aims  
IPN is the most serious viral disease affecting the UK salmon farming industry. 
Advancing current knowledge of the salmonid immune response to IPNV may highlight 
potential control measures against this major pathogen.  The macrophage is an important 
component of the innate immune response. Although macrophages are recognised as a 
potential site of viral replication and persistence in IPNV-infected salmon, the virus-host 
relationship in this cell type is not well characterised. The salmonid IFN response to IPNV 
has been studied in cell lines such as RTG and chinhook salmon embryo (CHSE-214), 
however there is a distinct lack of knowledge of the interferon response to IPNV in salmon 
macrophages. Therefore, the overarching goal of this thesis is to characterise aspects of the 
antiviral response to IPNV in Atlantic salmon macrophages, and to investigate whether the 
antiviral mechanisms in these cells can be manipulated with immunostimulants so as to 
mitigate IPNV infection and thus potentially limit development of a carrier state.  
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This thesis comprises the following seven objectives: 
 
• Development of methods for the isolation and in vitro culture of Atlantic salmon 
macrophages. 
• Development of a procedure for the extraction of RNA from Atlantic salmon 
macrophages maintained in vitro. 
• Establishment of real-time RT-PCR procedures for the quantitation of immune 
response gene expression in IPNV-infected Atlantic salmon macrophages and 
uninfected controls. This involves the development of assays to detect IFN and 
Mx, and also Elongation factor 1 (ELF-1). The latter is used as a “housekeeping” 
control gene in quantitative real-time RT-PCR. 
• Establishment of a real-time RT-PCR procedure for the quantitation of IPNV in 
IPNV-infected Atlantic salmon macrophages and uninfected controls.  
• To determine whether Atlantic salmon macrophages cultures maintained in vitro 
can be infected with IPNV. 
• To characterise the effect of IPNV infection on expression of immune related 
genes in Atlantic salmon macrophages. 
• To investigate whether the expression of immune related genes in IPNV-infected 
Atlantic salmon macrophages can be manipulated with immunostimulants. The 
following immunostimulants will be studied: Glucan, MAF, and LPS.  
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Chapter 2 -  General Materials and Methods 
2.1     Virology 
2.1.1  Cell culture  
A Shetland isolate of IPNV (IPNV 975/99); (Bowden et al, 2002) obtained from FRS 
Marine Laboratory, Aberdeen was grown in CHSE-214 cells. Cells were maintained in 
Eagles minimum essential medium (EMEM); (Gibco), without L-Glutamine, 
supplemented with 10% foetal calf serum (FCS); (Gibco), 2mM L-Glutamine (Gibco) 
and 1x non-essential amino acids (NEAA); (Sigma). The cells were cultured in closed 25 
cm2 plastic flasks (Nunc, Roskilde, Denmark) at 22˚C.  
 
2.1.2  Virus culture  
CHSE-214 cells were infected with IPNV by simultaneous inoculation. A 25cm2 culture 
flask of fully confluent CHSE-214 cells was split to a ratio of 1:3 and IPNV was 
inoculated at 1/10th of the volume of the suspended cells. The cells and virus were 
incubated at 15°C. The cells were examined on a daily basis for the development of 
cytopathic effects (CPE), in comparison to uninfected control cells which were inoculated 
with Hanks’ Balanced Salt Solution (HBSS) (Gibco). On observation of extensive CPE 
the supernatant was centrifuged at 1410 x g for 10 minutes at 5˚C (Eppendorf 5804R). 
The pellet was discarded and the virus-containing supernatant was aliquoted and stored at 
-70˚C.  
Chapter 2: General Materials and Methods 
 
32 
2.1.3   Estimation of virus titre 
The titre of IPNV preparations was performed by infectivity titration in CHSE-214 cells 
grown in 96 well plates (Nunc, Roskilde, Denmark). 90µl of EMEM supplemented with 
10% FCS was added to each plate well together with 10µl of the IPNV preparation, 
which was then diluted in ten-fold dilutions across the plate. For each 96 well plate a 
fully confluent 25cm2 flask of CHSE-214 cells was harvested, and 100µl of CHSE-214 
cells was added to each plate well. For a negative control, each plate contained two rows 
of CHSE-214 cells and EMEM. The plates were incubated for 7 days at 15ºC and 
inspected daily for the development of CPE. The titre of the virus expressed as TCID50 
was calculated using the Spearman-Karber method (Hierholzer and Killington, 1996) as 
described below.  
 
Log10 Median Dose = (X0 -(d/2) + d(∑ ri/ni) 
 
X0   = log10 of the reciprocal of the lowest dilution at which all test inocula are positive. 
D = log10 of the dilution factor (i.e. the difference between the log dilution intervals) 
ni = number of test inocula used at each individual dilution (after discounting accidental losses) 
ri = number of positive test inocula (out of ni). 
∑(ri/ni) = ∑(P) = sum of the proportion of positive tests beginning at the lowest dilution showing 
100% positive result.                                                                                                       
 
Summation is started at dilution X0  
Chapter 2: General Materials and Methods 
 
33 
2.2     Isolation and culture of macrophages 
2.2.1   Fish 
All the experiments conducted in this thesis used head kidneys derived from Atlantic 
salmon, (Salmo salar L.) of average weight 500g originating from the Marine 
Environmental Research Laboratory at Machrihanish.  
 
2.2.2  Sampling 
Prior to sampling the fish were killed by a lethal exposure to ethyl p-amino-benzoate (0.8 
g/L) and ex-sanguinated by withdrawing blood from the caudal vein. The surface of the 
fish was sprayed with 70% ethanol (BDH) prior to dissection and the head kidney was 
aseptically removed and placed in 9ml of chilled Leibovitz medium (L-15); (Sigma) 
supplemented with 10% FCS, 50 U ml-1 penicillin (Gibco), 50 µg ml-1 streptomycin 
(Gibco), 2% polymyxin B sulphate (Sigma) (10 000 U ml-1) and 2% gentamycin (Gibco) 
(50 mg ml-1). The head kidneys was passed through a 100µm mesh with L-15 medium 
supplemented with 2% FCS, 1% penicillin/streptomycin (P/S) (Gibco) and 20 U ml-1 
heparin (Sigma). All kidneys were processed within 24 hours of sampling.  
 
2.2.3  Isolation of macrophages on 34-51% discontinous gradient  
The head kidney cell suspension was split into three and was subsequently layered gently 
onto three 34-51% percoll (Sigma) gradients. The gradients were centrifuged at 540 x g 
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for 35 minutes at 4°C with no brake. The band of cells at the percoll interface was 
carefully collected so as not to disturb the 51% layer and washed with L-15 containing 
0.1% FCS, 1% P/S and 20 U ml-1 heparin. The cells were centrifuged at 540 x g for 35 
minutes at 4°C with no brake to wash off any percoll. After centrifugation the supernatant 
was removed and the pellet was resuspended in 1ml of L-15 medium.  
 
2.2.4  Isolation of macrophages on 51% percoll  
The head kidney cell suspension was split into three and was subsequently layered onto 
51% percoll. The tubes were centrifuged at 540 x g for 35 minutes at 4°C with no brake. 
The band of cells at the medium-51% percoll interface was carefully collected so as not 
to disturb the 51% layer (as shown in Figure 1) and diluted in 10ml of L-15 medium. The 
cells were centrifuged at 540 x g for 35 minutes at 4°C with no brake to wash off any 
percoll. After centrifugation the supernatant was removed and the pellet was resuspended 
in 1ml of L-15 medium. The cells were counted using a haemocytometer and their 
viability was assessed by trypan blue exclusion. Cells were suspended to a concentration 
of 2 x 10-7 ml-1 in L-15 plus 0.1 % FCS. 
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Figure 1: Isolation of macrophages on a 51% percoll gradient gave rise to 3 main layers. Layer 
1; L-15 medium containing cell debris (a). Layer two; the L-15 medium-51% percoll interface 
containing macrophages (b). Layer three; 51% percoll with pelleted red blood cells (c).  
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2.2.5  Culture of macrophages  
Aliquots of the cell suspension were added to culture plates, 100µl to each well of a 96-
well culture plate whilst 400µl were added to each well of a 24-well culture plate, and the 
cells were left to attach at 15°C. After three hours the wells were washed three times with 
L-15 medium to remove any non-adherent cells. The adherent macrophage monolayers 
were maintained in L-15 medium supplemented with 50 units ml-1 penicillin, 50µg ml-1 
streptomycin and 5% FCS at 15 °C. Over the course of the experiment, the medium was 
replaced every two days. 
 
2.2.6  Estimation of macrophage cell numbers in vitro  
Each day the number of viable macrophages was estimated. Following the removal of the 
culture medium from the well, lysis buffer (0.1 M citric acid, 1% Tween-20, 0.05% 
crystal violet). After 2 minutes the bean shaped nuclei were counted in a haemocytometer  
under an inverted microscope at 100x magnification.   
 
2.2.7   IPNV infection of macrophages in vitro  
Cell counts were performed in representitative wells to assess the numbers of viable 
macrophages 24 hours after initial washing of the macrophage monolayers to remove 
non-adherent cells. In the experimental wells the culture medium was removed and IPNV 
containing supernatant (section 2.1.2) diluted in L-15 medium was added at a multiplicity 
of infection (MOI) of 1 for 12 hours at 15°C. The virus titre of the IPNV containing 
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supernatant was 1.15 × 108 TCID50 ml−1. Control wells were inoculated in the same way 
with L-15 culture medium.  
 
2.2.8  Extracellular IPNV titre  
To determine if any IPNV had been released from the IPNV in vitro infected 
macrophages, 10µl of culture medium was removed from the macrophage culture wells 
on a daily basis and inoculated onto 24 well plates containing CHSE-214 cells. Had CPE 
been detected in these cultures over a 21 day period, 10ul of this culture medium would 
have been serially ten fold diluted and inoculated into 96 well plates containing CHSE-
214 cells. These plates would then incubated for 7 days at 15ºC and inspected daily for 
the development of CPE. The titre of the virus would then calculated using the 
Spearman-Karber method (Hierholzer and Killington, 1996) as described in section 2.1.3.  
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Chapter 3 - Development of a protocol for the in vitro culture of 
Atlantic salmon macrophages  
3.1    Introduction  
The macrophage is believed to be a key component in the salmon immune response to 
IPNV, and a possible site for persistent virus infection in this host (Johansen and 
Sommer, 1995). Consequently, in vitro cultures of salmon macrophages represent a 
useful model to study aspects of the relationship between IPNV and its host. This model 
system would also permit experimental investigation of the effects of immunostimulants 
on the immune response of the macrophage to IPNV. The objectives of this chapter are to 
investigate the effect of isolation method and culture conditions on macrophage 
preparations used for in vitro culture. 
3.2    Materials and Methods 
3.2.1  Isolation of macrophages on 34 - 51% discontinuous percoll gradient or 51% 
percoll.  
Head kidneys were obtained from the fish as outlined in section 2.2.2. Macrophages were 
isolated using either 34 – 51% percoll gradients (section 2.2.3) or using 51% percoll 
(section 2.2.4). The cells were seeded into either 96 or 24 well plates at concentrations of 
2 x 10-7 ml-1 and maintained in culture for 9 days post isolation at 15°C as described in 
section 2.2.5. 
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3.2.2  Statistical analysis of the cells produced by the 34-51% percoll gradient and 
those on 51% percoll 
Cell counts were performed regarding the number of cells produced from 6 different 34-
51% and 51% percoll isolation preparations, using a haemocytometer and their viability 
was assessed by trypan blue exclusion. Triplicate counts were recorded for each 
preparation. Comparisons between the numbers of cells produced by the two isolation 
methods were analysed by a Mann and Whitney test, using the Minitab software package. 
Differences were considered statistically significant when probability (P) values < 0.05 
were obtained.  
 
3.2.3  Staining of adherent cells obtained from 34-51% and 51% percoll gradients 
Microscope slides were cleaned in 100% ethanol. Two circles were drawn on each slide 
using a PAP pen (AGAR scientific). 100µl of cell suspension from the 34-51% and 51% 
percoll gradients were placed in each circle. The cells were left to attach for three hours 
at 15ºC. The non adherent cells were removed by washing the slides the slides three times 
with L-15 medium and gently tapped dry. The slides were dipped in 70% ethanol to fix 
the cells and then stained with a Quick stain kit (Raymond Lamb Ltd) following the 
manufacturer’s instructions. The cells were then mounted using pertex and viewed under 
oil immersion at x 100 magnification.  
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3.2.4  In vitro virus infection in isolated macrophages 
Macrophages maintained in 96 and 24 well plates were infected, in triplicate, with IPNV 
at a multiplicity of infection (MOI) of 1 (section 2.2.7) and incubated overnight at 15°C. 
The next day, the cells were washed three times with L-15 medium and then maintained 
in culture for nine days at 15°C as described in section 2.2.5. Control wells of 
macrophages were inoculated in the same way with L-15 culture medium.  
 
3.2.5  Extraction of RNA from in vitro macrophage monolayer 
Each day over a 9-day period, the supernatants were removed and total RNA was isolated 
from the macrophage monolayer using TRIzol reagent (Gibco) following the 
manufacturer’s protocol. Triplicate wells were sampled for each time point. The resulting 
RNA was resuspended in 10µl of RNase/DNase free water, left to sit on ice for 2 hours to 
allow satisfactory resuspension of the pellet and the concentration was estimated from 
optical density (OD) measurements performed on a NanoDrop spectrophotometer 
(NanoDrop Technologies). In addition, total RNA was isolated from the macrophage 
monolayers in 24 well plates using a modified version of the TRIzol procedure 
incorporating the use of a commercial co-precipiatant, Glycoblue (Ambion) and also an 
overnight precipitation step at -20ºC. The modified procedure is as follows. Each day 
over a nine day period the supernatants were discarded and the macrophages were lysed 
by adding 800µl of TRIzol reagent to each well for 5 minutes at 15-30ºC and the 
resulting cell lysate was passed through a pipette several times and passed into a sterile 
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diethylpyrocarbonate (DEPC)-treated 1.5ml tube. To each tube, 160µl of ice cold 
chloroform was added and the tubes were shaken vigorously by hand for 15 seconds. The 
tubes were incubated at 15-30ºC for 2-3 minutes before centrifugation at 12,000 x g for 
15 minutes at 4ºC. The clear aqueous phase was transferred to a new sterile DEPC-treated 
1.5ml tube, to which a co-precipitant, GlycoBlue (Ambion) was added at a concentration 
of 150µg/ml prior to the addition of 400µl ice cold isopropyl alcohol. The tubes were 
gently inverted 7 times and the samples were allowed to precipitate overnight at -20ºC. 
The following day samples were centrifuged at 12,000 x g for 15 minutes at 4ºC to pellet 
the RNA. The supernatant was discarded and the pellet was washed with 200µl ice cold 
70% ethanol and centrifuged at 7,500 x g for 10 minutes at 4ºC. The supernatant was 
removed and the pellet was allowed to dry. Once dried the pellet was resuspended in 10µl 
RNase/DNase free water and left on ice for 2 hours to ensure adequate resolubilization 
before the concentration of extracted RNA was assessed. The concentration was 
estimated from Optical density measurements performed on a Nanodrop 
spectrophotometer.  
 
3.2.6  Viability of in vitro macrophage cultures 
Prior to harvesting, the number of viable adherent macrophages in representitative wells 
was determined as outlined in section 2.2.6.  
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3.3    Results  
3.3.1  In vitro culture of macrophages and extraction of RNA from cells grown in a 
96 well plate 
Macrophages were not able to survive past 4 days post infection as reflected by the cell 
counts in Table 1. It was found that the macrophage monolayer was either significantly or 
almost totally destroyed after day 3 of culture, as reflected in the steep fall in cell 
numbers (Figure 2). This coincided with the 3rd wash, as the cells were first washed after 
the initial incubation, washed again after being inoculated with virus, and then again after 
a second day in the culture medium as recommended by Secombes (1990). The pattern of 
damage to the monolayer was evidently linked to the washing of the cells as when the 
wells were viewed under the microscope after each wash the macrophage monolayer was 
greatly reduced compared to before washing. There was also a distinctive pattern in 
which the macrophages detached and this corresponded to where the washing medium 
impacted on the culture surface of the wells. To perform the experiments proposed for 
this thesis the monolayer would be required to withstand many washes to accommodate 
the various treatments required to perform this project. Together with the maintenance 
wash required every 48 hours, this would lead to considerable physical stress being 
imposed upon the macrophage monolayer during the duration of experiments. After many 
attempts to maintain an adequate macrophage culture in a 96 well plate it was decided 
that an alternative culture vessel would need to be used. It was also found that sufficient 
quantities of RNA for RT-PCR analyses could not be obtained from damaged 
macrophage cultures. Throughout the nine days, it was not possible to detect the presence 
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of any RNA after conducting extraction from the culture wells. As a result no RT-PCR 
amplification from this procedure was performed.  
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Figure 2: Number of viable adherent head kidney macrophages maintained in vitro over time in a 
96 well plate. Cells were derived from Atlantic salmon head kidney and isolated on 34-51% 
percoll gradients. The cells were seeded in wells at a concentration of 2 x 10-7 ml-1, then washed 
after 3 hours to remove non-adherent cells. Cultures were incubated overnight at 15°C, before 
being infected with IPNV at an MOI of 1, 24 hours after initial seeding. Negative control 
macrophages were inoculated with L-15 medium. Counts of viable macrophages were taken for 9 
days after virus inoculation. Data represent mean counts (N=3) ± SD.  
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Table 1: Data collected from cell counts of viable adherent head kidney macrophages maintained 
in vitro over time in a 96 well plate after IPNV inoculation. Data represent mean counts (N=3) ± 
SD.  
 
 Neg  IPNV  
Day Mean Stnd dev Mean Stnd dev 
1 136666.7 11547.01 136666.7 5773.503 
2 18000 1000 21000 1000 
3 103.3333 90.73772 86.66667 75.71878 
4 0 0 0 0 
5 0 0 0 0 
6 0 0 0 0 
7 0 0 0 0 
8 0 0 0 0 
9 0 0 0 0 
 
3.3.2  Comparison of cells isolated from 34-51% percoll gradient and 51% percoll 
In light of the problems encountered with maintaining macrophages in 96 well plates it 
was proposed that it might be necessary to culture the cells in larger wells. The use of 
larger volume culture wells might not only reduce the damage caused by washing, but 
would also yield more cells due to their larger surface area. This would facilitate the 
recovery of larger amounts of RNA from cultured macrophages. To support this larger 
culture well format more macrophages would therefore be necessary. As 34-51% percoll 
gradients are very labour demanding it was proposed that simply isolating macrophages 
on 51% percoll may be a better suited technique to meet the increased demand for cells. 
However, before this move could be made a comparison was made between the cells 
isolated from 34-51% percoll gradients and those from 51% percoll. On visual 
examination of the cells stained on the slides, it was confirmed that macrophages were 
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present after the three hour wash in both cell suspension preparations obtained using 34-
51% percoll gradients (Figure 4) and 51% percoll (Figure 5). Further verification was 
provided through statistical analysis, performed on the cell counts immediately after 
isolation (section 3.2.2), which showed that there was no significant difference between 
the number of macrophages present in the cell suspension produced by the two methods 
(P = 0.4290). Therefore, it was concluded that the 51% percoll isolation method was a 
suitable replacement for the 34-51% percoll gradient isolation method.   
 
 
34/51 Percoll  gradient  N =  18     Median =      5.9000 
51 Percoll               N =  18     Median =      5.9000 
Point estimate for ETA1-ETA2 is      0.0000 
95.2 Percent CI for ETA1-ETA2 is (-0.0000,0.1000) 
W = 358.5 
Test of ETA1 = ETA2  vs  ETA1 not = ETA2 is significant at 0.4290 
The test is significant at 0.4037 (adjusted for ties) 
 
Cannot reject at alpha = 0.05  
 
Figure 3: Mann and Whitney Statistical test preformed on macrophage counts obtained from cell 
suspensions derived from Atlantic salmon head kidneys. Comparisons were made concerning the 
numbers of macrophages obtained from 34-51% percoll gradients and those on 51% percoll 
(N=18). Differences were considered statistically significant when P <0.05.  
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Figure 4: Adherent cell populations obtained following isolation on 34-51% percoll gradients. 
Aliquots of cell suspension at the 34-51% percoll interface were allowed to adhere to glass slides 
for 3 hours.  Unattached cells were removed by washing and the remaining adhered cells were 
stained. Cells were identified as being either macrophages (M) or Lymphocytes (L). Photographs 
were taken using an Olympus BX51 inverted microscope under oil immersion at x 100 
magnification.   
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Figure 5: Adherent cell populations obtained following isolation on 51% percoll. Aliquots of cell 
suspension at the 51%-medium interface were allowed to adhere to glass slides for 3 hours.  
Unattached cells were removed by washing and the remaining adhered cells were stained.  Cells 
were identified as being either macrophages (M), or Lymphocytes (L). Photographs were taken 
using an Olympus BX51 inverted microscope under oil immersion at x 100 magnification.   
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3.3.3  In vitro culture of macrophages and extraction of RNA from cell monolayers 
grown in 24 well plates 
Through the use of 24 well culture plates it was possible to maintain macrophages in 
culture for nine days (Figure 6). The larger wells could be washed without total 
destruction of the macrophage monolayer as for the first time it was possible to obtain 
cell counts for each day of the experiment Table 2. The 24 well plate format meant that a 
multi-channel pipette could not be used for washing and it was necessary to use a 1ml 
pipette for this purpose. Despite the fact that this increased the time required to wash the 
plates, in essence, each well could be washed individually, and thus more care and 
attention could be allocated to each individual well. The effect of the washing was 
confined to a small area around the outer side of the well, thus leaving a monolayer of 
attached macrophages on the remainder of the culture surface of the well. RNA was 
extracted from the macrophages on a daily basis using TRIzol following the 
manufacturer’s protocol. However, the extractions failed to reliably provide sufficient 
RNA to permit analysis of gene expression by real time RT-PCR (Figure 7). Previously, 
the 96 well plates was a major contributing factor to inability to obtain RNA yields. 
However, with using a culture system such as the 24 well plate which is able to maintain 
cells over the required experimental period, contributory factors could also include the 
loss of RNA during the extraction method, arising from a small amount of starting 
material. In this case, it is easy to lose pelleted RNA during extraction due to lack of 
visibility. To combat this it was decided to include a co-precipitant into the extraction 
process to increase the efficiency of RNA precipitation and to increase the visibility of 
the RNA pellet. In addition, an overnight precipitation step was included. By modifying 
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the TRIzol extraction method and incorporating the use of a co-precipitant it was possible 
to consistently extract a high yield RNA from macrophages (Figure 8). Extractions 
yielded on ranged between 115ng/µl to 400ng/µl of total RNA per well of a 24 well plate 
throughout the duration of the experimental time course. This corresponded to a total 
yield between 1150ng and 4000ng of total RNA per well.  
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Figure 6: Number of viable adherent head kidney macrophages maintained in vitro over time in a 
24 well plate. Cells were derived from Atlantic salmon head kidney and isolated on 51% percoll. 
The cells were seeded in wells at a concentration of 2 x 10-7 ml-1, then washed after 3 hours to 
remove non-adherent cells. Cultures were incubated overnight at 15°C, before being infected with 
IPNV at an MOI of 1, 24 hours after initial seeding. Negative control macrophages were 
inoculated with L-15 medium. Counts of viable macrophages were taken for 9 days after virus 
inoculation. Data represent mean counts (log 10); (N=3) ± SD.  
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Table 2: Data collected from cell counts of viable adherent head kidney macrophages maintained 
in vitro over time in a 24 well plate after IPNV inoculation. Data represent mean counts (N=3) ± 
SD.  
 
  Neg    IPNV   
Day  Mean Stnd dev Mean  Stnd dev 
1 2866667 152752.5 2833333.333 115470.0538 
2 966666.7 15275.25 963333.3333 5773.502692 
3 236666.7 15275.25 236666.6667 11547.00538 
4 70666.67 1527.525 71000 1732.050808 
5 43333.33 577.3503 23666.66667 1154.700538 
6 37666.67 1154.701 17333.33333 1154.700538 
7 11666.67 1527.525 12333.33333 1527.525232 
8 8600 200 8633.333333 115.4700538 
9 7366.667 152.7525 7300 173.2050808 
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Figure 7: Yield of RNA extracted from adherent head kidney macrophages maintained in vitro 
over time in a 24 well plate. Cells were derived from Atlantic salmon head kidney and isolated on 
51% percoll. Prior to extraction, the macrophages had been infected with IPNV at an MOI of 1, 
24 hours after initial seeding. Negative control macrophages were inoculated with L-15 medium. 
RNA was extracted from macrophage monolayers for 9 days after virus inoculation; extractions 
followed the TRIzol manufacturer’s protocol. Data represent mean concentration (N=3) ± SD.  
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Figure 8: Yield of RNA extracted from adherent head kidney macrophages maintained in vitro 
over time in a 24 well plate. Cells were derived from Atlantic salmon head kidney and isolated on 
51% percoll. Prior to extraction, the macrophages had been infected with IPNV at an MOI of 1, 
24 hours after initial seeding. Negative control macrophages were inoculated with L-15 medium. 
RNA was extracted from macrophage monolayers for 9 days after virus infection. Extractions 
were performed using a modified version of the TRIzol manufacturer’s protocol, which included 
the an overnight precipitation step at -20°C and the use of a co-precipitant. Data represent mean 
concentration (N=3) ± SD. 
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3.4    Discussion 
3.4.1  Macrophage isolation conditions 
Whilst the results of this chapter show that it was eventually possible to maintain an 
adequate culture of macrophages for 9 days, the use of a 24 well culture plates was not 
without problems. Firstly, increased numbers of macrophages were required for seeding 
wells. Originally, only 100µl of macrophage suspension was needed per well, however 
400µl of macrophage suspension were required to seed the larger sized wells. Obtaining 
enough macrophages to satisfy the number of replicates needed to conduct an experiment 
would involve the use of significantly more percoll gradients, which are costly to produce 
and labour intensive to process. The most obvious solution to this problem was to 
implement the use of an alternative isolation technique that would lend itself to isolating 
large amounts of macrophages from salmon head kidney. As 51% percoll gradients are 
easier to prepare and faster to process than 34-51% gradients, their use permits 
macrophage isolation in reduced time, which is beneficial when several macrophage 
isolations are required to set up a single experiment. It was also feared that the large 
numbers of gradients required would increase the delay between removal of macrophages 
from transport medium and final transfer to culture plates. It was believed that this would 
have a detrimental effect on the physical condition and health of the macrophages, which 
could subsequently affect their ability to survive in culture. The use of 51% gradients 
allowed a faster processing time as it took less time to make these gradients and it was 
also quicker to load the kidney homogenate as the 51% percoll gradients are more stable 
than 34-51% gradients. This permitted processing of a greater number of kidneys which 
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was necessary to perform the number of replicates required for the experiments planned 
for this thesis. Originally, there was concern that using 51% percoll gradients would be 
less efficacious than the use of 34-51% gradient. It was anticipated that that the 51% 
gradient technique would almost certainly produce a less pure macrophage preparation 
compared to the 34-51% gradient technique, however it was hoped this would not hinder 
the macrophages present in the end cell suspension from adhering. As long as 
macrophages were allowed to adhere to the surface of the culture well there was 
confidence that the washing would make use of the attaching properties of the 
macrophages to remove the other cell types that may have been present in the wells. As 
Figure 4 and Figure 5 show, as a result of the wash after 3 hours, it was possible to show 
the appearance of macrophages from either isolation protocol. As there was no significant 
difference between the 34-51% percoll gradients and the 51% in terms of the number of 
macrophages present in the isolated cell suspension, the 51% percoll gradient isolation 
technique was considered to be a suitable procedure for isolating macrophages for the in 
vitro studies described in this thesis. Finally, a commonly overlooked factor in choosing a 
suitable experimental technique is financial cost, a factor which is of crucial importance 
for small scale research projects with limited financial support. The use of 51% gradients 
to obtain macrophages permitted a reduction in the amount of percoll used. Percoll is an 
expensive chemical and therefore lowering its consumption reduced the overall cost of 
the isolation method. Although 34-51% percoll gradients are the traditional way to isolate 
macrophages (Secombes, 1990; Nova et al., 1996; Taffalla and Nova, 2000; Munro et al., 
2004), 51% gradients have previously been used to successfully isolate macrophages for 
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in vitro studies (Jorgensen and Robertsen, 1995; Sangrador-Vegas et al., 2000; Munzo et 
al., 1999) and 54% gradients (Rise et al., 2004).  
3.4.2  In vitro culture of macrophages and extraction of RNA 
Initially growth of macrophages on 96 well plates was attempted, as this would require 
the use of fewer experimental animals, an important consideration given the ongoing 
debate on the use of animals in scientific research. However, as a result of poor survival 
of isolated macrophages, it was necessary to use 24 well plates. By using a 24 well 
culture plate, it was possible to maintain the macrophages in culture for at least 9 days 
post infection with IPNV. A similar pattern of viable cells in the IPNV infected and 
uninfected macrophages over time as shown in Figure 6 would confirm that the decrease 
in cell number over time in a direct result of washing and natural cell death/detachment in 
the monolayer and not as it could have been suggested due to the actions of the 
inoculated virus. Johansen and Sommer 1995  and Collet et al., 2007, also report that 
IPNV infected macrophages can be maintained in vitro for at least 7 and 9 days post 
infection, respectively, without the development of CPE in the cells. It is probable that 
this would have been necessary even if better macrophage survival occurred in the 96 
well plate format. This is because even with 24 well plates, in some cases it was difficult 
to obtain sufficient cells to perform RNA isolation and subsequent first strand 
amplification. This is especially relevant for studies investigating low copy transcripts 
that represent a small proportion of the total RNA yield. Whilst Table 2 shows that the 
number of macrophages declines throughout time, the remaining cell numbers were 
proven sufficient to obtain an adequate amount of RNA for subsequent amplification 
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Figure 8. However, this was only possible after the TRIzol extraction technique was 
developed so that it was sensitive enough to yield sufficient RNA for subsequent real-
time RT-PCR analysis. It was necessary to adapt the manufacturer’s protocol to increase 
the efficiency of the precipitation step. The inclusion of a co-precipitant into the 
extraction method proved to be a crucial part of the extraction procedure as before its 
addition it was not possible to routinely visualise RNA pellets. Sørensen et al., (1997) 
reported that in an in vitro culture of Atlantic cod (Gadus morhua L) macrophage 95% of 
the cells had detached and died by 7 days, however they were able to maintain the culture 
for up to 3 weeks when the medium was carefully changed every third day. Similarly 
Johansen and Sommer (1995) observed that after 3 days in culture, about 30-40% of  the 
adherent Atlantic salmon macrophage in vitro culture was still viable, however only 10% 
maintained adherence at day 7. The effect of the decline in the numbers of macrophages 
during the course of the experiment will not influence the results of gene expression, as 
the method of quantitation selected for this thesis is relative expression. Therefore, the 
expression of each target gene of interest will be compared to the expression of an 
internal control. The long term viability of the macrophage cultures was further reflected 
through the uniform ELF-1 Ct values across day 1-day 9 time points (section 5.3.1). This 
would indicate that the in vitro culture conditions do not influence the expression of the 
internal control gene, therefore demonstrating that the cell is stable in culture.  
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3.5    Conclusion  
Although the need use a culture plate with a larger surface area was necessary to achieve 
adequate cell survival and sub-sequential RNA yield for real time RT-PCR amplification, 
the demand for increased cell numbers to successfully conduct an in vitro experiment was 
counterbalanced by identifying a optimal cell isolation and RNA extraction technique. 
According to Braun-Nesje et al., (1981) the ability to separate, identify and maintain cells 
under in vitro culture conditions can facilitate the study of immunity in Atlantic salmon. 
In the present study, a reliable isolation and culture method for macrophages and a 
reproducible RNA extraction method have been developed that can be used to study the 
interaction between macrophages and IPNV. In conjunction with real-time RT-PCR 
assays for specific components of the innate immune system, macrophage culture in vitro 
may help to advance the understanding of IPN and thus contribute to the control of this 
disease. 
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Chapter 4 - Optimization of qRT-PCR assays for the quantitation of 
the expression of immune response genes in Atlantic salmon 
macrophages 
4.1     Introduction  
PCR is a powerful tool for the amplification of small amounts of DNA or RNA for various 
molecular analyses (Wang et al., 1989). The introduction of real-time PCR has 
revolutionised quantification with this procedure, but requires careful assay design and 
reaction optimisation to maximize sensitivity (Peters et al., 2004). According to Bustin and 
Nolan (2004), it is vital to consider each stage of the experimental protocol, starting with 
the laboratory setup and proceeding through sample acquisition, template preparation, 
reverse transcription, and finally amplification. Only if every one of these stages is properly 
validated is it possible to obtain reliable quantitative data.  The aims of this chapter are; 
 
a) To establish real time RT-PCR (q RT-PCR) assays to detect IFN, Mx, IPNV and ELF-1.  
 
b) To identify a suitable quantitative model to investigate expression of IFN, Mx relative to 
ELF-1 in macrophages maintained in vitro throughout the course of an experiment.    
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4.2    Materials and Methods 
4.2.1  Isolation of macrophages from head kidney  
Head kidneys were obtained from Atlantic salmon (section 2.2.2) and macrophages were 
isolated on 51% percoll as described in 2.2.4. Macrophages were seeded into 24 well plates 
at concentrations of 2 x 10-7 ml-1 and maintained at 15°C as described in section 2.2.5.  
 
4.2.2  IPNV infection of Atlantic salmon macrophages in vitro 
After 24 hours incubation at 15°C, macrophage monolayers were processed in triplicate 
using one of the following two treatments.  
 
a) IPNV-infected group. Macrophages were infected with IPNV at a multiplicity of 
infection (MOI) of 1 (section 2.2.7).  
b) Poly-I:C-stimulated group. Macrophages were incubated with L-15 medium 
supplemented with 5% FCS and 50 units ml-1 penicillin, 50µg ml-1 streptomycin 
containing polyinosinic-polycytidylic acid (Poly I:C) (Sigma); (25 µg ml-1).  
 
After 24 hours incubation at 15°C, the monolayers were washed three times with L-15 
medium and the RNA was extracted using the modified TRIzol protocol as described in 
section 3.2.5. It was necessary to reduce the post-infection sampling time from 24 hours to 
12 hours to assess the amplification efficiency of the IFN primer/probe set because of the 
results of chapter 6 with respect to the time course of IFN expression.  
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4.2.3  Two-step RT-PCR 
4.2.3.1    First strand cDNA synthesis  
RNA from IPNV-infected or Poly I:C stimulated Atlantic salmon head kidney macrophages 
was selected to optimize the reverse transcription step, as it was considered that the RNA 
originating from these cells would contain all of the mRNA target sequences of interest in 
this study. The optimization was performed using TaqMan® Reverse Transcription reagents 
(Applied Biosystems) following the manufacturer’s recommendations. This involved 
varying the reaction temperatures in the range of 42°C to 52°C, and the reaction times 
between 20 to 60 minutes. Due to cost restrictions the reaction temperatures studied were 
42°C, 46.4°C and 52°C, whilst the reaction times were increased in 10-minute increments. 
cDNA synthesis was performed using TaqMan® Reverse Transcription reagents. The 
reaction mixtures for the RT reactions followed the guidelines in the TaqMan® Reverse 
Transcription reagents protocol; for each 10µl reaction; 1x 10x TaqMan RT buffer, 5.5 mM 
25mM Magnesium Chloride, 500µM of each dNTP in a deoxyNTP mixture 
(deoxyadenosine triphosphate, deoxycytidine triphosphate, deoxyguanosine triphosphate, 
deoxythymidine triphosphate) 2.5µM random hexamers, 0.4 U/µl RNase inhibitor and 
MultiScribe Reverse Transcriptase (50 U/µl) 1.25 U/µl. The RT mix containing random 
hexamers was heated to 95°C for 10 minutes to denature the secondary structure of the 
IPNV template. After heating, samples were held on ice for 2 minutes before the second 
step amplification on the Rotorgene real-time thermal cycler (section 4.2.3.2). Again, as a 
result of financial restraints reverse transcription and amplification of only one of the target 
genes of interest, Mx and the housekeeping gene ELF-1 were optimized. Results were used 
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to define common optimal amplification conditions which would then be used for all 
amplifications.  
 
4.2.3.2    IFN, Mx, IPNV and ELF-1 q RT-PCR 
Primer and probe sequences for IFN, Mx, IPNV and ELF-1 were kindly provided by B. 
Collet, FRS Marine Laboratory, Aberdeen (Table 3). All primers and probes were designed 
and synthesized by Applied Biosystems. The probes were` 5' labelled with the fluorescent 
reporter molecule FAM (carboxyfluorescein), whilst the 3’ termini were modified with an 
minor groove binding (MGB) moiety. Real-time quantitative PCR was preformed on a 
Corbett Research Rotor-Gene. Each 20µl reaction contained: 1x TaqMan® Universal PCR 
mastermix (Applied Biosystems), 0.9mM forward and reverse primers, 0.25mM MGB 
probe. Cycling conditions were as follows: 10 min at 95°C, followed by 40 cycles of 92°C 
for 15 seconds and 60°C for 1 minute. All of the probes were designed to flank an RNA 
splice site in order prevent amplification of genomic DNA.  
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Table 3: Primer and probe nucleotide sequences used in real-time qRT-PCR  
 
Gene  Forward primer Reverse primer MGB probe 
 
IPNV 
 
 
5’GCCAAGATGACC 
CAGTCCAT 3’ 
 
 
5’TGACAGCTTGAC 
CCTGGTGAT 3’ 
 
 
6-FAM-CCGACCGAG 
AACAT-MGB 
 
Mx 5’GATGCTGCAC 
CTCAAGTCCTATTA 3’ 
 
5’CGGATCACCA 
TGGGAATCTGA 3’ 
 
6-FAM-CAGGATATCC 
AGTCAACGTT-MGB 
Type 1        
IFN 
5’ACTGAAACGCT 
ACTTCAAGAAGTTGA 3’ 
 
5’AGGAAAGAGAC 
AAAACGTCATCTGC 3’ 
 
6-FAM-CTGTGCACT 
GTAGTTCATTT-MGB 
 
ELF-1 5’CCCCTCCAG 
GACGTTTACAAA 3’ 
 
5’CACACGGCC 
CACAGGTACA 3’ 
 
6-FAM-ATCGGTGGTA 
TTGGAAC-MGB 
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4.3    Reverse transcription of total RNA extracted from macrophages 
incorporating the optimised cycling conditions. 
All samples were diluted to a concentration of 100ng/µl in RNase/DNase free water. 
Amplifications were performed using TaqMan® Reverse Transcription reagents. The 
reaction mixtures for the RT reactions followed the guidelines recommended in the 
TaqMan® Reverse Transcription reagents protocol as described in 4.2.3.1. Prior to cycling, 
the amplification mix was heated to 95°C for 10 minutes and then placed back on ice. The 
RT conditions were as recommended in the TaqMan® Reverse Transcription reagents and 
incorporated optimised reaction duration and temperatures identified from the first strand 
synthesis optimization experiment (section 4.5.1). These were 10 minutes at 25°C, 60 
minutes at 46.4°C, 5 minutes at 95°C.  
4.4    Standard curve production  
Standard curves of real-time RT-PCR experiments were produced by amplifying a ten fold 
dilution series of target in RNase/DNase free water. A master mix was prepared and 
distributed into 0.2ml tubes prior to the addition of template. Amplifications were 
performed in triplicate under optimised conditions. On completion of the run, a standard 
curve was produced using the Rotorgene software Version 6, which was also used to 
calculate amplification efficiency.  
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4.5    Results 
4.5.1  Optimization of the reverse transcription of RNA extracted from Atlantic 
salmon macrophages.  
Optimization of reverse transcription conditions was performed using a gradient 
thermocycler, a range of reverse transcription duration and temperature variables were used 
to generate cDNA from a sample originating from IPNV-inoculated macrophages. 
Optimization was performed in accordance with the recommendations contained in the 
TaqMan® Reverse Transcription reagents protocol. Thus, reaction temperatures in the 
range of 42°C to 52°C were tested together with reaction durations ranging from 20 to 60 
minutes (section 4.2.3.1). The cDNA produced was then amplified using the primers and 
probes for the Mx and ELF-1 genes. The optimal conditions for reverse transcription for 
ELF and Mx were chosen by selected by the samples that amplified at the earliest Ct value 
as shown in Figure 9 and Figure 10. The conditions considered to represent optimal 
amplification parameters were 60 minutes at 46.4°C (Table 4). These experimental 
parameters were subsequently used for reverse transcription in all RT-PCR experiments 
performed in this study. 
 
 
Chapter 4: Optimization of real time qRT-PCR assays  
 
64 
 
 
 
Figure 9: Real time RT-PCR amplification using ELF-1 specific primers and ELF-1 probe to 
amplify a cDNA template derived from Poly I:C stimulated macrophages. The following variables 
in the reverse transcription step were investigated: reaction temperatures, 42°C, 46.4°C and 52°C;  
reaction duration 20, 30, 40, 50, and 60 minutes. The sample showing the earliest Ct value 
corresponded to reverse transcription condition 60 minutes at 46.4°C (a). No template controls and 
RT-minus controls were incorporated into amplification runs (b).   
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Figure 10: Real time RT-PCR amplification using Mx specific primers and Mx probe to amplify a 
cDNA template derived from Poly I:C stimulated macrophages. The following variables in the 
reverse transcription step were investigated: reaction temperatures, 42°C, 46.4°C and 52°C;  
reaction duration 20, 30, 40, 50, and 60 minutes. The sample showing the earliest ct value 
corresponded to reverse transcription condition 60 minutes at 46.4°C (a). No template controls and 
RT-minus controls were incorporated into amplification runs (b).  
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Table 4: Ct values corresponding to the real time RT-PCR amplification using both ELF-1 and Mx 
specific primers along with ELF-1 and Mx specific probes to amplify a cDNA template derived 
from Poly I:C stimulated macrophages.  
 
ELF-1 
sample  Conditions Ct 
Average 
Ct   
Mx 
sample Name Ct 
Average 
Ct 
1 20 mins 42  26.31    1 20 mins 42  29.14   
2 20 mins 42  28.15 27.23  2 20 mins 42  28.7 28.92 
3 20 mins 46.4 25.85    3 20 mins 46.4 28.33   
4 20 mins 46.4 28.56 27.205  4 20 mins 46.4 28.23 28.28 
5 20 mins 52 25.97    5 20 mins 52 28.53   
6 20 mins 52 25.48 25.725  6 20 mins 52 28.83 28.68 
7 30 mins 42  28.63    7 30 mins 42  28.66   
8 30 mins 42  28.42 28.525  8 30 mins 42  29.84 29.25 
9 30 mins 46.4 28.66    9 30 mins 46.4 31.45   
10 30 mins 46.4 25.83 27.245  10 30 mins 46.4 27.7 29.575 
11 30 mins 52 26.98    11 30 mins 52 28.43   
12 30 mins 52 33.04 30.01  12 30 mins 52 28.64 28.535 
13 40 mins 42 26.5    13 40 mins 42 27.75   
14 40 mins 42 31.31 28.905  14 40 mins 42 28.26 28.005 
15 40 mins 46.4  25.18    15 40 mins 46.4  28.72   
16 40 mins 46.4  27.95 26.565  16 40 mins 46.4  28.5 28.61 
17 40 mins 52 27.45    17 40 mins 52 28.46   
18 40 mins 52 25.68 26.565  18 40 mins 52 29.17 28.815 
19 50 mins 42  26.34    19 50 mins 42  27.79   
20 50 mins 42  26.15 26.245  20 50 mins 42  27.95 27.87 
21 50 mins 46.4 28.86    21 50 mins 46.4 28.19   
22 50 mins 46.4 25.08 26.97  22 50 mins 46.4 28.35 28.27 
23 50 mins 52 26.59    23 50 mins 52 28.7   
24 50 mins 52 25.6 26.095  24 50 mins 52 28.83 28.765 
25 60 mins 42  30.38    25 60 mins 42  27.7   
26 60 mins 42  25.49 27.935  26 60 mins 42  28.33 28.015 
27 60 mins 46.4  25.68    27 60 mins 46.4  27.04   
28 60 mins 46.4  25.51 25.595  28 60 mins 46.4  26.87 26.955 
29 60 mins 52  25.81    29 60 mins 52  29.49   
30 60 mins 52  25.75 25.78  30 60 mins 52  28.68 29.085 
31 RT- 0    31 RT- 0   
32 RT- 0 0  32 RT- 0 0 
33 NTC 0    33 NTC 0   
34 NTC 0 0   34 NTC 0 0 
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4.5.2  Sensitivity of real time RT-PCR assays  
The amplification efficiencies for all the targets investigated in this thesis were estimated by 
amplifying a 10-fold dilution series of the gene target (Figure 11, Figure 13, Figure 15 and 
Figure 17). Using the slope of the resulting trend line the PCR efficiencies of the genes 
were calculated through the Rotor-Gene software (Figure 12, Figure 14, Figure 16, Figure 
18). Table 5 shows that all of the efficiencies for the targets in this study were above 85%.  
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Figure 11: Real time RT-PCR amplification using ELF-1 specific primers and ELF-1 probe to 
amplify a ten-fold dilution series of a cDNA template derived from Poly I:C stimulated 
macrophages. Amplifications were performed in triplicate. Target dilutions tested were 100 (a), 101 
(b), 102 (c), 103 (d), 104 (e), No template controls and RT-minus controls were incorporated into 
amplification runs (f). 
 
 
Figure 12: Standard curve obtained from amplification using ELF-1 specific primers and ELF-1 
probe produced using the Rotor-Gene software. Amplification efficiencies were calculated 
according to the equation: E = 10[-1/slope].  
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Figure 13: Real time RT-PCR amplification using Mx-specific primers and Mx probe to amplify a 
ten-fold dilution series of a cDNA template derived from Poly I:C stimulated macrophages. 
Amplifications were performed in triplicate. Target dilutions tested were 100 (a), 101 (b), 102 (c), 103 
(d), 104 (e), No template controls and RT-minus controls were incorporated into amplification runs 
(f).  
 
 
Figure 14: Standard curve obtained from amplification using Mx-specific primers and Mx-specific 
probe produced using the Rotor-Gene software. Amplification efficiencies were calculated 
according to the equation: E = 10[-1/slope].  
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Figure 15: Real time RT-PCR amplification using IPNV-specific primers and IPNV probe to 
amplify a ten fold dilution series of cDNA derived from IPNV-infected macrophages. 
Amplifications were performed in triplicate. Target dilutions tested were 100 (a), 101 (b), 102 (c), 103 
(d), 104 (e), 105 (f), No template controls and RT-minus controls were incorporated into 
amplification runs (g).  
 
 
Figure 16: Standard curve obtained from amplification using IPNV-specific primers and probes 
produced using the Rotor-Gene software. Amplification efficiencies were calculated according to 
the equation: E = 10[-1/slope].  
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Figure 17: Real time RT-PCR amplification using IFN-specific primers and IFN probe to amplify a 
ten fold dilution series of a cDNA derived from Poly I:C stimulated macrophages. Amplifications 
were performed in triplicate. Target dilutions tested were 100 (a), 101 (b), 102 (c), 103 (d), No 
template controls and RT-minus controls were incorporated into amplification runs (e).  
 
 
Figure 18: Standard curve obtained from amplification using IFN-specific primers and probes 
produced using the Rotor-Gene software. Amplification efficiencies were calculated according to 
the equation: E = 10[-1/slope].   
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Table 5: Amplification efficiencies and R values for the primers and probes used in this study 
 
Target R Value Efficiency 
ELF-1 0.99 0.99 
Mx 0.98 0.92 
IPNV 0.99 0.98 
IFN  0.99 0.85 
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4.6    Discussion 
4.6.1  Optimization of first strand cDNA synthesis 
The RT step is the source of most of the variability in a quantitative RT-PCR experiment 
(Freeman et al., 1999). Therefore, the conditions for the first strand synthesis of cDNA 
from the extracted RNA were optimised. Random hexamers were selected for the 
production of cDNA from RNA extracted from macrophages. Random hexamer primers 
contain all possible nucleotide sequences of a 6 base oligonucleotide, and bind to multiple 
points on target nucleic acid. They are particularly useful for targets with significant 
secondary structure such as the IPNV genome. The products of RT reactions primed by 
random hexamers can be split for use in several PCR reactions each utilising a different 
gene-specific primer pair. This method maximises the number of genes that can be assayed 
from a small sample (Freeman et al., 1999). As the expression of all targets will be from the 
same cDNA, it was therefore necessary to use first strand primers that will amplify total 
RNA. As IPNV does not have an poly-A tail it was not possible to use oligo d(T)16 primers 
and therefore random hexamers were the most suitable choice for first strand synthesis. It is 
necessary to acknowledge that the different priming methods used to generate cDNA differ 
significantly with respect to specificity and cDNA yield and variety (Bustin et al., 2005). 
However as the cDNA is generated in the same way and the RT conditions are the same for 
all of the targets studied these problems should not impact on the work performed in this 
thesis. RNA can exhibit significant secondary structure that affects the ability of the RNA-
dependant DNA polymerase (reverse transcriptase, RT) to generate transcripts (Bustin, 
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2000). The 10 minute denaturation of the total RNA and primers prior to first strand 
synthesis was incorporated in response to the findings of Lopez-Lastra et al., (1994). These 
workers concluded that first strand synthesis is the most important reaction step with respect 
to amplification of IPNV, due to its double stranded genome. The use of a two step RT-
PCR method, i.e. separating the RT and the PCR steps, as compared to single step RT-PCR 
provides a considerable advantage in that it produces a cDNA pool or library which can be 
kept indefinitely (Bustin, 2000, Peters et al., 2004), therefore other mRNA targets can be 
quantified with relative ease provided that specific primers and probes are available.  
4.6.2  Selection of the housekeeping gene for use in relative quantitation by real-time 
qRT-PCR 
An ideal housekeeping gene should be expressed at a constant level among different tissues 
of an organism, at all stages of development, and should be unaffected by experimental 
treatment (Zhang et al., 2005). Studies have shown that expression of some of the 
commonly used housekeeping genes can vary under experimental conditions (Radonic et 
al., 2004;Vandesompele et al., 2002; Schmittgen and Zakrajsek 2000). It is the opinion of 
Radonic et al., (2004), that whilst it seems unreasonable that the transcription of any gene in 
a living cell is absolutely resistant to cell cycle fluctuations or nutrient status, it is important 
to identify candidate genes that are least minimally regulated during individual experiments 
allowing the accuracy of RNA transcription analysis that real-time PCR offers. 
Unfortunately, due to constraints imposed by funding and time, it was not possible to 
perform efficacy studies on internal control genes. Therefore, a housekeeping gene (ELF-1) 
was obtained from FRS Marine Laboratory, Aberdeen, which has successfully been used in 
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real time RT-PCR studies of fish immune gene expression (McBeath et al., 2006); (Collet et 
al., 2007); (Lockhart et al., 2007).  
4.6.3  Real-time quantitative PCR for IFN, Mx, IPNV and ELF-1 
In this study MGB probes were used to monitor product accumulation in real-time. The 
choice of MGB probes was based on their successful use at FRS laboratory, Aberdeen. 
Probes of all types are more expensive than reporter dyes such as SYBR Green I, but they 
permit sequence-specific detection, minimising false positive reactions due to detection of 
non-specific amplification products and primer dimers (Peters et al., 2004). The advantage 
of these MGB probes over the SYBR Green I DNA binding probes is based on the specific 
binding between probe and target that is required to generate a signal, unlike SYBR Green 
I, which binds to any double stranded DNA produced during amplification. Hydrolysis 
probes achieve fluorescence by separating the fluorophore and quencher through the 5’ to 3’ 
endonuclease activity of Taq polymerase during primer extension (Steuerwald et al., 1999). 
The use of probes with modified chemistry, such as those containing high-affinity DNA 
minor-groove binding moieties has further improved quantitative PCR sensitivity by 
increasing both probe hybridization and signal-to-noise ratios (Grace et al., 2003). The 
probes used in this study were synthesised with 3’ MGB modifications, which raises the 
effective melting temperature (Tm) of the probe, thereby enabling the probe to be 
significantly shorter (Ginzinger, 2002).  Kutyavin et al., (2000) have shown that MGB 
probes with their shorter sequence lengths give better sequence specificity and lower 
fluorescent background in comparison with conventional TaqMan probes. Hybridization 
probes provide a very high sensitivity due to low background fluorescence levels, however, 
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as previously mentioned, there is a high cost for synthesis of each new gene specific probe 
(Kreuzer et al., 1999). As a lot of the work done in this study involved an investigation of 
changes in expression of targets expressed at a relatively low level, the use of these highly 
sensitive and specific MGB probes was important. The use such specific amplification 
chemistry permitted detection of all targets studied over a concentration of several log10. 
The IFN gene, which was expected to be the most difficult to detect target due to its very 
confined and short lived expression, could only be detected over a concentration range of 2 
log10 (Figure 17).  PCR in this study was performed using a Universal PCR mastermix made 
by Applied Biosystems. According to the manufacturer’s notes it is not necessary to 
perform titration experiments to obtain optimal concentrations of reaction components, such 
as magnesium chloride, as their master mix is specifically designed to provide optimal 
performance for TaqMan assays that use cDNA as a substrate under universal cycling 
conditions. The amplification efficiency of a given gene can be estimated by amplifying a 
10-fold dilution series of the gene target, and by plotting the Ct values obtained as a 
function of the log10 of target concentration. The slope of the resulting trend line will be a 
function of the PCR efficiency (Ginzinger, 2002). The results of the present study show that 
RT-PCR assays for all of the genes studied had good efficiency values all above 90% apart 
from IFN which had an efficiency of only 85% (Table 5). According to Ginzinger (2002) 
using the relative quantitation method requires that the PCR efficiencies of all genes be 
similar and preferably at or above 90%. It was decided that as only one gene had efficiency 
below 90% it was still possible to use the relative quantitation method as there are relative 
mathematical methods available that incorporate amplification efficiency correction into 
their calculations and additionally do not require the reaction efficiencies to be similar. 
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Other studies have successfully utilised RT-PCR procedures with efficiencies as low as 
70% for quantitation (Jorgensen et al., 2006).  
4.6.4  Selection of method for quantification in real-time RT-PCR 
Two different methods of analyzing data from real-time, quantitative PCR exist: absolute 
quantification and relative quantification (Livak and Schmittgen, 2001). Relative 
quantification is based on the relative expression of a target gene versus a reference gene 
(Pfaffl, 2001) whilst absolute quantification uses serially diluted standards of known 
concentrations to generate a standard curve (Wong and Mendrano, 2005). The advantage of 
absolute quantification is that it is easier to compare expression data between different days 
and laboratories, because the calibration curve provides a fixed reference point (Pfaffl, 
2002). However, absolute quantification requires a number of extra conditions and 
treatments that relative quantification does not (Freeman et al., 1999). It was decided that 
relative quantification would be adequate for analysis of gene expression associated with in 
vitro activity, as the main emphasis would be on patterns of expression over time in relation 
to stimuli rather than the exact copy numbers of specific genes at specific time points. The 
decision regarding the choice of method used to analyse the results from this study was 
made in reference to Table 6 from Wong and Medrano (2005) which compares the various 
relative quantitation mathematical methods available and Figure 19, which is a flow 
diagram, which recommends appropriate methods concerning the nature of the results being 
evaluated. 
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Table 6: Characteristics of various relative quantitation methods 
 
Methods  Amplification 
Efficiency 
Correction  
Amplification 
Efficiency 
Calculation  
Amplification 
Efficiency 
Assumptions  
Automated Excel-
Based Program 
Standard Curve 
(Livak, 1997).   
No  Standard curve  No experimental 
sample variation  
No  
Comparative Ct (2 -∆∆ Ct)  
(Livak,Schmittgen, 2001)  
Yes  Standard curve  Reference = 
target  
No  
Pfaffl  
(Pfaffl, 2001)  
 
Yes  Standard curve Sample = control  REST 
Q-Gene  
(Muller, Janovjak, Miserez, 
Dobbie, 2002).  
Yes  Standard curve Sample = control Q-Gene  
Gentle  
(Gentle, Anastasopoulos, 
McBrien, 2001). 
Yes  Raw data  Researcher 
defines log-
linear phase  
No  
Lui and Saint  
(Lui & Saint, 2002). 
Yes  Raw data Reference and 
target genes can 
have different 
target 
efficiencies  
No  
DART-PCR 
(Peirson, Butler, Foster, 
2003).  
Yes  Raw data Statistically 
defined log-
linear phase  
DART-PCR  
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Key  
ROX = Reporter dye associated with probe/beacon 
HKG = Housekeeping gene 
 
Figure 19: Flow diagram for the selection of a quantitative mathematical method 
(www.wzw.tum.de/gene-quantification)  
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The Pfaffl method for relative quantification was chosen for the following reasons. As the 
amplification reaction efficiencies were not all similar the method required amplification 
efficiency correction, a function which was not provided by the standard curve method. 
According to Table 6 whilst the Comparative Ct (2-∆∆ Ct) method includes a correction for 
non-ideal reaction efficiencies, it has been shown that when using this method the 
amplification efficiencies of the target gene and reference genes must be approximately 
equal, otherwise differences in efficiencies will generate errors (Livak and Schmittgen, 
2001; Lui and Saint, 2002). Therefore, as Figure 19 shows, this method is not suitable for a 
test which requires efficiency correction, for this reason the Pfaffl mathematical model was 
used in the present study. REST is a software tool to estimate up and down-regulation for 
gene expression studies. The purpose of REST is to determine whether there is a significant 
difference between samples and controls, while taking into account issues of reaction 
efficiency and reference gene normalisation. REST uses the Pfaffl mathematical model to 
generate relative expression ratios, and subsequently the significance of the results are 
investigated using a randomisation test. Unfortunately, from talking to representatives for 
the REST software, it is not possible to use REST for time course experiments. Whilst the 
developers of REST recognize this as a major limitation of the software, it is however still 
possible to analyze the results of any experiment with the Pfaffl mathematical model 
without the aid of the REST programme. The Pfaffl mathematical model combines gene 
quantification and normalization into a single calculation (Wong and Mendrano, 2005). 
According to Pfaffl (2001), this method has taken into consideration the mathematics of the 
Comparative Ct (2-∆∆ Ct) method in order to better understand the mode of Ct data analysis 
and for a more reliable and exact gene expression. The Pfaffl method is simply calculated 
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from the real-time PCR efficiencies and the cycle threshold (Ct) deviation of an unknown 
sample versus a control. This incorporation of the amplification efficiencies of the target 
and reference (normalization) genes allows for the correction of differences between two 
assays (Wong and Mendrano, 2005). Table 6 shows that in essence the Q-Gene method has 
the same characteristics as the Pfaffl method, however on the basis of a literature search the 
Pfaffl method appeared to be a more widely used method and it was for this reason that the 
Pfaffl method was selected over the Q-Gene method. It is the opinion of Pfaffl, (2001) that 
this mathematical method is an ideal and simple tool for the verification of amplification 
results without the need for more complex and time consuming quantification models based 
on calibration curves. The Pfaffl method uses the following equation as outlined in Figure 
20.   
 
 
 
Key   
E = Amplification efficiency of gene 
Ct = Cycle threshold  
 
Figure 20: Pfaffl calculation for the relative expression in real time PCR (from Pfaffl et al., 2002).  
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4.6.5  Explanation of components of Pfaffl calculation  
The Pfaffl mathematical model for the calculation of relative expression in real-time PCR. 
The relative expression ratio of a target gene is calculated based on its real-time PCR 
efficiencies (E) and the Ct deviation (∆) of an unknown sample versus a control (control-
sample). Prior to treatments, RNA was extracted from macrophages to identify the normal 
expression values for all of the targets investigated in the experiment. This extraction was 
termed “time 0” and the values were incorporated within the Pfaffl relative quantification 
calculation as the “control”. 
4.7    Conclusion  
This chapter is concerned with optimization of the conditions for amplification and 
subsequent detection of target mRNA obtained from Atlantic salmon macrophages. The 
results from chapters 3 and 4 can be used to successfully develop an in vitro infectious 
experimental protocol. Alongside the optimised real time RT-PCR method, this will allow 
experiments to be conducted whose results will be subject to quantitative analysis to 
advance understanding of how IPNV affects the innate immune response within Atlantic 
salmon head kidney macrophages. 
Chapter 5: Induction and effect of immunostimulants in type I IFN response 
 
83 
Chapter 5 - Innate immune responses in Atlantic salmon 
macrophages infected with IPNV: induction and effect of 
immunostimulants 
5.1    Introduction 
Mammalian cells possess diverse defence mechanisms against viral infection, with one of 
the most important of these being an antiviral state induced by type I IFN (Collet et al., 
2007). The mammalian IFN system has been characterised in detail at the molecular 
level, however in fish, this system is poorly understood (Johansen et al., 2004). 
Advancing current knowledge of the non-specific antiviral defence mechanisms of 
Atlantic salmon might help to explain this species’ susceptibility to IPNV (Jensen and 
Robertsen, 2002). In particular, innate immune responses to IPNV within macrophages 
are poorly characterised. Knowledge of macrophage immune responses to IPNV could 
facilitate the design of vaccination strategies to counter IPNV, and breeding programmes 
aimed at the production of IPN-resistant fish.  
Immunostimulants are of potential importance for the control of fish diseases and 
may thus be useful in aquaculture of marine fish (Sakai, 1999). The use of 
immunostimulants in fish culture offers a wide range of attractive methods for inducing 
and boosting protection against infectious diseases (Anderson, 1992).  The susceptibility 
of Atlantic salmon to IPN is greatest in juvenile life cycle stages and in smolts shortly 
after seawater transfer (Rønneseth et al., 2006). It is the opinion of Anderson (1992) that 
in cases where disease can be predicted, losses may be reduced by elevating non-specific 
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defence mechanisms through the use of immunostimulants to prevent losses from 
diseases. The non-specific immune system has evolved towards recognition of 
structurally conserved microbial polymers such as fungal cell wall ß-glucans, bacterial 
lipopolysaccharide (LPS), bacterial DNA and double-stranded RNA (dsRNA) 
(Robertsen, 1999). In the last decade, many studies have focused on the use of 
immunostimulants in fish farming as alternatives or supplements to vaccination or 
chemotherapeutants (Salinas et al., 2004). Currently used fish immunostimulants, 
inclusive of both synthetic chemicals and biological substances have been reviewed Sakai 
(1999); (Bricknell and Dalmo, 2005), however, there are no records of any of them 
having an effect towards IPNV. Most of these studies have focused on the protection 
against bacterial pathogens and/or non-specific immune parameters such as phagocytic, 
complement or lysozyme activities whilst studies on increased protection against viral 
infection are scarce. Thus, the ability of the immunostimulants macrophage activation 
factor (MAF), lipopolysaccharide (LPS) and glucan to protect macrophages from 
infection with IPNV will be investigated in this chapter.  
 
The aims of this chapter are: 
a) To determine whether IPNV infects Atlantic salmon head kidney macrophages 
in vitro and if so is it able to replicate? (i.e. to a level greater than that contained 
in the inoculums used to infect macrophages). 
b) To characterise the IFN response of Atlantic salmon macrophages to IPNV: 
specifically to determine whether IPNV induces an Mx response, how this 
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compares to that induced by IFN, and whether IFN affects the replication and 
persistence of IPNV within macrophages.  
c) To investigate the effects of immunostimulants on the macrophage IFN 
response to IPNV. The effects of glucan, MAF and LPS on IFN and Mx 
expression will be determined in IPNV-infected macrophages and uninfected 
controls. The effects of these immunostimulants on IPNV replication will also be 
studied.  
d) Preparations of IFN are required to perform the experimental work outlined 
above, thus the chapter also includes a description of the methodology used to 
produce IFN from Atlantic salmon head kidney macrophages. 
5.2    Materials and Methods  
5.2.1  Production of IFN-preparations from Atlantic salmon macrophages 
Head kidneys were obtained from Atlantic salmon as outlined in section 2.2.2. 
Macrophages were isolated on 51% percoll as described in section 2.2.3 and maintained 
in culture as described in section 2.2.5. After 24 hours the macrophages were washed 
once in L-15 medium and then cultured in the same medium containing Poly I:C as 
described in section 4.2.2, whilst control wells received only L-15 medium in place of 
Poly I:C. After 12 hours, the cells were washed three times with L-15 medium and then 
cultured in fresh L-15 supplemented with 50 units ml-1 penicillin, 50µg ml-1 streptomycin 
and 5% FCS, at 15°C. The culture medium was harvested after 48 hours, centrifuged for 
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10 minutes at 400 x g and then the supernatant stored in aliquots at -70ºC until assayed 
for IFN activity.  
5.2.2  Efficacy of IFN-preparations in stimulation of Mx response  
Detection of IFN-like activity in the macrophage supernatants was performed using 
RTG-P1 cells, obtained from the Marine laboratory, Aberdeen. RTG-P1 cells are 
transfected with a luciferase reporter gene under the control of the Mx promoter gene 
(Collet et al., 2004), thus the transcriptional activity of the Mx promoter can be readily 
quantified through luciferase assays. RTG-P1 cells were cultured in L-15 medium 
supplemented with 10% FCS and 200µg ml-1 Neomycin (Sigma) at 20ºC. RTG-P1 cells 
were grown to 100% confluence and seeded onto 24 well plates and incubated overnight 
at 20ºC. The following day 500µl of the macrophage supernatant was added to the RTG-
P1 cells in triplicate wells and incubated for 48 hours at 20ºC. Controls received 
supernatants originating from untreated macrophages and L-15 medium which had no 
previous contact with macrophages. The supernatants were removed and 100µl of 
luciferase substrate (Steady-Glo, Promega) was added to the wells for 2 minutes and the 
resulting cell lysate was stored at -70ºC prior to testing for luciferase expression.  
5.2.3  Luciferase assay 
Luciferase activity was measured by a luciferin-ATP assay and photon emission was 
measured using a MLX luminometer (Dynex Tecnology) by recording the integrated sum 
of light emitted for 10 seconds and expressed as relative light units (RLU). Results are 
expressed as the mean (N=3) ± SD of the luciferase activity expressed by RTG-P1 cells. 
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Data was analysed on the MINITAB software package by a one-way ANOVA, and a 
Tukey’s test was used perform comparisons between the luciferase activating properties 
of the IFN supernatants. Differences were considered statistically significant when 
P<0.05.  
5.2.4  Production of MAF containing supernatants by salmon leucocytes  
Head kidneys were obtained from Atlantic salmon as outlined in section 2.2.2. The head 
kidney cell suspension was layered over 51% percoll gradients and centrifuged at 400 x g 
for 30 minutes at 4°C. The leucocyte fraction was removed from the percoll-medium 
interface and then washed in serum free L-15 medium. The leucocytes were adjusted to a 
concentration of 5 x 10-6 live cells/ml L-15 medium containing 5 x 10-5 M 2-
mercaptoethanol (2ME). 25cm2 tissue culture flasks were then seeded with 5ml aliquots 
of the leucocyte suspension and pulsed for 3 hours at 15°C with concanavalin A (ConA); 
(Sigma) 10µg/ml-1 and 5ng/ml-1 phorbol myristate acetate (PMA); (Sigma). Cells were 
then washed three times with phosphate buffered saline to remove any residual ConA and 
PMA and cultured in L-15 medium containing 10% FCS at 15ºC. Immediately after 
addition of the medium, 300µl was removed from each flask and frozen to provide a 
control to show that any observed effects result from the MAF supernatant and not from 
any remaining residual Con A or PMA. After 48 hours, the supernatants were harvested, 
centrifuged and stored at -70ºC until use.  
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5.2.5  Measurement of MAF activity  
Head kidneys were obtained from Atlantic salmon as outlined in section 2.2.2. 
Macrophages were isolated on 51% percoll as described in section 2.2.3 and maintained 
in culture as described in section 2.2.5. The cell suspension was seeded into 96 well 
culture plates, adding 100µl to each well. Unattached cells were washed off after 3 hours 
and the macrophage monolayers were maintained in L-15 medium supplemented with 50 
units ml-1 penicillin, 50µg ml-1 streptomycin and 5% FCS overnight. The following day 
the culture medium was removed and replaced with MAF-containing supernatants diluted 
1:4 and 1:8 in L-15 medium, 10% FCS and 5 x 10-5 M 2ME. These macrophage 
monolayers were incubated with the MAF supernatants for 48 hours. After incubation, 
the macrophage activating properties of the supernatants were evaluated by respiratory 
burst assays. Triplicate wells in 96 well plates of macrophages were incubated with 100µl 
of L-15 medium containing 1mg/ml nitroblue tetrazolium (NBT); (Sigma) and 1µl/ml 
PMA for 30 minutes whilst control wells were incubated with 100µl of L-15 medium 
containing 1mg/ml NBT. The reaction was stopped by fixing the macrophages with 
100% methanol, followed by washing with 70% methanol to remove any extracellular 
formazan. The reduced intracellular formazan was solubilised in 120µl 2M potassium 
hydroxide (KOH) and 140µl dimethyl sulfoxide (DMSO). The plates were then read at a 
wavelength of 620nm using a plate reader.  
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5.2.6  Lipopolysaccharide (LPS) and glucan 
LPS was kindly provided by Remi Gratacap, Department of Aquaculture, Stirling 
University, and was extracted from the marine pathogen Vibrio anguillarum using butan-
1-ol (Gratacap pers comm.). Laminarin was purchased from Sigma in order to make the 
glucan supernatants. Laminarin and LPS were resuspended in L-15 medium to 100µg ml-
1
 and 10µg ml-1 respectively. 
5.2.7  Isolation of macrophages to obtain macrophage monolayers for in vitro 
experiments   
Head kidneys were obtained from Atlantic salmon (section 2.2.2) and macrophages were  
isolated on 51% percoll as described in 2.2.4. Macrophages were seeded into 24 well 
plates at concentrations of 2 x 10-7 cells ml-1 and maintained at 15°C as described in 
section 2.2.5. 
5.2.8  In vitro virus infection in isolated macrophages 
In this chapter, two experiments were performed. Firstly, a trial infection of Atlantic 
salmon head kidney macrophages with IPNV was conducted. As this thesis is concerned 
with the interaction between IPNV and the macrophage innate immune response, it was 
necessary to demonstrate that Atlantic salmon macrophages could be infected with IPNV  
(i.e. – that the level of IPNV in infected macrophages increases over that contained in the 
inoculum used to infect these cells). To conduct the experiment, macrophage monolayers 
were processed following the guidelines as set out below regarding the positive control 
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group and negative control group. The IPNV levels in macrophages were examined by 
conducting RNA extraction on the macrophage monolayers immediately after infection 
(time 0) and at days 1,3,5,7 and 9 days post-infection, following the modified protocol as 
described in section 3.2.5. In the second experiment the ability of a number of different 
immunostimulants to protect macrophages from infection with IPNV were investigated. 
To conduct this experiment the macrophage monolayers were processed in triplicate 
using one of the following ten treatments at 15°C. Inoculation of virus for the treatment 
groups was performed as described in section 2.2.7. 
 
a) IFN-stimulated group. Macrophages were incubated for 24 hours with IFN 
supernatants only. 
b) IFN-stimulated and IPNV-infected group. Macrophages were incubated for 24 
hours with IFN supernatants prior to infection with IPNV at an MOI of 1.  
c) LPS-stimulated group. Macrophages were incubated for 24 hours with L-15 
medium, supplemented with 50 units ml-1 penicillin, 50µg ml-1 streptomycin and 
5% FCS, containing LPS at 10µg ml-1 only  
d) LPS-stimulated and IPNV-infected group. Macrophages were incubated for 24 
hours with L-15, supplemented with 50 units ml-1 penicillin, 50µg ml-1 
streptomycin and 5% FCS, containing LPS at 10µg ml-1 prior to infection with 
IPNV at an MOI of 1.  
e) MAF-stimulated group. Macrophages were incubated for 24 hours with MAF 
diluted 1:8 in L- 15 medium, supplemented with 50 units ml-1 penicillin, 50µg ml-
1
 streptomycin and 5% FCS only.  
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f) MAF-stimulated and IPNV-infected group. Macrophages were incubated for 24 
hours with MAF diluted 1:8 in L-15 medium, supplemented with 50 units ml-1 
penicillin, 50µg ml-1 streptomycin and 5% FCS, prior to infection with IPNV at 
an MOI of 1.  
g) Glucan-stimulated group. Macrophages were incubated for 24 hours with L-15 
medium, supplemented with 50 units ml-1 penicillin, 50µg ml-1 streptomycin and 
5% FCS, containing glucan at 100µg ml-1 only.  
h) Glucan-stimulated and IPNV-infected group. Macrophages were incubated for 
24 hours with L-15 medium, supplemented with 50 units ml-1 penicillin, 50µg ml-
1
 streptomycin and 5% FCS, containing glucan at 100µg ml-1 prior to infection 
with IPNV at an MOI of 1.  
i) Positive control group. Macrophages were infected with IPNV at an MOI of 1.  
j) Negative control group. Macrophages were maintained in L-15 medium 
supplemented with 50 units ml-1 penicillin, 50µg ml-1 streptomycin and 5% FCS 
at 15ºC.  
 
Between 1-9 days post treatment the monolayers were washed three times with L-15 
medium and the RNA was extracted following the modified TRIzol protocol as described 
in section 3.2.5. RNA was extracted from macrophage monolayers sampled on a daily 
basis until 9 days post infection from macrophages groups a and b as described in section. 
However, RNA was extracted from macrophage groups c – h on 1, 3, 6 and 9 days post 
infection. In these latter groups, reducing the number of sampling time points lowered the 
number of macrophages required to perform an experiment. The reduction in sampling 
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points did not compromise results as the sampling points were carefully selected so as to 
permit analysis of expression of the chosen targets subsequent to treatment.  
5.2.9  Real time q RT-PCR of extracted RNA 
The quality and quantity of the extracted RNA were evaluated using a Nanodrop 
Spectrophotometer. All samples were diluted to 100ng/µl in RNAse/DNAse free water 
prior to first strand synthesis. Two-step RT-PCR was performed on extracted RNA 
following the steps outlined in section 4.2.3 and 4.3. All the samples were tested for the 
presence of Mx, IFN and IPNV. The results of the real time amplification of each target 
was expressed as a ratio to the internal RT-PCR control ELF-1, using the Pfaffl 
mathematical equation for relative quantification (Figure 20). Prior to treatments, RNA 
was extracted from macrophages to identify the normal expression values for each of the 
targets investigated in the experiment. This time point was termed “time 0” and the 
experimental data obtained from it was used in the relative quantitation calculation. 
5.2.10  Statistical analysis of gene expression in macrophages 
Results are expressed as the relative expression ratio between the target of interest and 
ELF-1 house keeping gene. Data was analysed on the MINITAB software package by a 
two way ANOVA, and a Tukey’s test was used to perform multiple comparisons to 
determine the differences between the treatments and time during the course of the 
experiment. Differences were considered statistically significant when P<0.05.  
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5.2.11  Detection of extracellular IPNV    
Prior to extraction of RNA from the macrophage monolayer the culture medium was 
tested for the presence of extracellular IPNV as described in section 2.2.8.  
5.3    Results  
5.3.1  IPNV levels in infected macrophages  
Levels of IPNV in infected macrophages and uninfected controls were monitored by real 
time RT-PCR and were calculated relative to the expression of the “housekeeping gene” 
ELF-1 (Figure 21 and Figure 22). The two way ANOVA results of Figure 23 shows that 
both treatment, time and a combination of treatment and time had a significant effect on 
IPNV:ELF-1 expression (P=0.001). The Tukey test revealed that there was a significant 
difference between IPNV levels immediately after infection (i.e. time 0), and at 
subsequent time points (day 1 P = < 0.0001, day 3 P = 0.0001, day 5 P = < 0.0001, day 7 
P = 0.0002, day 9 P = 0.0006). IPNV levels were elevated at all time points studied, and 
were greatest at days 1, 3, and 5 post infection Figure 24. These data strongly suggest that 
IPNV has the ability to replicate in Atlantic salmon head kidney macrophages maintained 
in vitro. No IPNV was detected in uninfected control macrophages.  
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Figure 21: IPNV levels in infected Atlantic salmon macrophages and uninfected controls. The 
figure shows a RT-PCR amplification plot performed with ELF-1 and IPNV-specific primers and 
probe of  macrophage cDNA. The cDNA samples were taken from IPNV-infected macrophages 
and controls at 0 hours (a) and 24 hours (b) post infection. IPNV levels were quantified relative to 
expression of the housekeeping gene ELF-1 (c) using the method described by Pfaffl for relative 
quantification. The difference in IPNV Ct values between the time 0 and 24h samples (a and b) is 
clearly evident, whereas the Ct values for ELF-1 from these time points remains relatively 
constant (c). No template controls and RT- controls were incorporated into amplification runs (d).  
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Figure 22: IPNV levels in infected Atlantic salmon macrophages and uninfected controls. The 
figure shows an RT-PCR amplification plot performed with ELF-1 and IPNV-specific primers 
and probe of macrophage cDNA. The cDNA samples were taken from IPNV-infected 
macrophages and controls at 5 days post infection. IPNV levels (a) were quantified relative to 
expression of the housekeeping gene ELF-1 (b) using the method described by Pfaffl. No 
template controls and RT- controls were incorporated into amplification runs (d).  
 
Analysis of Variance for Ratio, using Adjusted SS for Tests 
 
Source         DF     Seq SS     Adj SS     Adj MS       F      P 
Time            4  346998335  346998335   86749584   20.14  0.001 
Treatment       1  246442562  246442562  246442562   57.22  0.001 
Time*Treatment   4  346856241  346856241   86714060   20.13  0.001 
Error          20   86141676   86141676    4307084 
Total          29 1026438814   
 
Figure 23: Two way ANOVA results for relative IPNV:ELF-1 expressed in IPNV inoculated 
Atlantic salmon head kidney macrophages and negative controls over time. Differences were 
considered statistically significant when P <0.05.  
 
Chapter 5: Induction and effect of immunostimulants in type I IFN response 
 
96 
-5000
0
5000
10000
15000
20000
25000
30000
0 1 3 5 7 9
Days post infection 
IP
NV
:E
LF
 
ra
tio
Neg 
IPNV
 
 
Figure 24: Levels of IPNV in Atlantic salmon head kidney macrophages and uninfected controls 
detected by qRT-PCR. IPNV levels were studied over a period of 9 days post-infection, and were 
quantified in relation to expression of the housekeeping gene ELF-1 using method described by 
Pfaffl.  
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5.3.2  Preparation of IFN-preparations 
IFN for use in macrophage stimulation experiments was produced by harvesting the 
culture medium of cells stimulated with poly I:C, which is a potent IFN-inducer. The 
efficacy of IFN preparations was tested with a RTG-1 cell-based assay that utilised a 
luciferase reporter gene. A triplicate of IFN preparations were tested, these were 
designated Poly 1, Poly 2, Poly 3 and Poly neg (Figure 25). The one way ANOVA results  
(Figure 26) shows that there is significant difference in the ability of the IFN supernatants 
to induce luciferase activity (P = 0.001). The tukey test revealed that after 24 hours of 
stimulation with IFN there was a significant increase in luciferase activity (P = <0.0001) 
in RTG-P1 cells compared to negative controls (RTG-1 cells receiving no Poly I:C 
treatment or L-15 medium). IFN-preparation “Poly 1” induced expression of the 
luciferase reporter to the greatest extent; therefore, this preparation was selected for use 
in macrophage stimulation experiments.  
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Figure 25: Induction of the Mx-promoter reporter gene activity by IFN containing supernatants in 
RTG-P1 cells. Histogram bars represent mean luciferase activity expressed in RLU (N = 3) ± SD. 
* indicates that the RLU value of an IFN preparation was significantly greater than that exhibited 
by the negative control (P < 0.05).  
 
 
Analysis of Variance for Luciferase activity, using Adjusted SS for Tests 
 
Source     DF     Seq SS     Adj SS     Adj MS       F      P 
Treatment   4   37143087   37143087    9285772  154.99  0.001 
Error      10     599132     599132      59913 
Total      14   37742220   
 
Figure 26: One way ANOVA results for Luciferase activity expressed in RTG-P1 cells stimulated 
with IFN supernatant compared to negative controls. Differences were considered statistically 
significant when P <0.05.  
 
   * 
      * 
* 
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5.3.3  Assessment of MAF activity in supernatants  
It was not possible to confirm the efficacy of the MAF preparations used in this study. 
Numerous attempts were performed to test the MAF preparations; however, no positive 
results were obtained.  
 
5.3.4  Expression of innate immune genes by Atlantic salmon macrophages in 
response to IFN treatment 
According to Collet et al., (2007) the expression of Mx is up-regulated after Poly I:C 
treatment or incubation with conditioned medium containing an IFN-like activity. 
Therefore, as Mx is widely regarded as a marker for IFN expression (Robertsen, et al., 
1997; Nygaard et al., 2000), incubation of the Atlantic salmon macrophages with the IFN 
preparations described in section 5.2.1 should induce IFN expression. However, no IFN-
expression occurred in any of macrophage groups studied throughout the course of the 
experiment (Figure 27). The two-way ANOVA report of IFN:ELF-1 expression shows 
that there is no significant difference in the ability of the treatments (P = 0.948), time (P = 
0.130) or a combination of treatment and time (P = 0.089) to induce IFN expression 
(Figure 28). The tukey test revealed that there was no significant difference in levels of 
IFN expression between IPNV-infected macrophages and uninfected controls at any 
sampling point studied (P = 1.0000). However, some experimental groups of 
macrophages did exhibit elevated expression of Mx expression (Figure 29). This could 
potentially be a reflection of the time points chosen in this series of experiments. It is 
Chapter 5: Induction and effect of immunostimulants in type I IFN response 
 
100 
theoretically possible that transient IFN expression could occur in the initial stages of 
infection. Such expression would not be detected in this experiment because of the timing 
of sampling points. The two way ANOVA report of Mx:ELF-1 expression shows that 
there was a significant difference in the ability of the treatments (P = 0.001), time (P = 
0.001) and a combination of time and treatment (P = 0.007) to induce Mx expression. The 
tukey test revealed that uninfected macrophages stimulated with IFN exhibited 
significantly increased levels of Mx expression as compared to unstimulated controls day 
1, 3, 4, 5, 7 P =0.0001; day 2 P = 0.0004; day 8 P = 0.0089; day 9 P = 0.0002) (Figure 
29). For both groups of macrophages stimulated with IFN, Mx expression was greatest at 
2 days post treatment, and was elevated throughout the course of the experiment. 
Interestingly, macrophages that were treated with IFN prior to infection with IPNV 
exhibited levels of Mx expression that closely mirrored those occurring in IFN-treated 
but uninfected macrophages. There was no significant difference between levels of Mx 
expression within these two experimental groups at any time point studied (P = 1.0000). 
Interestingly, Mx expression in IPNV-infected macrophages was not statistically different 
from that observed in uninfected controls at any of the sampling time points (P >0.9929). 
This result suggests that IPNV-infected macrophages do not exhibit increased expression 
of Mx.  
 
 
 
 
 
Chapter 5: Induction and effect of immunostimulants in type I IFN response 
 
101 
0
0.1
0.2
0.3
0.4
1 2 3 4 5 7 8 9
Days post treatment
IF
N:
EL
F-
1 
ra
tio Neg
IFN
IFN + IPNV
IPNV
 
Figure 27: IFN expression in Atlantic salmon head kidney macrophages determined by qRT-
PCR. The following experimental groups were studied: (a) IPNV-infected; (b) IFN-stimulated 
and IPNV-infected; (c) IFN stimulated and (d) untreated macrophages.  Expression of IFN was 
investigated over a period of nine days post-infection and was estimated in relation to expression 
of the housekeeping gene ELF-1. Data represent mean IFN:ELF-1 ratio (N = 3) ± SD. 
 
Analysis of Variance for IFN:ELF-1 ratio, using Adjusted SS for Tests 
 
Source         DF     Seq SS     Adj SS     Adj MS       F      P 
Time            7  0.0020073  0.0020073  0.0002868    1.68  0.130 
Treatmen        3  0.0000615  0.0000615  0.0000205    0.12  0.948 
Time*Treatmen  21  0.0055969  0.0055969  0.0002665    1.56  0.089 
Error          64  0.0109333  0.0109333  0.0001708 
Total          95  0.0185990   
 
Figure 28: Two way ANOVA results for relative IFN:ELF-1 expression in (a) IPNV-infected; (b) 
IFN-stimulated and IPNV-infected; (c) IFN stimulated and (d) untreated Atlantic salmon head 
kidney macrophages over time. Differences were considered statistically significant when 
P<0.05.  
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Figure 29: Mx expression in Atlantic salmon head kidney macrophages determined by qRT-PCR. 
The following experimental groups were studied: (a) IPNV-infected; (b) IFN-stimulated and 
IPNV-infected; (c) IFN stimulated and (d) untreated macrophages. Expression of Mx was 
investigated over a period of nine days post-infection and was estimated in relation to expression 
of the housekeeping gene ELF-1. Data represent mean Mx:ELF-1 ratio (N = 3) ± SD. 
 
 
Analysis of Variance for Mx:ELF-1 ratio, using Adjusted SS for Tests 
 
Source         DF     Seq SS     Adj SS     Adj MS       F      P 
Time            7     31.865     31.865      4.552   10.88  0.001 
Treatmen        3    292.005    292.005     97.335  232.69  0.001 
Time*Treatmen  21     19.629     19.629      0.935    2.23  0.007 
Error          64     26.771     26.771      0.418 
Total          95    370.270   
 
Figure 30: Two way ANOVA results for relative Mx:ELF-1 expression in (a) IPNV-infected; (b) 
IFN-stimulated and IPNV-infected; (c) IFN stimulated and (d) untreated Atlantic salmon head 
kidney macrophages over time. Differences were considered statistically significant when 
P<0.05.  
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5.3.5  Expression of innate immune genes by Atlantic salmon macrophages in 
response to treatment with immunostimulants.   
No IFN or Mx expression was detected in macrophages treated with either MAF, glucan, 
or LPS (Figure 31 and Figure 33). The absence of Mx and IFN expression within 
immunostimulant treated macrophages may be a consequence of the inability of the these 
substances to induce a macrophage type I IFN response. The results also suggest that 
IPNV infection of macrophages may result in suppression of the IFN response. The two-
way ANOVA results of Figure 32 shows that neither treatment (P = 0.151), time (P = 
0.579) or a combination of treatment and time (P = 0.090) had a significant effect on the 
expression of IFN. Likewise, the two-way ANOVA results of Figure 34 show that neither 
treatment (P = 0.381), time (P = 0.914) or a combination of treatment and time (P = 
0.232) had a significant effect on Mx expression. The tukey test revealed that there was 
no significant difference in the IFN expression detected in infected macrophages and in 
negative controls at any time in the experiment (P = 1.0000). No experimental groups 
(i.e. experimental groups c-h (section 5.2.8) exhibited an Mx response that was 
significantly greater than that occurring in negative controls. MAF-containing 
supernatants, glucan and LPS did not induce Mx expression within macrophages at any 
time point during the experiment. Interestingly, macrophages failed to produce Mx 
response in response to IPNV infection, in agreement with results from the IPNV-
infected positive control group in the experiment described above (section 5.3.4). IPNV-
infected positive control macrophages showed no significant increase in expression of 
Mx when compared to the negative control macrophages at any of the sampling points 
studied (P = 1.0000 at days 1, 3 and 6 with P = 0.5844 day 9).   
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Figure 31: IFN expression in Atlantic salmon head kidney macrophages determined by qRT-
PCR. The following experimental groups were studied: (a) IPNV-infected; (b) MAF-stimulated 
and IPNV-infected; (c) MAF stimulated (d) glucan-stimulated and IPNV-infected; (e) glucan 
stimulated (f) LPS-stimulated and IPNV-infected; (g) LPS stimulated; (h) Untreated 
macrophages. Expression of IFN was investigated over a period of nine days post-infection and 
was estimated in relation to expression of the housekeeping gene ELF-1. Data represent mean 
IFN:ELF-1 ratio (N = 3) ± SD. 
 
 
Analysis of Variance for IFN:ELF-1 ratio, using Adjusted SS for Tests 
 
Source         DF     Seq SS     Adj SS     Adj MS       F      P 
Time            3  0.0001281  0.0001281  0.0000427    0.66  0.579 
Treatmen        7  0.0007240  0.0007240  0.0001034    1.60  0.151 
Time*Treatmen  21  0.0021135  0.0021135  0.0001006    1.56  0.090 
Error          64  0.0041333  0.0041333  0.0000646 
Total          95  0.0070990   
 
Figure 32: Two way ANOVA results for relative IFN:ELF-1 expression in (a) IPNV-infected; (b) 
MAF-stimulated and IPNV-infected; (c) MAF stimulated (d) glucan-stimulated and IPNV-
infected; (e) glucan stimulated (f) LPS-stimulated and IPNV-infected; (g) LPS stimulated; (h) 
Untreated Atlantic salmon head kidney macrophages over time. Differences were considered 
statistically significant when P<0.05.  
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Figure 33: Mx expression in Atlantic salmon head kidney macrophages determined by qRT-PCR. 
The following experimental groups were studied: (a) IPNV-infected; (b) MAF-stimulated and 
IPNV-infected; (c) MAF stimulated (d) glucan-stimulated and IPNV-infected; (e) glucan 
stimulated (f) LPS-stimulated and IPNV-infected; (g) LPS stimulated; (h) Untreated 
macrophages. Expression of Mx was investigated over a period of nine days post-infection and 
was estimated in relation to expression of the housekeeping gene ELF-1. Data represent mean 
Mx:ELF-1 ratio (N = 3) ± SD. 
 
 
 
Analysis of Variance for Mx:ELF-1, using Adjusted SS for Tests 
 
Source         DF     Seq SS     Adj SS     Adj MS       F      P 
Time            3  0.0000365  0.0000365  0.0000122    0.17  0.914 
Treatmen        7  0.0005323  0.0005323  0.0000760    1.09  0.381 
Time*Treatmen  21  0.0018552  0.0018552  0.0000883    1.27  0.232 
Error          64  0.0044667  0.0044667  0.0000698 
 
Figure 34: Two way ANOVA results for relative Mx:ELF-1 expression in (a) IPNV-infected; (b) 
MAF-stimulated and IPNV-infected; (c) MAF stimulated (d) glucan-stimulated and IPNV-
infected; (e) glucan stimulated (f) LPS-stimulated and IPNV-infected; (g) LPS stimulated; (h) 
Untreated Atlantic salmon head kidney macrophages over time. Differences were considered 
statistically significant when P<0.05.  
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5.3.6  IPNV levels in IFN-treated macrophages  
Levels of IPNV in infected macrophages treated with IFN and untreated controls (i.e. 
experimental groups b and i, section 5.2.8) were monitored by real-time RT-PCR. IPNV 
was detected in both experimental groups of macrophages that were infected with this 
virus (Figure 35). These included macrophages that had been exposed to IFN prior to 
infection indicating that IFN does not protect macrophages from infection with IPNV. 
The two-way ANOVA results (Figure 36) show that treatment (P = 0.001), time (P = 
0.002) and a combination of time and treatment (P = 0.001) had a significant effect on 
IPNV expression. The tukey test revealed that the negative control macrophages 
exhibited statistically different IPNV:ELF-1 expression compared to those treated with 
IFN + IPNV (P = <0.0001) and IPNV (P = <0.0001 on all days apart from day 2; P = 
0.9929) throughout the duration of the experiment. IPNV levels were elevated at 1 day 
post-inoculation, and peaked at 5 days in positive control infected macrophages. 
However, there was no significant difference between the IPNV:ELF-1 ratios on day 1 
and 5 post infection (P = 1.0000) or day 4 and 5 post infection (P = 0.9222). Infected 
macrophages stimulated with IFN exhibited peak virus levels at 3 days post-inoculation. 
However there was no significant difference between day 1 and 3 (P =1.0000) or day 2 
and 3 (P = 1.0000). Therefore, as an increase in the mean IPNV:ELF-1 data was observed 
(Figure 35) it is probable  that the virus replicated in the macrophages following infection 
at a low level. Virus levels tended to decrease at the later time points; therefore, it is 
possible that intracellular virus may have been broken down by the macrophages. The 
absence of infectious IPNV in the growth media of infected macrophages as assessed by 
virus isolation in CHSE-214 cells lends support to this conclusion. There was a 
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significant difference between the IPNV:ELF-1 ratio occurring on day 1 and that 
occurring on day 9 for IFN-stimulated and IPNV-infected macrophage groups (P = 
0.0011). However there was no significant difference in IPNV levels on day 1 (P= 
0.9503) day 5 (P = 0.1170) and day 9. This suggests that IFN treatment promotes a 
reduction in IPNV levels in infected macrophages, which could limit the ability of IPNV 
to persist in these cells. No IPNV was detected in negative control groups (uninfected-
macrophages, and IFN stimulated uninfected macrophages).  
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Figure 35: IPNV expression in Atlantic salmon head kidney macrophages determined by qRT-
PCR. The following experimental groups were studied: (a) IPNV-infected; (b) IFN-stimulated 
and IPNV-infected; (c) IFN stimulated and (d) untreated macrophages.  Expression of IPNV was 
investigated over a period of nine days post-infection and was estimated in relation to expression 
of the housekeeping gene ELF-1. Data represent mean IPNV:ELF-1 ratio (N = 3) ± SD. 
 
Analysis of Variance for IPNV:ELF-1, using Adjusted SS for Tests 
 
Source         DF     Seq SS     Adj SS     Adj MS       F      P 
Time            7     11.594     11.594      1.656    3.70  0.002 
Treatmen        3   1598.458   1598.458    532.819 1189.14  0.001 
Time*Treatmen  21     32.432     32.432      1.544    3.45  0.001 
Error          64     28.676     28.676      0.448 
Total          95   1671.160   
 
Figure 36: Two way ANOVA results for relative IPNV:ELF-1 expression in (a) IPNV-infected; 
(b) IFN-stimulated and IPNV-infected; (c) IFN stimulated and (d) untreated Atlantic salmon head 
kidney macrophages over time. Differences were considered statistically significant when 
P<0.05.  
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5.3.7  IPNV levels in immunostimulant-treated macrophages.   
Treatment of macrophages (experimental groups c-h section 5.2.8) with 
immunostimulants did not prevent infection with IPNV, since infected macrophages 
exhibited raised IPNV:ELF-1 ratios compared to uninfected cells (Figure 37). The two-
way ANOVA results (Figure 38) shows that treatment (P = 0.001), time (P = 0.001) and a 
combination of treatment and time (P = 0.012) had a significant effect on IPNV 
expression. The tukey test revealed that a significant difference in IPNV:ELF-1 ratios 
was evident between the negative control macrophages and those exposed to LPS and 
IPNV, IPNV, MAF and IPNV, and glucan and IPNV treatments throughout the duration 
of the experiment (P = 0.0001). As expected macrophages treated only with 
immunostimulants and the negative control treatment group showed the lowest 
IPNV:ELF-1 ratio of all experimental groups. Macrophages receiving only glucan, LPS 
or MAF were all shown to have significantly different IPNV:ELF-1 ratios (P = 0.0001) 
compared to those receiving glucan + IPNV, LPS + IPNV or MAF + IPNV for all of the 
sampling points. The highest IPNV:ELF-1 ratios were observed in macrophages treated 
with MAF and glucan prior to exposure to IPNV. Macrophages stimulated with MAF 
prior to infection with IPNV were found to have significantly different IPNV:ELF-1 
ratios compared to IPNV infected positive control macrophages at 6 days (P = 0.0001) 
and 9 days post infection (P = 0.0015). Similarly, macrophages stimulated with glucan 
prior to infection were also found to have significantly different IPNV:ELF-1 ratios 
compared to IPNV infected positive control macrophages on day 6 (P =0.0071) and 9 
days post treatment (P = 0.0091). Macrophages stimulated with MAF and glucan prior to 
infection exhibited similar levels of IPNV:ELF-1 ratios over time, with increases evident 
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from day 1 that peaked at day 6, however these increases were not statistically significant 
for either MAF (P =0.2069) or glucan (P =0.4628). IPNV:ELF-1 ratios subsequently 
declined between days 6 and day 9. Whilst Figure 37 showed an increase in IPNV:ELF-1 
ratios during the experiment, the increase in IPNV:ELF1 ratios between day 1 and 9 post 
infection was not proven significantly different in the macrophages stimulated with MAF 
(P = 0.6733), glucan (P = 0.7128)  or LPS (P = 0.1934) prior to infection. In the positive 
control group there was also no significant difference between the day 1 and 9 
IPNV:ELF-1 ratios (P = 0.9999). As observed in the IPNV infected macrophages in the 
IFN experiment (section 5.3.6) whilst there appears to be an increase in the IPNV levels 
(Figure 35), this did not attain statistical significance. Therefore, it is likely that the virus 
replicated at low levels in the macrophages following infection. This suggests that, as 
there was no significant reduction in the viral levels during the experiment MAF, glucan 
or LPS are unlikely to represent effective treatments for IPN. However, it is possible that 
these substances could influence immune function in cell types other than macrophages. 
No IPNV was detected in negative control groups (uninfected macrophages, and MAF, 
glucan and LPS stimulated uninfected macrophages).  
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Figure 37: IPNV expression in Atlantic salmon head kidney macrophages determined by qRT-
PCR. The following experimental groups were studied: (a) IPNV-infected; (b) MAF-stimulated 
and IPNV-infected; (c) MAF stimulated (d) glucan-stimulated and IPNV-infected; (e) glucan 
stimulated (f) LPS-stimulated and IPNV-infected; (g) LPS stimulated; (h) untreated macrophages. 
Expression of IPNV was investigated over a period of nine days post-infection and was estimated 
in relation to expression of the housekeeping gene ELF-1. Data represent mean IPNV:ELF-1 ratio 
(N = 3) ± SD. 
 
 
Analysis of Variance for IPNV:ELF-1 ratio, using Adjusted SS for Tests 
 
Source         DF     Seq SS     Adj SS     Adj MS       F      P 
Time            3     12.785     12.785      4.262   31.12  0.001 
Treatment       7    706.160    706.160    100.880  736.69  0.001 
Time*Treatment 21      6.080      6.080      0.290    2.11  0.012 
Error          64      8.764      8.764      0.137 
Total          95    733.789   
 
Figure 38: Two way ANOVA results for relative IPNV:ELF-1 expression in (a) IPNV-infected; 
(b) MAF-stimulated and IPNV-infected; (c) MAF stimulated (d) glucan-stimulated and IPNV-
infected; (e) glucan stimulated (f) LPS-stimulated and IPNV-infected; (g) LPS stimulated; (h) 
untreated Atlantic salmon head kidney macrophages over time. Differences were considered 
statistically significant when P<0.05.  
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5.3.8  Determination of IPNV levels in the culture media of infected macrophages  
No CPE was observed in CHSE-214 monolayers inoculated with culture media from any 
experimental group of IPNV-infected macrophages. This indicates that IPNV-infected 
macrophages do not release virus into the macrophage culture medium during the course 
of the experiments. In response to IPNV infection, it has been observed in both 
experiments that the IPNV-infected macrophages do not express Mx (sections 5.3.4 and 
5.3.5). This observation, combined with the results of the present experiment suggest that 
IPNV may have the ability to suppress the type I IFN response in macrophages, which in 
turn may facilitate the development of a carrier state that occurs in IPN of Atlantic 
salmon.  
5.4    Discussion 
5.4.1  IPNV levels in infected macrophages in vitro 
IPNV:ELF-1 ratios increased between time 0 and 1 day post infection (Figure 24, P = 
<0.0001) demonstrating that it is possible to infect Atlantic salmon head kidney 
macrophages with IPNV in vitro. In the context of the aims of this thesis, this validation 
is essential. Without confirmation that it is possible to successfully infect macrophages in 
vitro would not be possible to conclude that IPNV levels are associated with replicating 
virus as opposed to virus which has adhered to cells and then decayed during the course 
of experiments. Furthermore, without this data, it would not be possible to draw 
conclusions on the ability of immunostimulants to mitigate infection or to aid 
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macrophages in clearing virus. Figure 24 indicates that IPNV levels in macrophages are 
elevated in comparison to those occurring immediately after infection at all time points 
studied. The data also suggest that peak levels of IPNV replication occur in the early 
stages of infection, and that replication declines at the later time points studied. The 
persistence of low levels of virus in macrophages in vitro for up to 9 days, as noted in this 
study, is in agreement with the findings of Yu et al., (1982), Johansen and Sommer 
(1995), Novoa et al., (1996), Munro et al., (2006) and Collet et al., (2007) However only 
Yu et al., (1982) and Johansen and Sommer (1995) have suggested that IPNV can 
replicate within macrophages in vitro. The results of the present study therefore agree 
with other studies that suggest there is a potential role for head kidney macrophages in 
maintaining an IPNV carrier state in Atlantic salmon. The results of this experiment 
indicate that IPNV replicates within macrophages in vitro. On this basis, it was possible 
to pursue the subsequent objectives of this thesis. These are described in the ensuing 
sections of this chapter, and in chapter 6. 
5.4.2  Effect of IPNV infection on the innate immune response of macrophages in 
vitro 
One objective of this chapter was to investigate the effect of IPNV infection on 
macrophage expression of Mx, an important component of the anti-viral innate immune 
response. Stimulation of macrophages with IFN was studied to determine the potential of 
this IFN as a means of preventing IPNV infection or persistence, either directly or 
through the use of IFN-inducing immunostimulants. The results indicate that Atlantic 
salmon macrophages maintained in vitro do exhibit an Mx response when stimulated with 
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IFN. The efficacy of the IFN preparations used in this study was confirmed with reporter 
gene assays performed in RTG-P1 cells, which are a rainbow trout fibroblastic cell line 
permanently transfected with the luciferase gene under the control of Mx promoter 
(Figure 25). On exposure to IFN or IFN-inducing agents, the RTG-P1 cells express 
luciferase, (Johansen et al., 2004). Each of the three IFN preparations (Poly 1, 2, 3) 
produced in this study exhibited IFN-inducing abilities. The first experiment in this 
chapter was aimed at providing an answer to the following questions summarised in the 
subsequent sections (5.4.3  to 5.4.5.3).  
5.4.3  Does IPNV induce an Mx response, and how does this compare to that 
induced by IFN?  
Little is known about the molecular and immunological mechanisms involved in the 
establishment of an IPNV carrier state (Santi et al., 2005). IPNV-infected macrophages 
did not induce an Mx response at any time point studied (Figure 29). Whilst an Mx 
response was induced within macrophages stimulated with IFN prior to IPNV infection, 
this was not found to be significantly different from uninfected controls at any sampling 
time point studied. This suggests that IPNV has evolved in such a way so as not to induce 
an Mx response. Larsen et al., (2004) transfected CHSE-214 cells with the Atlantic 
salmon Mx1 protein (ASMx1) and demonstrated the antiviral effect of these cells towards 
IPNV. This finding indicates that Mx is capable of inhibiting IPNV replication. However, 
the results of the present study suggest that IPNV may suppress the immune response 
within head kidney macrophages, facilitating persistence and the development of a carrier 
state. The type I IFN system has a crucial role in the first line of defence against virus 
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infections (Johansen et al., 2004). The IFNs provide vertebrates with a first line of 
defence against viral infection. These cytokines are produced by virus-infected cells and 
stimulate the production of IFN-induced proteins in neighbouring, uninfected cells. These 
IFN-induced proteins in turn, confer an anti-viral state upon uninfected cells (Trobridge 
et al., 1997). According to Levy and Garcia-Sastre (2001), the IFN system is one of the 
earliest defence mechanisms against virus infections acquired during evolution by higher 
eukaryotes. Not surprisingly, millions of years of co-evolution between hosts and their 
pathogens have resulted in the acquisition of mechanisms by most viruses to inhibit, at 
least to some extent, the host IFN system. In this study, no IFN expression was detected 
by real time RT-PCR in any of macrophage groups studied (Figure 27). There was no 
significant difference in IFN expression exhibited by treated macrophages and untreated 
controls throughout the experimental study period. As it was possible to detect the 
presence of Mx in macrophages exposed to IFN, it was assumed IFN expression occurred 
early in the course of infection at a time not covered by the initial sampling points. IFN’s 
are unstable molecules that are rapidly degraded. Mx proteins however, which are strictly 
induced by type I IFNs, can persist for weeks after virus infection (Bergan and Robertsen, 
2004). Consequently, Mx has been regarded as a good molecular marker for type I IFN 
(Robertsen, et al., 1997; Nygaard et al., 2000). As a result, where Mx was detected within 
macrophages, it can be assumed that IFN induction occurred. However, this assumption 
cannot be made with respect to IPNV-infected macrophages, as it was not possible to 
detect the presence of Mx. Collet et al., (2007) reported the detection of IFN in the 
supernatant of Atlantic salmon head kidney macrophages following in vitro infection 
with IPNV, however in a parallel experiment IPNV suppressed Mx expression in RTG-
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P1 cells. Unfortunately Collet et al., (2007) did not investigate expression of Mx in 
macrophages, confounding attempts to make comparisons with the present study. 
Opinion is divided as to whether IPNV induces IFN in fish cells. It has been shown that 
head kidney leucocytes from rainbow trout expressed Mx mRNA when infected in vitro 
with IPNV (Boudinot et al., 1999). However, IPNV infection in vitro has been shown not 
to induce an Mx response in the TO-cell line (Jensen and Robertsen, 2002) which 
originates from Atlantic salmon head kidney (Wergeland and Johansen, 2001). Jensen 
and Robertsen (2000) reported that Mx was strongly induced in vivo by IPNV in Atlantic 
halibut. It is possible that the ability of IPNV to induce Mx may be dependent upon cell 
type (Jensen and Robertsen, 2002; Bergan and Robersen, 2004; Collet et al., 2007) or due 
to temperature effects (Bergan and Robersen, 2004). For a virus to persist within its host, 
it must actively curtail or evade the antiviral immune response (Oldstone, 2006), the 
same author suggests that there are certain foundations upon which the understanding of 
persistent infection rests. One of these is that the host’s immune response fails to form or 
fails to purge virus from the infected host. Thus, viral persistence is synonymous with 
evasion of the host’s immunologic surveillance system. Another foundation that Oldstone 
(2006) describes is that viruses can acquire unique component(s) or strategies of 
replication. That is viruses can regulate expression of both their own genes and host 
genes to achieve residence in a non-lytic state within the cells they infect. From the 
results of this experiment, it appears that both these statements made by Oldstone (2006) 
apply to the observations described in the results of this experiment and propose how 
IPNV is able to persist within Atlantic salmon head kidney macrophages. 
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5.4.4  Does IFN reduce IPNV levels in Atlantic salmon macrophages?  
Little is known about the mechanisms involved in viral persistence and viral carrier states 
in fish and how viruses evade host defences (Ellis, 2001). In the present study, treatment 
of macrophages with IFN was used to activate antiviral host responses prior to infection 
with IPNV. Through a comparison of the levels of IPNV:ELF-1 ratios in IFN stimulated 
and unstimulated macrophages it was possible to investigate the effect of the antiviral 
state on IPNV replication. The results indicate that macrophages become infected with 
IPNV despite the presence of an Mx response. Figure 35 shows that there was an increase 
in the mean IPNV levels in both the IFN-stimulated macrophages and positive controls, 
suggesting that the virus may have replicated after infection at a low level in the 
macrophages. However, these differences did not attain statistical significance. 
Johansen and Sommer (1995) reported increases in both intracellular and 
extracellular IPNV levels in adherent head kidney leucocytes, originating from IPNV 
carrier Atlantic salmon, during 7 days in culture and demonstrated that IPNV multiplied 
in these cells. However, the results of other studies do not support the idea that IPNV 
replicates in head kidney macrophages. Munro et al., (2006) demonstrated that IPNV 
persisted within Atlantic salmon head kidney macrophages infected in vitro over a period 
of 7 days without replicating. Collet et al., (2007) similarly demonstrated that in vitro 
infection of Atlantic salmon head kidney macrophages resulted in the persistence of the 
virus for nine days within the cells without replicating. Nova, et al., (1996b) and Yu et 
al., (1982) both suggested that although adherent rainbow trout macrophages harbour 
non-replicating IPNV, the virus replicates in other cell types. Nova et al., (1996) 
demonstrated that IPNV did not replicate in rainbow trout macrophages cultured in vitro, 
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but a limited increase in viral titre was observed when total leucocytes were infected with 
the culture. Whilst the results of this thesis would appear to suggest that it is possible for 
IPNV to replicate in Atlantic salmon head kidney macrophages in vitro, they do not agree 
with the majority of published studies. Unfortunately, it was only possible to investigate 
virus levels in macrophages using relative quantification, however a more accurate 
assessment of the ability of IPNV to replicate within macrophages in vitro could be 
achieved using absolute quantification. Financial and logistical constraints prevented this 
approach in the present study. 
In IFN treated macrophages infected with IPNV, the IPNV:ELF-1 ratio was  
significantly different between day 1 and day 9 (P = 0.0011), however in unstimulated 
IPNV-infected macrophages the IPNV:ELF-1 ratio was not statistically different at these 
times (P = 0.1932). This result suggests that IFN stimulation reduces IPNV levels in 
macrophages after infection. This corresponds with the results of section 5.4.3, which 
demonstrate that macrophages stimulated with IFN prior to infection with IPNV exhibit 
significantly greater levels of Mx expression than unstimulated IPNV-infected 
macrophages. This suggests that IPNV have evolved the capability to suppress the type I 
IFN system in Atlantic salmon macrophages. Macrophages stimulated with type I IFN, 
should express IFN-inducible antiviral mechanisms when subsequently infected with 
IPNV. Thus, those antiviral responses which would under normal circumstances be 
suppressed by IPNV should be active within the macrophages, explaining the difference 
in virus levels in these two experimental groups of macrophages. Although these results 
suggest that IFN may have potential as a means of reducing IPNV levels in Atlantic 
salmon, the differences in the mean IPNV:ELF-1 ratios were shown to decline between 
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day 1 (4486.8) and 9 (1320.7) in the positive control IPNV infected macrophages even 
though they were not exposed to IFN. Whilst this decline was not statistically significant, 
it could be argued that a decline in the IPNV:ELF-1 ratio still occurred with the IPNV-
infected control group. As no Mx was detected in this experimental group, this therefore 
raises questions over the exclusive role of Mx in reducing IPNV levels in infected 
macrophages. The observed reduction in IPNV levels within infected macrophages is 
unlikely to be due to shedding of the virus. No IPNV was detected in the macrophage 
culture medium as judged by virus isolation in CHSE-214 cells. Washing of macrophage 
cultures and replacement of culture medium took place every second day as 
recommended by Secombes (1990) and it is theoretically possible that this will have led 
to the removal of any IPNV shed into the media. However, daily sampling of the culture 
medium took place prior to any washing and renewal of the culture medium to ensure 
that extracellular virus would not be lost. Munro et al., (2006) studied the level of 
infection by IPNV of kidney macrophages from asymptomatic carrier Atlantic salmon 
post-smolts. The macrophages were cultured for up to 7 days with or without renewal of 
medium on day 3. Their results showed that the removal of the medium on day 3 had a 
significant effect on IPNV persistence within macrophages. In cultures where the 
medium was not removed, on day 7, IPNV was detected in macrophage lysates and the 
supernatants were also found to be IPNV positive. However where the medium was 
renewed IPNV was not detected. Munro et al., (2006) concluded that IPNV might persist 
within a macrophage population for long periods by circulating amongst cells.  
IFN and Mx were the only immune markers investigated in the present study due 
to financial and logistical restrictions. It is possible that other components of the immune 
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response may have been responsible for the decline in the IPNV detected in infected 
macrophages. A cascade of cytokines is released in macrophages as part of the innate 
immune response (Bird et al., 2005). However, very little is known about the role of 
cytokines in fish antiviral responses (Tafalla et al., 2005). In the last few years, many 
cytokine and other immune related genes have been identified in different teleost species, 
thus facilitating their study at a molecular level, these include tumour necrosis factor-α 
(TNF-α); (Zou et al., 2002), interleukin- 1ß (IL-1ß); (Bird et al., 2005),  interleukin-6 
(IL-6); (Bird et al., 2005),  interleukin-8 (IL-8); (Laing et al., 2004). TNF-α is primarily a 
product of monocytes and macrophages that have been activated by foreign substances 
including viruses, and is the principal mediator of the host inflammatory response 
(Secombes, 1994). According to McBeath et al., (2007) TNF-α is often associated with 
type I IFN production following a viral infection. Yoshiura et al., (2003) reported that IL-
12 in fish may be involved in antiviral defence. Tafalla et al., (2005) observed that 
rainbow trout infected with viral haemorrhagic septicaemia virus (VHSV) showed 
increased IL-1ß transcription. Semi-quantitative RT-PCR showed the virus induced an 
increased transcription of IL-1β in the spleen and to a lesser extent in the head kidney and 
liver at early times post-infection. However, it is unlikely that any of these cytokines 
played a role in the decrease of the IPNV levels. McBeath et al., (2007) measured several 
aspects of the Atlantic salmon immune response following experimental infection with 
IPNV. They demonstrated that the IPNV failed to induce the expression of TNF-α and 
IL-1ß. Interestingly, McBeath et al., (2007) reported that Type II IFN was greatly 
upregulated in IPNV infected fish. The salmon type II IFN gene has been shown to 
function in fish in a similar manner to mammals (Zou et al., 2005). For many years type 
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II IFN was thought to be only expressed by T cells, however in recent years it has been 
demonstrated that other cell types, originally thought not to be producers of type II IFN, 
are in fact capable of IFN expression. Type II IFN production has been reported in human 
macrophages (Gessani and Belardelli, 1998; Frucht et al., 2001; Ellermann-Eriksen, 
2005). The results of McBeath et al., (2007) could not verify if the peak type II IFN 
expression in response to IPNV was the result of activation of antigen-specific cytotoxic 
CD8+ T-cells, macrophages or NK cells. Unfortunately, due to financial constraints it 
was not possible to investigate expression of other immune markers, such as those 
involved in the type II IFN pathway.  
No CPE was evident in these macrophages during the course of the experiment. 
The strain of IPNV used in this study induced CPE within 2 days in CHSE-214 cells, thus 
this strain of IPNV is capable of producing extensive CPE. The results of the present 
study are in agreement with those of Estapa and Coll (1991), Johansen and Sommer 
(1995), and Collet et al., (2007) who showed that in both rainbow trout and Atlantic 
salmon, in vitro infection of macrophages with IPNV did not lead to a CPE, suggesting 
that the level of virus was reduced by a non-cytolytic process.  
5.4.5  Do immunostimulants induce IFN and Mx responses in macrophages and do 
immunostimulant-treated macrophages clear IPNV?  
The remainder of this chapter is focused on the potential of three 
immunostimulant; (MAF, glucan and LPS), to protect Atlantic salmon head kidney 
macrophages from infection with IPNV. Bricknell and Dalmo (2005) have stated that the 
theoretical benefit of immunostimulants is considerable. They have the potential to 
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elevate the innate immune defence mechanisms of fish prior to the exposure to a 
pathogen, or improve survival following exposure to a specific pathogen when treated 
with an immunostimulant. The majority of publications in the scientific literature on LPS 
and glucan as immunostimulants are concerned with bacterial diseases, dealing with their 
ability to stimulate the respiratory burst of macrophages and lysozyme activity (Solem, et 
al., 1995; Neumann, et al., 1995; Jørgensen and Robertsen, 1995; Robertsen, 1999; 
Paulsen, et al., 2003; Bridle et al., 2005). Studies on the protection against viral infection 
offered by immunostimulants are scarce, and little is known about their IFN and Mx 
inducing properties in fish (Salinas, et al., 2004).  
5.4.5.1    Glucan 
ß-Glucan potentiates and modulates the immune response primarily through its effects on 
macrophage and reticulo-endothelial cells and is generally recognized as safe without 
toxicity or side effects (Kumari and Sahoo, 2006). According to Bricknell and Dalmo 
(2005), one of the earliest applications of immunostimulants in aquaculture was the use 
of glucan in salmon diets. These diets were considered to be effective in managing 
disease outbreaks after stressful events such as grading. In the present study, the glucan 
used was Laminarin, a ß (1,6)-branched ß (1,3)-D-glucan, which is a major component in 
sublittoral brown algae and occurs principally in the Laminariae (Peat et al., 1958). 
Laminaran has the potential to enhance the non-specific defence against infectious 
diseases, administered either perorally as a feed additive, or intraperitoneally by injection 
(Dalmo et al., 1996).  
The results of this experiment (section 5.3.5) show that glucan was unable to 
induce IFN (Figure 31) or Mx (Figure 33) expression in Atlantic salmon head kidney  
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macrophages. There was no significant difference between the Mx:ELF-1 ratios observed 
in glucan-stimulated macrophages, glucan stimulated IPNV-infected macrophages and 
negative controls This result is in agreement with other published studies. Robertsen et 
al., (1997) compared the ability of glucan to induce an Mx response in trout and salmon. 
Glucan was not able to induce Mx expression in either species by injection. Salinas et al., 
(2004) reported the same observations when they conducted experiments on Atlantic 
salmon parr and concluded that neither glucan or yeast are capable of stimulating the type 
I IFN pathway in salmon parr. Kumari and Sahoo (2006) report that glucan incorporated 
into Asian catfish (Clarias batrachus L.) feed was able to successfully activate non-
specific immune functions such as lysozyme, and superoxide production, which led to 
protection against septicaemia caused by the motile aeromonad Aeromonas hydrophila. 
Thus, glucan has been shown to increase the resistance of fish to bacterial diseases. 
(Robertsen et al., 1990; Chen and Ainsworth, 1992; Guselle et al., 2006; Kumari and 
Sahoo, 2006). Engstad and Robertsen (1993) report that Atlantic salmon macrophages 
express a specific receptor for glucan, which supports a role for macrophages in glucan-
induced antibacterial responses in fish. This finding could explain why glucan has been 
successfully used to control bacterial diseases in fish and can also possibly explain the 
inability of glucan to induce an Mx response. It is possible that the putative glucan 
receptor is not coupled to the IFN or Mx pathways.  
The inability of glucan to induce an antiviral response in Atlantic salmon head 
kidney macrophages was in agreement with the observed IPNV levels in infected 
macrophages that were stimulated with glucan prior to infection. Between day 1 and 6 
there was a marked increase in intracellular IPNV:ELF-1 ratios (156.17 to 339.85 - 
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Figure 37). IPNV levels in glucan-treated macrophages were higher than those occurring 
in untreated controls. Initially this increase would appear to suggest that IPNV replicated 
to high levels until 6 days post infection. However in the same time period the 
IPNV:ELF-1 ratio in the IPNV treated group only rose from 49.73 on day 1 post infection 
to 86.67 on day 6 post infection. The difference in IPNV:ELF-1 ratios between the two 
treatments is surprising as untreated macrophages infected with IPNV would be expected 
to exhibit equivalent levels of IPNV. Although it is surprising that IPNV:ELF-1 ratios are 
higher in glucan-treated macrophages than in the untreated controls, virus levels in these 
experimental groups were not significantly different. This indicated that glucan does not 
stimulate infected macrophages so as to reduce IPNV levels. This strongly suggests that 
glucan would not function as an ineffective immunostimulant against IPNV in Atlantic 
salmon.  
5.4.5.2    MAF 
The inability of MAF to induce elements of the antiviral response in the macrophages 
(Figure 31 and Figure 33) was unexpected, since this substance has been shown to be a 
potent inducer of IFN. There was no significant difference between the Mx:ELF-1 ratios 
observed in MAF stimulated macrophages and negative controls. Furthermore, there was 
no significant difference between the IFN:ELF-1 ratios in any experimental group at days 
1, 3, 6 and 9 days post infection. 
This may be due to the characteristics of the IFN response induced by MAF. The 
MAF produced by T-lymphocytes stimulated with the T-cell mitogen concanavalin A 
appears to be similar to IFN-γ (Secombes and Graham, 1990). Thus, the MAF 
preparations used in this study may have acted so as to induce IFN γ expression in treated 
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macrophages. IFN γ belongs to the family of type II IFNs, whereas IFNs α and ß are type 
I IFNs (Levy and Sastre, 2001; Goodburn et al., 2000; Robertsen, 2005). Type I IFNs are 
known as viral IFNs, whilst type II IFNs are known as immune IFNs. The viral IFNs are, 
as their name suggests, induced by viral infection, whereas type II IFN is induced by 
mitogenic or antigenic stimuli (Samuel, 2001). Both types of IFNs induce an antiviral 
state in target cells through which virus replication is inhibited (Hengel et al., 2005), 
however as in higher vertebrates, fish Mx transcripts and proteins are typically inducible 
by type I IFN, poly I:C and virus infection (Robertsen, 2005). In the previous experiment 
Poly I:C was used to stimulate the macrophages to make the IFN supernatants, which 
were subsequently able to induce Mx in the isolated Atlantic salmon head kidney 
macrophages, demonstrating that the IFN secreted by these cells was predominantly type 
I. The inability of the MAF supernatants in this experiment highlights the specificity of 
the IFN and Mx responses within Atlantic salmon macrophages in response to 
stimulation with type I IFN. It is necessary to acknowledge the results of the respiratory 
burst assays performed in this project, which do not permit verification of the efficacy of 
the MAF-containing supernatants. However, if it is assumed that the MAF preparations 
induced a type II IFN response within treated macrophages, we can conclude that such an 
IFN response is incapable of protecting macrophages from infection with IPNV. This 
inability to protect macrophages from IPNV infection was reflected in the high 
IPNV:ELF-1 ratios (Figure 37). The IPNV:ELF-1 ratio rose from 154.63 on day 1 to 
473.01 on day 6. However in the control macrophages the IPNV:ELF1 ratio in the only 
rose from 49.73 on day 1 post infection to 89.91 on day 6 post infection. The difference 
between these two treatments was significantly different (P = 0.0001 day 1 and P = 
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0.0015 day 6). Although it is uncertain why these IPNV levels occurred in infected 
macrophages, the inability of MAF to prevent infection or induce an Mx response would 
indicate that this substance is unlikely to prevent IPNV from establishing a carrier state. 
This raises questions over the potential of MAF as a therapeutic approach to mitigating 
IPN, as it does not exhibit the ability to prevent infection or reduce the IPNV levels 
within infected macrophages.  
5.4.5.3     LPS  
No expression of IFN or Mx was detected in macrophages treated with LPS, or treated 
with LPS and inoculated with IPNV (Figure 31 and Figure 33). Previous studies of the 
effects of LPS on fish innate immune responses have yielded conflicting results. 
Robertsen et al., (1997) detected the expression of Mx by northern blotting in the head 
kidney and liver of Atlantic salmon intra-peritoneally injected with poly I:C. However, 
no Mx expression was detected after injection of LPS. Collet and Secombes (2002) could 
not detect Mx transcripts by RT-PCR in LPS treated RTG cells, in contrast to the 
efficient induction of Mx by poly I:C in these cells. Johansen et al., (2004) developed an 
assay for the detection of IFN-like activity in Atlantic salmon based on the transient 
transfection of CHSE-214 cells with a rainbow trout Mx1 promoter linked to a luciferase 
reporter. Johansen et al., (2004) tested this by incubating the transfected CHSE-214 cells 
with supernatants from LPS and Poly I:C stimulated head kidney leucocytes. IFN 
preparations derived from leucocytes stimulated with poly I:C induced high luciferase 
expression ( greater than 60-fold induction compared to supernatants from non-stimulated 
cells) in these CHSE-214 cells. However there was no response to supernatants from 
LPS-stimulated leucocytes, demonstrating the specificity for type I IFN-like activity. 
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Similarly Robertsen et al., (1997) concluded that Mx genes are induced selectively by 
double stranded RNA, as LPS or the mere stress of injecting a saline solution did not 
induce Mx transcription.  
However, there have been reports in the literature which indicate that LPS has the 
ability to induce a type I IFN response in fish. Salinas et al., (2004) detected very low and 
transient Mx response in the liver of Atlantic salmon parr 2-3 days after administration of 
Esherichia coli (E. coli) LPS. However, they suggested that Mx expression may occur in 
non-hepatic sites, and that liver tissue, which is not rich in macrophages, may not have 
represented the most appropriate tissue for assessment of the Mx response. Interestingly, 
Salinas et al., (2004) reported a strong induction of Mx expression in the livers of 
Atlantic salmon parr following an injection of a commercially available vibrio bacterin, 
but the bacterial components responsible for this were not investigated. In response to 
this result Acosta et al., (2004) conducted an experiment to identify the specific 
components of the bacterin that provides the stimulation. They suggested that the Mx 
induction may occur in response to LPS or bacterial DNA and subsequently examined the 
Mx responses of Atlantic salmon to purified Listonella anguillarum (L. anguillarum) LPS 
and DNA. They showed that the kinetics of the Mx response to L. anguillarum DNA was 
strikingly similar to that occurring in response to vibrio bacterin and to poly I:C. They 
suggested that the induction of Mx by L. anguillarum DNA is due to the presence of CpG 
motifs which have been shown to induce Mx expression in Atlantic salmon by Jorgensen 
et al., (2003). Interestingly Acosta et al., (2004) found that purified L. anguillarum LPS 
induced an Mx response whereas LPS from E. coli and Salmonella typhimurium (S. 
typhimurium) failed to so. They suggested that LPS from L. anguillarum has unique 
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effects on the innate immune system not present in LPS from the other species 
investigated. As the V. anguillarum LPS in the experiment described in this thesis failed 
to induce an Mx response within macrophages, this would agree with the suggestion by 
Acosta et al., (2004) that L. anguillarum has unique effects on the innate immune system 
not present in LPS from the other species. There are several examples in the literature of 
studies which fail to demonstrate induction of the type I IFN response by LPS. Johansen 
et al., (2004) used LPS derived from E. coli, whereas, Collet and Secombes (2002) did 
not specify the origin of the LPS that they used. Whilst Salinas et al., (2004) 
demonstrated an Mx response within Atlantic salmon using V. anguillarum derived LPS, 
it was not as strong as that observed in experiments using LPS sourced from L. 
anguillarum.  
In the present study there was no significant difference between the Mx:ELF-1 
ratios occurring in LPS-treated macrophages (Figure 33), LPS treated IPNV-infected 
macrophages and negative controls. Similarly at 1, 3, 6 and 9 days post infection there 
was no significant difference between the IFN:ELF-1 ratios occurring in treated 
macrophages and untreated controls. The inability of LPS to induce an Mx response in 
macrophages was reflected in LPS-treated, IPNV-infected macrophages. IPNV:ELF-1 
ratios fluctuated throughout the period of the study, on day 1 and day 6 the IPNV:ELF-1 
ratios (62.15 and 89.91 respectively) were similar to those observed in the control group 
(day 1, 49.73; day 6, 63.13). However, on days 3 (204.98) and 9 (186.43) the IPNV:ELF-
1 ratios rose above those observed in the controls (day 3, 129.90; day 9, 86.67). As the 
IPNV:ELF-1 ratios in macrophages exposed to LPS were lower than in macrophages 
exposed to glucan or MAF prior to infection with IPNV, it is possible that LPS is more 
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efficient at stimulating viral clearance than MAF or glucan.  Although it is not possible to 
completely rule out immunostimulatory effects attributable to LPS based on the results of 
this thesis, the inability of this substance to reduce the IPNV levels in macrophages 
between day 1 and day 9 post infection suggest that that LPS is not an effective 
immunostimulant against IPN. However there is still much to learn concerning the use of 
LPS as an immunostimulant to mitigate IPN due to the uncertainty surrounding which 
types of LPS have the ability to induce Mx, and what makes one type of LPS more 
effective than another. 
 
Whilst the second part of this chapter is concerned with the ability of 
immunostimulants to mitigate IPNV-infection of Atlantic salmon macrophages, some of 
the results are relevant to an understanding of macrophage innate immune responses to 
IPNV. There was no significant difference in the Mx:ELF-1 ratios occurring in IPNV-
infected macrophages and those exhibited by negative controls (Figure 33). This finding 
is in agreement with the lack of an antiviral response in positive control macrophages (i.e. 
IPNV-infected) in the experiment described in section 5.4.3. The results suggest that 
IPNV can suppress the type I IFN response in Atlantic salmon head kidney macrophages. 
Clearly, viruses are unlikely to be successful pathogens if they had not evolved efficient 
strategies that allow them to suppress IFN production, to down regulate IFN signalling 
and to block the action of antiviral effector proteins (Haller et al., 2006). There are many 
reports concerned with the induction of the antiviral state resulting from infection with 
diverse viruses including IPNV. The results of the present study suggest that IPNV alone 
does not induce Mx within Atlantic salmon head kidney macrophages. According to 
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Goodburn et al., (2000) in order to replicate efficiently, it seems likely that all viruses 
must, at least to a degree, have some means of circumventing the IFN response either by 
limiting IFN production or blocking IFN actions. The results of the experiments 
described in sections 5.3.6 and 5.3.7 do not permit definite conclusions to be made to 
explain the lack of Mx expression in IPNV-infected macrophages. No IFN expression 
was detected in those macrophages that expressed Mx. Therefore, it would be logical to 
investigate innate immune responses occurring at the initial stages of infection to 
determine the timing and manner of the immunosuppression caused by IPNV. 
5.5    Conclusion   
5.5.1  IFN as a treatment for IPNV  
IFN treatment of macrophages prior to infection with IPNV does not prevent infection 
with this virus. However, the potential may exist for IFN therapy in aquaculture to treat 
viral diseases such as IPNV because IFN-α/ß is used to treat chronic active hepatitis C or 
hepatitis B in humans (Samuel, 2001; Sen, 2001). IFN may have therapeutic use as 
against IPN since macrophages exposed to IFN exhibit enhanced virus clearance. 
Assuming head kidney macrophages are an important site of virus replication in IPN, IFN 
could help prevent the establishment of the carrier state. However, it is uncertain what 
causes IPNV levels to decline in untreated IPNV-infected macrophages, as occurred in 
Figure 35. This may be due to the existence of antiviral mechanisms in macrophages that 
are not controlled by the type I IFN/Mx pathway. Alternatively, IPNV may quite simply 
be destroyed by macrophages.   
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5.5.2  Immunostimulants as potential treatments for IPN 
Development of vaccines against infectious diseases is time consuming and ultimately 
expensive (Randonic et al., 2004). As a result, it may be more practical to combine good 
husbandry and the enhancement of disease resistance through the use of 
immunostimulants to mitigate the effects of infectious diseases such as IPN. There are 
currently no therapeutic feeds available that are specifically designed to combat viral 
diseases in fish. Whilst immunostimulants have been proven applicable to aquaculture, 
the results of the present study suggest that the immunostimulants tested may be better 
suited to the control of bacterial diseases, as none of those studied were able to induce the 
antiviral Mx protein. Thus, further studies are required to identify effective 
immunostimulants for the control of IPN.  
5.5.3  The effect of IPNV on the antiviral response within Atlantic salmon head 
kidney macrophages 
In the experiments described in this chapter, expression of Mx or IFN in IPNV-infected 
macrophages was not significantly greater than that exhibited by uninfected controls. As 
suggested by McBeath et al., (2007), an improved understanding of the complex host-
pathogen relationship in IPN at the molecular level might allow the development of 
husbandry conditions that favour the host and thus lead to improvements in disease 
control and fish welfare. The host response to viral infection represents a complex 
coordination of gene products, which are precisely tuned to activate or inactivate specific 
pathways and finally counteract the effects of viral gene products (O’Farrell et al., 2002). 
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According to Rønneseth et al., (2006) viruses interact with immune cells in diverse ways 
and many viruses act so as to impair or inhibit anti viral responses. It is the opinion of 
McBeath et al., (2007) that the interaction of IPNV with the IFN system is complex and 
probably plays a critical role in determining states of resistance or susceptibility in the 
fish host. The results of this thesis suggest that that IPNV either completely prevents IFN 
expression or else it blocks IFN from inducing Mx expression. An investigation of IFN 
expression in the initial stages of infection may elucidate the interaction between IPNV 
and the innate immune response. This objective is pursued in the following chapter.  
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Chapter 6 - Comparison of the effects of IPNV and Poly I:C 
treatment to demonstrate the type I IFN suppressing properties of 
IPNV in Atlantic salmon head kidney macrophages.  
6.1    Introduction  
Work described in the previous chapters of this thesis suggests that IPNV does not induce 
an Mx response in head kidney macrophages of Atlantic salmon. The aim of this chapter is 
to characterise the antiviral responses within the macrophages at the early stages of 
infection. The results may lead to a greater understanding of the mechanism through which 
IPNV inhibits anti-viral responses in macrophages. The expression of IFN in IPNV-infected 
macrophages will be compared to that induced by Poly I:C. This substance is a potent 
inducer of type I IFN in mammals and salmonids (Ellis, 2001). From observing the IFN 
response in IPNV infected macrophages it may be possible to determine whether IPNV has 
the ability to suppress the IFN response. Despite the fact that the type I IFN system appears 
to be a potent and efficient mechanism for the host to counteract viruses at early stages of 
infection, viruses are remarkably successful in infecting their host species. This is probably 
due to the evolutionary acquisition by viruses of molecular mechanisms which counteract 
the IFN-α/ß system to allow virus replication (Garcia-Sastre, 2002). Goodburn et al., (2000) 
summarises some of the major strategies employed by viruses to subvert the IFN system;  
 
i) Inhibition of IFN production  
ii) Inhibition of IFN signalling  
iii) Inhibition of IFN-induced antiviral enzymes 
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Experiments conducted in the last chapter (sections 5.3.4 and 5.3.5) demonstrate that 
neither IFN or Mx are expressed in IPNV-infected macrophages. On the basis of the 
strategies described by Goodburn et al., (2000), it can be assumed that the strategy 
employed by IPNV is achieved through inhibition of IFN production or the inhibition of 
IFN signalling. The sampling points selected in this experiment are designed to detect IFN 
expression occurring in the early stages of infection. If the results of this experiment show 
that IFN is expressed in IPNV infected macrophages it can be assumed that IPNV inhibits 
IFN signalling, thus explaining the inability to detect Mx expression in the previous 
experiments (section 5.3.4 and 5.3.5). However if no IFN expression is detected in IPNV 
treated macrophages but Poly I:C induces IFN expression it can be assumed that IPNV 
inhibits IFN production.  
6.2    Materials and Methods 
6.2.1  Isolation of macrophages from head kidney  
Head kidneys were obtained from Atlantic salmon (section 2.2.2) and macrophages were 
isolated on 51% percoll as described in section 2.2.4. Macrophages were seeded into 24 
well plates at concentrations of 2 x 10-7 cells ml-1 and maintained at 15°C as described in 
section 2.2.5.  
6.2.2  In vitro virus infection in isolated macrophages  
After 24 hours incubation at 15°C, macrophage monolayers were processed in triplicate 
using one of the following three treatments.  
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a) IPNV-infected group. Macrophages were infected with IPNV at an MOI of 1 
(section 2.2.7).  
b) Poly-IC-stimulated group. Macrophages were incubated with L-15 medium 
supplemented with 5% FCS and 50 units ml-1 penicillin, 50µg ml-1 
streptomycin containing Poly I:C (25 µg ml-1).  
c) Negative control group. Macrophages were maintained in L-15 medium 
supplemented with 50 units ml-1 penicillin, 50µg ml-1 streptomycin and 5% 
FCS.  
 
6.2.3  RNA extraction and quantitative real-time RT-PCR 
After 3, 12, 24 and 36 hours the monolayers were washed three times with L-15 medium 
and RNA was extracted following the modified TRIzol protocol as described in section 
3.2.5. Prior to treatments, RNA was extracted from macrophages to identify the normal 
expression values for all of the targets investigated in the experiment. This time point was 
termed “time 0” and the values were incorporated within the Pfaffl relative quantification 
calculation. The quality and quantity of the extracted RNA was evaluated using a Nanodrop 
Spectrophotometer. All samples were diluted to 100ng/µl prior to first strand synthesis 
using RNAse/DNAse free water. Two step RT-PCR was performed on extracted RNA 
following the steps outlined in sections 4.2.3 and 4.3. All samples were tested for the 
presence of Mx, IFN and IPNV. The results of the real time amplification of each target was 
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expressed as a ratio to the internal RT-PCR control ELF-1, using the Pfaffl mathematical 
equation for relative quantification. 
 
6.2.4  Statistical analysis of real time RT-PCR gene expression  
Results are expressed as the relative expression ratio between the target of interest and ELF-
1 house keeping gene. Data was analysed on the MINITAB software package by a two way 
ANOVA, and a Tukey’s test was used to perform multiple comparisons to determine the 
differences between the treatments and time during the course of the experiment. 
Differences were considered statistically significant when P<0.05.  
 
6.2.5  Detection of extracellular IPNV 
Prior to extraction of RNA from the macrophage monolayer, the culture medium was tested 
for the presence of extracellular IPNV as described in section 2.2.8.  
 
6.3    Results 
6.3.1  Expression of antiviral genes 
IFN expression increased in macrophages treated with Poly I:C (Figure 39). The two-way 
ANOVA results (Figure 40) show that treatment, time and a combination of treatment and 
time (P = 0.001) all had a significant effect on IFN expression. The tukey test revealed that 
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after 3 hours treatment with Poly I:C macrophages had significantly higher IFN:ELF-1 
ratios than those treated with IPNV (P = <0.0001) and untreated controls (P = <0.0001). 
Peak IFN expression within Poly I:C treated macrophages occurred at 24 hours post 
treatment, which was significantly higher than observed 3 hours post treatment (P = 
0.0001). IFN expression declined between 24 hours and 36 hours (P = <0.0001). At 36 
hours post treatment there was no significant difference in IFN expression between Poly I:C 
stimulated macrophages and those infected with  IPNV (P = 0.9587) or untreated 
macrophages (P = 0.9995). This result would agree with the opinion of Honda et al., (2005) 
that the hallmark of mammalian IFN-α/ß is their rapid induction by virus infection as a 
result of the recognition of viral dsRNA products. In the experiments conducted in the last 
chapter it would appear that the sampling points may not have been optimal to detect this 
rapid induction of IFN. Whilst IFN expression increased in macrophages treated with Poly 
I:C, which is a synthetic double- stranded RNA that is used experimentally to model viral 
infections, there was no significant difference between the IFN:ELF-1 ratios in IPNV-
infected macrophages and negative controls at any of the sample time points,  3 hours after 
treatment (P = 1.0000); 12 hours (P = 1.0000);  24 hours (P = 0.1578) and 36 hours (P = 
1.0000).  This suggests that the reason for the inability to detect Mx and IFN expression in 
IPNV-infected macrophages is a result of the virus blocking IFN production.  
IFN induction in the Poly I:C treated macrophages corresponded to an increase in 
the expression of  Mx (Figure 41). The two-way ANOVA results (Figure 42) show that 
treatment, time and a combination of treatment and time (P = 0.001) all had a significant 
effect on IFN expression. The tukey test revealed that at 3 hours post-infection, Mx levels in 
macrophages treated with Poly I:C, or infected with IPNV (P = 0.9241) did not differ from 
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those exhibited by negative control macrophages (P = 1.0000). However between 3 hours 
and 12 hours there was a significant increase in Mx expression (P = <0.0001) in Poly I:C 
treated macrophages, which was maintained up to 24 hours post-treatment (P = <0.0001) 
when peak levels of Mx expression occurred. IPNV blocked IFN induction in infected 
macrophages, which did not express Mx at levels greater than those occurring in Poly I:C 
treated macrophages. Mx:ELF-1 ratios were significantly different in IPNV-infected 
macrophages and poly I:C treated macrophages at 12, 24 and 36 hours post treatment (P = 
<0.0001). There was no significant difference in Mx expression in IPNV-infected and 
negative control macrophages at 3, 12, 24 and 36 (P = 0.9957) hours post infection (P = 
0.9101; 1.0000; 1.0000; 0.9957 respectively).  
These results strongly suggest that IPNV inhibits the expression of IFN in 
macrophages and subsequently the induction of Mx. This could explain why IPNV is able 
to persist within Atlantic salmon head kidney macrophages and establish a carrier state 
within Atlantic salmon. Furthermore, the kinetics of IFN induction observed in the present 
experiment confirms that the sampling points studied in chapter 4 were not optimal to detect 
IFN expression.  
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Figure 39: IFN expression in Atlantic salmon head kidney macrophages in response to infection 
with IPNV or treatment with Poly I:C.  Mock-treated macrophages (L-15 alone) served as a negative 
controls. IFN levels were quantified in relation to expression of the housekeeping gene ELF-1 using 
the method described by Pfaffl. Data points represent mean IFN:ELF-1 ratios (N = 3) ± SD. 
 
Analysis of Variance for IFN:ELF-1 ratio, using Adjusted SS for Tests 
 
Source         DF     Seq SS     Adj SS     Adj MS       F      P 
Time            3    248.627    248.627     82.876  205.21  0.001 
Treatment       2    163.146    163.146     81.573  201.98  0.001 
Time*Treatment  6     98.345     98.345     16.391   40.59  0.001 
Error          24      9.693      9.693      0.404 
Total          35    519.811   
 
Figure 40: Two way ANOVA results for relative IFN:ELF-1 expressed in (a) IPNV infected; (b) 
Poly I:C stimulated; (c) untreated Atlantic salmon head kidney macrophages over time. Differences 
were considered statistically significant when P<0.05.  
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Figure 41: Mx expression in Atlantic salmon head kidney macrophages in response to infection with 
IPNV or treatment with Poly I:C. Mock-treated macrophages (L-15 alone served as negative 
controls). Mx levels were quantified in relation to expression of the housekeeping gene ELF-1 using 
the method described by Pfaffl. Data points represent mean Mx:ELF-1 ratios (N = 3) ± SD. 
 
 
Analysis of Variance for Mx:ELF-1 ratio, using Adjusted SS for Tests 
 
Source         DF     Seq SS     Adj SS     Adj MS       F      P 
Time            3     65.277     65.277     21.759  208.57  0.001 
Treatmen        2     57.907     57.907     28.954  277.53  0.001 
Time*Treatmen   6     24.316     24.316      4.053   38.85  0.001 
Error          24      2.504      2.504      0.104 
Total          35    150.004   
 
Figure 42: Two way ANOVA results for relative Mx:ELF-1 expressed in (a) IPNV infected; (b) 
Poly I:C stimulated; (c) untreated Atlantic salmon head kidney macrophages over time. Differences 
were considered statistically significant when P<0.05.  
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6.3.2  IPNV-levels in infected macrophages  
IPNV was detected within infected-macrophages at 3 hours post-inoculation (Figure 43). 
The two way ANOVA (Figure 44) show that treatment (P = 0.001), time (P = 0.001) and a 
combination of treatment and time (P = 0.016) had a significant effect on the expression of 
IPNV. The tukey test revealed that there was an increase in IPNV:ELF-1 ratio between 0 
and three hours post-infection (P = 0.0001). The mean IPNV:ELF-1 ratios indicate that 
there was an increase in the IPNV levels over time, strongly suggesting that IPNV 
replication occurs in macrophages. Whilst the IPNV:ELF-1 ratio increased from 19007.97 
at 3 hours post treatment to 45417.04 at 36 hours post infection, statistical analysis showed 
that there was no significant difference between the IPNV:ELF-1 ratio observed at 3 hours 
post infection and 12 hours (P = 0.6575), 24 hours (P = 0.6025) and 36 hours (P = 0.1193). 
However, IPNV levels at all time points studied were greater than those occurring in 
macrophages sampled immediately after infection (i.e. time 0, P = <0.0001). Thus, 
replication of IPNV to a level greater than that contained in the original inoculum did occur, 
although it is possible that the extent and kinetics of infection differ from those occurring in 
vivo. IPNV was not detected in macrophages treated with Poly I:C or negative controls. 
6.3.3  Determination of IPNV levels in the culture media of infected macrophages  
No CPE was observed in CHSE-214 monolayers examined over a period 21 days. This 
indicates that none of the macrophage experimental groups studied released detectable 
amounts of IPNV into the culture medium. The results of the present study demonstrate that 
IPNV infection results in the suppression of both IFN and Mx expression. This suppression 
of the type I IFN response suggests that the ability of macrophages to clear IPNV is 
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impaired, which may facilitate the establishment of a carrier state that occurs in IPNV-
infected Atlantic salmon. 
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Figure 43: IPNV levels in infected Atlantic salmon head kidney macrophages. Untreated 
macrophages were used as a negative control. IPNV levels were quantified relative to expression of 
the housekeeping gene ELF-1 using the method described by Pfaffl. Data points represent mean 
IPNV:ELF-1 ratios (N = 3) ± SD. 
 
Analysis of Variance for IPNV:ELF ratio, using Adjusted SS for Tests 
 
Source         DF     Seq SS     Adj SS     Adj MS       F      P 
Time            3      4.451      4.451      1.484   15.73  0.001 
Treatmen        2    679.794    679.794    339.897 3603.94  0.001 
Time*Treatmen   6      1.095      1.095      0.182    1.93  0.116 
Error          24      2.264      2.264      0.094 
Total          35    687.604   
 
Figure 44: Two way ANOVA results for relative IPNV:ELF-1 expressed in (a) IPNV infected; (b) 
Poly I:C stimulated; (c) untreated Atlantic salmon head kidney macrophages over time. Differences 
were considered statistically significant when P<0.05.  
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6.4    Discussion  
6.4.1  Type I IFN response of Atlantic salmon head kidney macrophages to IPNV 
infection  
For a virus to persist, it must actively curtail the host’s antiviral immune response 
(Oldstone, 2006). Little is known about the mechanisms involved in the establishment of 
carrier states in fish and how viruses evade the host immune defences (Ellis, 2001; McBeath 
et al., 2007). Understanding the principles by which persistence is initiated and maintained, 
as well as the pathologic consequences of continued virus replication in a host over its life 
in terms of causing disease, represents a research area of high significance, and provides 
opportunities for challenging investigation (Oldstone, 2006). Many viruses have evolved 
specific mechanisms that antagonize the production or action of IFNs (Goodburn, et al., 
2000). As observed in the previous experiments, the inability of IPNV-infected 
macrophages to express Mx suggested that the virus suppressed antiviral responses within 
Atlantic salmon head kidney macrophages. In the experiments conducted in chapter 4 
(section 5.2.8), due to the experimental design whereby the early stages of infection were 
not studied, it was not possible to investigate the immediate response of macrophages to the 
virus. Thus, it was not possible to ascertain where suppression occurred. It is possible that 
IPNV prevented the induction of IFN; alternatively, it is possible that IPNV infection 
induces IFN expression, and that the downstream expression of Mx within the macrophage 
is subsequently blocked. The latter scenario would be in accord with the observations of 
Collet et al., (2007), who identified high levels of IFN in the supernatant of IPNV-infected 
macrophage cultures. On the basis of these findings, the sampling points used in the present 
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study were repositioned to permit analysis of the initial stages of the virus-host interaction, 
as opposed to sampling at 24 hour intervals over a period of 9 days. 
At this point, it is useful to consider the series of events that lead to an antiviral state 
within a cell following viral infection so as to identify possible points at which suppression 
may occur during IPNV infection. Figure 45 is a schematic illustration of type I IFN 
induction in mammalian cells following viral infection. The mammalian IFN-system has 
been characterised in detail at the molecular level, and the albeit limited number of 
functional studies that have been performed with the cloned fish IFNs show that they too 
have characteristic properties of type I IFNs. Virus infected cells synthesize and secrete 
type I IFNs (IFN-α/ß), which circulate and protect other cells from viral infection (Bergan 
et al., 2006). During viral infection of mammalian cells, transcription of IFN-ß is induced 
first through the co-ordinated activation of the transcription factors IFN regulatory factor 
(IRF) 3 (Robertson, 2005) and nuclear factor kappa B (NF-қ B); (Haller et al., 2006). This 
“first wave” IFN triggers expression of a related factor IRF-7 (Haller et al., 2006). The 
induction of IFN-α/ß genes by viruses involves IRF-3 and IRF-7, and expression of the 
latter is dependant on IFN-stimulated gene factor 3 (ISGF3); (Taniguchi and Takaoka, 
2002).   
 Cells respond rapidly following stimulation with IFN through the JAK-STAT 
pathway signal inducing pathway (Muñoz-Jordan et al., 2003; Haller et al., 2006). Briefly, 
the specific receptor complex for each IFN-α/ß and IFN-γ is composed of two major 
subunits (IFNAR1/IFNAR2 for IFN-α/ß and IFNGR1/IFNGR2 for IFN-γ) and various JAK 
tyrosine kinases constitutively associated with the receptor. Jak1 and Tyk2 are required for 
IFN- α/ß signalling; Jak1 and Jak2 are required for IFN-γ signalling (Best et al., 2005). The 
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signal transducer and activator of transcription (STAT) family of proteins are latent 
cytoplasmic transcription factors that become tyrosine phosphorylated by the JAK enzymes 
in response to cytokine stimulation (Samuel, 2001). In the case of signalling via IFN-α/ß, 
phosphorylated STAT1 and STAT2 bind each other aswell as IFN regulatory factor 9 (or 
p48), to form the transcription factor (ISGF3g/p48) (Best et al., 2005). This complex 
translocates to the nucleus and binds to the IFN-stimulated response element (ISRE) in the 
promoter region of IFN stimulated genes (ISGs) of which some code for antiviral proteins 
such as Mx (Haller et al., 2006).  
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Figure 45: Type I IFN induction, signalling and action. Left panel: dsRNA, a characteristic by-
product of virus replication, leads to activation of the transcription factors NF-қ B, IRF-3. The 
cooperative action of these factors is required for full activation of the IFN-ß promoter. Right panel: 
Newly synthesised IFN-ß binds to the type I receptor and activates the expression of numerous ISGs 
via the JAK/STAT pathway which leads to production of intracellular antiviral proteins such Mx 
protein (from Haller, 2006).  
Key 
Abbreviation                                     Term Abbreviation Term Abbreviation Term 
IFNAR Interferon–α/ß 
receptor 
JAK-1                                                          Janus kinase 1 STAT-2 Signal transducer 
and activator of 
transcription-2 
IFN- α       Interferon alpha MDA-5                                                 Melanoma
differentiation 
associated gene-5 
TBK-1  TANK-binding 
kinase-1 
IFN- ß                     Interferon beta NK –қB                                                                                                      Nuclear factor
kappa B 
TLR 3 Toll-receptor 3 
IGSF-3 Immunoglobulin 
superfamily-3 
OAS Oligoadenylate 
synthetases 
TRAF Tumour necrosis 
factor associated 
factor 
IKK α/ß     I kappa B kinase                                              PIAS Regulator of JAK 
STAT pathway 
TYK-2 Tyrosine kinase 2 
IKKε IқB kinase PKR Protein kineases   
IPS-1                                                              Interferon–ß-
promoter 
stimulator 1 
PKR Protein kinase   
IRF-9  Interferon 
regulatory factor- 9 
RIG-l                                                  RNA sensor 
protein 
  
ISG Interferon 
stimulated gene 
SOCS Suppressors of 
cytokine signalling 
  
ISRE Interferon 
stimulated response 
element  
STAT- 1                                             Signal transducer 
and activator of 
transcription-1 
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According to Garcia-Sastre (2002) the antiviral system is comprised of three main steps  
i) detection of viral infection and IFN secretion  
ii) binding of IFN to its receptors and transcriptional induction of IFN-stimulated 
genes  
iii) synthesis of antiviral enzymes and proteins which in most cases inhibit key 
cellular functions upon activation to prevent virus replication  
 
It is helpful to consider the series of events that lead to an antiviral state within a cell and 
the subsequent strategies that viruses have employed to subvert the IFN response. By doing 
so the results of this experiment can be used to identify where IPNV subverts the IFN 
system, thus facilitating its persistence. It has been demonstrated that there is a clear 
relationship between Mx and the protection of cells against IPNV (Jensen et al., 2002; 
Larsen et al., 2004). These authors reported that when CHSE-214 cells are either 
transfected with Poly I:C, an inducer of Mx (Jensen, 2002), or a plasmid containing the 
Atlantic salmon Mx 1 gene (Larsen et al., 2004), they are protected against IPNV infection. 
 Poly I:C is a very potent inducer of type I IFN in mammals and type I IFN-like 
activity in salmonids (Ellis, 2001). For this reason, Poly I:C represents a good positive 
control for studies of IFN induction, and its potential inhibition by IPNV. Macrophages 
treated with Poly I:C, exhibited a rapid IFN response (Figure 27) that commenced at 
between 3 (IFN:ELF1 ratio = 24219.36) and 12 hours (IFN:ELF1 ratio = 144086.2) post 
treatment, and peaked at 24 hours (IFN:ELF1 ratio = 805768.7). IFN expression decreased 
to almost undetectable levels at 36 hours post treatment (IFN:ELF1 ratio = 3.75). Since 
IFNs are unstable proteins that are rapidly degraded (Bergan and Robertson, 2004) it is 
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probable that the IFN response to a double stranded RNA virus is of short duration. Poly 
I:C is a synthetic double stranded RNA, as is the genome of the birnavirus IPNV, 
consequently macrophage responses to IPNV-infection would be expected to share features 
in common with those occurring in response to poly I:C treatment. 
 However, in the present study, no IFN expression was detected in IPNV-infected 
macrophages over the course of the 36 hour sampling period. This strongly suggests that 
IPNV suppresses macrophage IFN expression in vitro. Thus, suppression of macrophage 
defences by IPNV appears to be achieved through the inhibition of IFN production, as 
opposed to the inhibition of the IFN-induced antiviral enzymes such as Mx. The difference 
in IFN levels in IPNV-infected macrophages, and macrophages treated with poly I:C 
highlights the efficiency of this virus in blocking IFN expression (days 3, 12, 24 P = 
<0.0001).  
Goodburn, et al., (2000) have noted that the speed and efficiency of viral 
suppression of the IFN response may be critical determinants of host range and 
pathogenicity. As these results would indicate that IPNV has developed a way to block IFN 
production, it would therefore be interesting to identity the stage at which IPNV blocks IFN 
production and which part of the virus acts as the IFN antagonist. To be able to replicate 
efficiently in their hosts, most viruses have acquired genetic information encoding IFN 
antagonist molecules which block one or more steps of the IFN system (Garcia-Sastre, 
2002). Table 7 summarises examples on how specific viruses antagonize the IFN α/ß 
system.  
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Table 7: Examples of gene products from different human viruses which have been described to be 
involved in the inhibition of the IFN-mediated antiviral responses of the host (from Garcia-Sastre 
2002).  
Virus  Viral IFN antagonist Pathway targeted 
 
DNA viruses 
Adenovirus 
 
 
Vaccinia virus  
 
 
 
 
Herpes simplex virus  
 
 
Epstein–Barr virus  
 
Cytomegalovirus 
Herpesvirus 8 
 
 
Human papilloma virus  
 
Hepatitis B virus  
 
 
Retroviruses 
HIV-1 
 
 
 
Positive-strand RNA  viruses 
Hepatitis C virus  
 
 
Poliovirus 
 
Double-strand RNA viruses 
Reovirus 
 
 
Negative-strand RNA viruses 
Influenza A virus 
 
 
Measles virus 
Parainfluenza virus  
Ebola virus  
Mumps virus 
Parainfluenza virus  
 
 
 
E1A protein  
 
VA RNAs  
B18R protein  
E3L protein  
 
 
K3L protein  
ICP34. 5 protein  
US11 protein  
Unknown 
EBNA-2 protein  
EBER RNAs  
Unknown  
vIRF proteins  
  
 
E6 protein  
E7 protein  
Core antigen  
Terminal protein  
 
 
Tat protein 
TAR RNA  
Unknown 
 
 
NS5A protein  
E2 protein  
Unknown 
Unknown  
  
 
σ3 protein  
 
 
 
NS1 protein  
 
 
Unknown 
V protein  
VP35 protein  
V protein  
Unknown 
 
 
 
IFN synthesis (IRF-3) 
IFN signaling (IRF-9, STAT1) 
PKR 
IFN signaling (IFNAR) 
PKR 
OAS 
IFN synthesis (IRF-3/7) 
PKR 
PKR 
PKR 
OAS 
IFN signaling 
PKR 
IFN signaling (JAK1, IRF-9) 
IFN synthesis (IRF-1/3/7) 
IFN signaling 
PKR 
IFN signaling (TYK2) 
IFN synthesis 
IFN signaling (IRF-9) 
IFN signaling 
 
 
PKR 
PKR 
OAS 
 
 
PKR 
PKR 
IFN signaling 
PKR 
 
 
PKR 
 
 
 
IFN synthesis(IRF-3/7, NF-jB) 
PKR 
OAS 
IFN synthesis 
IFN signaling (STAT2) 
IFN signaling (STAT1) 
IFN synthesis 
IFN signaling (STAT1) 
 
 
Several viruses encode proteins that inhibit IFN synthesis (Sen, 2001). According to Haller 
et al., (2006) in many cases viruses use non-structural viral proteins to down-regulate IFN 
responses. This IFN suppression strategy can be exploited in the laboratory to generate 
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mutant viruses that lack the relevant non-essential proteins. Such viruses still grow in IFN-
non-responsive cells but are highly attenuated in IFN-competent hosts. Ferko et al., (2004) 
demonstrated that modifying the RNA-binding domain of the NS1 protein in influenza A 
virus, to produce a non replicating NS1 mutant virus, elicited higher levels of IFN-α/ß in 
serum of immunized mice than the wild-type virus. Similarly, Valarcher et al., (2003) 
investigated the effects of deletion of the NS genes on the induction of IFN-α/ß by bovine 
respiratory syncytial virus (BRSV) and their role in establishing BRSV in calves and 
demonstrated that the NS proteins had a clear role in inhibiting the production of IFN-α/ß. 
Further results showed that the NS deficient viruses had highly restricted replication within 
cells; however, immunization induced serum antibodies and protection against challenge 
with virulent BRSV. Valarcher et al., (2003) concluded that since IFN-α/ß have profound 
immunomodulatory effects and stimulate the adaptive immune response; it is possible that 
the greater ability of the NS deficient virus to induce IFN-α/ß may improve the efficacy of 
vaccines. These results indicate it is possible to produce vaccines lacking proteins with IFN-
antagonistic activity (Haller, 2006). This method could therefore provide an interesting area 
of research for develop of a vaccine for IPNV, which to date has proven difficult; however 
it is first necessary to identify the IFN-antagonistic structure of IPNV.   
 Interestingly, all the major essential components of the type I IFN signalling 
pathway, i.e. IFN-α/ß receptor, JAK1, Tyk2, STAT1, STAT2 and IRF9, have been 
described as targets for inhibition by viruses (Levy and Garcia-Sastre, 2001). One of the 
major strategies of viruses for blocking IFN-α/ß production is to target the activities of the 
IRF transcription factors that bind to the IFN-ß promoter (Goodbourn, 2000). According to 
Bergan et al., (2006) the role of IRF’s in induction of fish IFNs is as yet unknown. In 
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teleost fish, IRF-1 and IRF-2 have been cloned and sequenced from rainbow trout (Collet 
and Secombes, 2002) and Japanese flounder (Yabu et al., 1998), whilst an IRF-7 like gene 
has been cloned from crucian carp (Zhang et al., 2003). Zhang et al., (2003) reported that 
the carp IRF-7 like gene, similar to human IRF-7, is upregulated by virus infection and IFN 
treatment and suggested that it plays a critical role in fish IFN signalling and regulation in 
the expression of IFN-responsive genes. However, studies of IRF-3, which is constitutively 
expressed in mammalian cells, have not been published for fish (Robertsen, 2005). The 
importance of the positive feedback loop between the expression of IRF-3 and IRF-7 for the 
efficient induction of the IFN-α/ß response has been reviewed (Garcia-Sastre, 2002; 
Taniguchi and Takaoka, 2002; Robertsen, 2005).  
Sato et al., (2000) studied the roles of IRF-3 and IRF-7 in mice and showed that 
both IRF-3 and IRF-7 perform non-redundant and distinct roles from each other. Their 
results showed that mice cells lacking IRF-3 are more vulnerable to virus infection, whilst 
cells defective in IRF-7 expression totally fail to induce IFN-α/ß genes in response to 
infections by any of the virus types they tested. Finally, they demonstrated that a normal 
induction of IFN-α/ß mRNA could be achieved by co-expressing both IRF-3 and IRF-7, 
thus proving that together IRF-3 and IRF-7 ensure the transcriptional efficiency of IFN-α/ß 
genes for the antiviral response. As only two IRF’s are cloned in fish more work is required 
to clone and sequence the components which participate in promoting IFN-α/ß expression. 
This would therefore enable investigation into the steps in the IFN-α/ß signal transduction 
pathway that IPNV inhibits to suppress the resulting IFN-α/ß expression. Another 
interesting target to investigate would be the toll-like receptors (TLR). TLR are a group of 
transmembrane proteins expressed mainly in dendritic cells (DC) or macrophages (Hoshino 
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et al., 2002). The activation of cytokine production by TLRs plays an important role in 
recruiting other components of innate host defence against bacterial pathogens (Tosi, 2005). 
The mammalian TLR family consists of 10 members (Bricknell and Dalmo, 2005; Tosi, 
2005; Plouffe et al., 2005).  
Viruses have also been shown to induce a strong activation of cytokine responses 
mediated by the activation of TLRs (Machida et al., 2006). As Figure 45 shows dsRNA 
binds and activates the dsRNA activated protein kinase (PKR), however Akira and Hemmi 
(2003) report that cells dervived from PKR KO mice still respond to the viral RNA mimic 
Poly I:C, suggesting the existence of another receptor, which recognizes dsRNA. It has 
been demonstrated that mammalian TLR 3 recognises ds RNA, and that activation of the 
receptor induces the activation of NF-қ B and the production of type I IFNs (Alexopoulou 
et al., 2001; Matsumoto et al., 2002). It has also been suggested that TLR 4 is important for 
the activation for the activation of the innate immune response to viral infection (Haynes et 
al., 2001; Machida et al., 2006). According to Goodburn (2000) Since the activation of NF-
қ B by infection is a key trigger to inducing IFN-α/ß transcription and other immune 
responses, it would perhaps not be surprising to find that many viruses encoded inhibitors of 
NF-қ B activation or function.  
 The results of this experiment confirm that that the positioning of sampling points in 
previous experiments was not optimal for IFN detection. However due to the close 
relationship between expression of IFN and Mx (Figure 39 and Figure 41 respectively), it is 
probable that IFN expression occurred in macrophages expressing Mx. The relationship 
between IFN expression and Mx induction was clearly demonstrated in this experiment by 
the close correlation between Mx expression and IFN expression in Poly I:C treated 
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macrophages. In these cells, peak Mx expression (Figure 41) occurred at 24 hours post 
treatment (Mx:ELF1 ratio= 573.62) corresponding to peak IFN expression (Figure 39). 
However, macrophages infected with IPNV did not express IFN and thus would not be 
expected to exhibit an Mx response. There was no significant difference in Mx expression 
between the IPNV-infected and controls (3 hours P = 0.90101, 12 hours P = 1.0000, 24 
hours P = 1.0000, 36 hours P = 0.9957). 
 Whilst the results of this experiment appear to show conclusively that IPNV inhibits 
the IFN production in Atlantic salmon head macrophages, this conclusion is in conflict with 
other published studies of immunity to IPNV infection. The findings of De Sena and Rio 
(1975) suggested that RTG cells infected with IPNV produced IFN, with similar properties 
to mammalian and avian IFNs. As this example refers to infections in rainbow trout cell 
lines, this may suggest that different species, like rainbow trout are more resistant to IPNV 
infection than others. Whilst this may be true, the cell type investigated in this thesis could 
provide another explanation for the differences of opinion in literature. It could be 
hypothesized that the role of the macrophage explains why IPNV may have evolved 
mechanisms to suppress innate immune functions in this cell. Macrophages are of great 
importance as scavengers of dead and foreign material (Ellis, 1977). Thus, the macrophage 
is one of the cell types which a pathogen is likely to encounter upon entry to the host. Given 
the prominent role of macrophages as effector cells in the immune response, it is not 
surprising that certain pathogens have evolved mechanisms to promote their survival within 
these cells. Indeed, it is possible that viruses such as IPNV may exploit macrophages as a 
shield from other components of the cell-mediated and humoral immune responses 
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(Kaufmann, 1993). This may ultimately assist IPNV in developing a carrier state in fish 
populations (Johansen and Sommer, 1995). 
 The findings of this thesis concur with those of Jensen and Robersten (2002). They 
demonstrated that the TO-cell line, a cell line which originates from Atlantic salmon head 
kidney (Wegerland and Johansen, 2001) failed to induce an Mx response when infected 
with IPNV in vitro. On the contrary, Collet et al., (2007) reported the detection of IFN in 
the supernatant of macrophages from Atlantic salmon following infection with IPNV; 
however, they also demonstrated that IPNV appeared to suppress Mx expression in RTG 
cells. In agreement with the findings of Collet et al., (2007) an in vitro infection of IPNV 
was reported to have induced Mx in head kidney leucocytes isolated from rainbow trout 
(Boudinot et al., 1999).  Whilst these results do not agree with the results of this study and 
those of De Sena and Rio (1975) who reported IFN production in RTG cells, the differences 
in results could be explained by the nature of the virus. One explanation could be due to 
differences in the IFN inducing abilities of the strains of IPNV used in these studies. The 
strain (851/99) used by Collet et al., (2007) may have been more virulent than the one used 
in this study (975/99). Bruslind and Reno (2000) reported that the differences in amino acid 
residues located in the VP2 viral capsid protein correlate with the virulence of IPNV 
isolates. It has been shown that different strains of IPNV induce varying levels of mortality 
(Bruslind and Reno 2000; Shivappa, et al., 2004; Song et al., 2005); therefore, there may be 
a link between the differences in virulence between strains of IPNV and the ability of the 
virus to suppress the innate antiviral response of the host. As previously mentioned NS 
proteins of viruses have been shown to be IFN antagonists in a range of viral diseases (Joost 
Haasnoot et al., 2003; Campagna et al., 2005). The method by which RNA viruses replicate 
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is error-prone (Krönke et al., 2004), and therefore raises the possibility of slight variations 
in NS proteins occurring amongst the different strains of IPNV viruses which could provide 
one explanation as to why a conflict exists in the literature as to whether IPNV induces IFN 
responses in fish cells.  
 It could be argued that in vitro experiments do not give a true representation of the 
developments in vivo. When studying Mx mRNA induction by IHNV (Trobridge et al., 
1997) reported a strong expression of Mx following infection in vivo, whilst an in vitro 
infection failed to induce a response. They suggested that the induction was not as efficient 
as in fish tissues, where the presence and interaction of several cell types might lead to more 
potent induction of IFN. Jensen and Robertsen (2000) reported that two halibut Mx 
transcripts (2.2 kb and 2.6 kb) were strongly induced in vivo by both Poly I:C and IPNV in 
all organs studied.  IPNV has been reported to be capable of inducing an in vivo expression 
of Mx following IPNV challenge (Jensen and Robertsen, 2000; Jensen and Robertsen, 
2002; Bergan and Robertsen, 2004; Lockhart et al., 2006). It is possible that in vivo 
experiments report the Mx expression following IPNV infection that is derived from a range 
of different cell types. On the other hand, the reason why some in vitro experiments have 
demonstrated that IPNV infection fails to induce an Mx response may be from the use of 
cell types in which the virus is able to block the IFN response. If IPNV does exploit 
macrophages as a shield from components of the cell-mediated and humoral immune 
responses as Kaufmann (1993) suggests is possible, then this is could explain how fish that 
exhibit an Mx response become IPNV carriers.  
As the results of this thesis suggest that IPNV suppresses IFN production in Atlantic 
salmon head kidney macrophages, and the results of chapter 4 reveal that stimulation of 
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macrophages with IFN (section 5.3.6) prior to infection aids the reduction of intracellular 
viral levels, IFN therapy may represent a logical treatment to investigate as a means to treat 
IPN. IFN therapy has been used to treat a range of viral diseases in humans; IFN-α/ß is 
clinically used to treat chronic active hepatitis caused by hepatitis C or hepatitis B viruses 
(Samuel 2001; Sen, 2001). However Goodburn et al., (2000) suggest that the ability of 
viruses to block the IFN response may have consequences in relation to chronic or 
persistent viral disease. Thus, while initially it may appear to be the most logical choice, 
IFN may not represent an effective means of treatment of some chronic virus infections 
because viruses have mechanisms for circumventing the IFN response. The findings of 
Lockhart et al., (2004) agree with this suggestion, as IPNV continued to persist for 14 days, 
following an injection of Poly I:C, in naturally infected Atlantic salmon. Poly I:C 
administration was shown to successfully induce Mx, suggesting that induction of an IFN 
response with poly I:C is probably not a feasible means of treating Atlantic salmon 
broodstock that are also IPNV carriers. However, although IPNV has been shown to have 
the ability to circumvent the type I IFN response in Atlantic salmon head kidney 
macrophages, the results of the previous chapter showed that if the antivirial response was 
triggered in the cell prior to  infection, then the IFN treatment appears to have a significant 
effect on reducing the level of virus in the infected macrophage.  
In fish, there have been other positive results in terms of activating the innate 
immune response. Jorgensen et al., (2001) demonstrated that non-methylated CpG DNA 
induces production of antiviral cytokines in adherent salmon head kidney leucocytes, and 
suggested that the immune system recognises unmethylated CpG motifs as a “danger 
signal” which subsequently activates the immune system. Following this, Jorgensen et al., 
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(2003), reported that Atlantic salmon treated with CpG DNA prior to challenge with IPNV 
exhibited reduced viral titres and lower mortality compared to controls. Consequently, CpG 
DNA could be used as an adjuvant or immunostimulant with the aim of reducing IPNV-
associated mortality. 
6.4.2  Intracellular levels of IPNV following infection in Atlantic salmon macrophages 
IPNV:ELF-1 ratios of macrophages inoculated with IPNV were examined to ensure that the 
virus  successfully infected the cells. Figure 43 demonstrates unequivocally that there was 
an increase in IPNV:ELF-1 ratio between 0 and three hours post-infection (P = 0.0001). 
IPNV levels also increased between three hours (19007.97) and 36 hours (45417.04) post 
infection. However this increase was not significantly different (P = 0.116). Experiments in 
the previous chapter (sections 5.3.6 and 5.3.7) demonstrate that IPNV levels did not 
markedly increase throughout the duration of the experiment. This suggests why IPNV is 
described as harbouring within Atlantic salmon head kidney macrophages (Johansen and 
Sommer, 1995). This may enable IPNV virus to persist within its salmonid host and 
maintain a life long carrier status within the fish.  
6.5    Conclusion 
The results of this study are in agreement with published studies which demonstrate that 
teleosts possess an innate antiviral defence system, incorporating the type I IFN system. 
This includes IFN-induced effector proteins such as Mx. Poly I:C was found to be a good 
inducer of IFN, whilst IPNV appears to have evolved a strategy to avoid the type I IFN 
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defence system of Atlantic salmon, possibly facilitating persistence within macrophages. 
The results suggest that IPNV circumvents the antiviral immune response in Atlantic 
salmon head kidney macrophages by blocking IFN production. In Poly I:C treated 
macrophages IFN expression peaked at 24 hours post treatment and then immediately 
declined to undetectable levels. The inability to detect IFN at later time points confirmed 
that the sampling points used in initial experiments were unsuitable for detection of the IFN 
response. Blocking of IFN production would explain why macrophages and peripheral 
monocytes are a target cell for IPNV in persistently infected fish (Collet et al., 2007). The 
results of this study appear to be in contrast with other studies that demonstrate IPNV has 
an ability to induce Mx. However, these studies were performed in different types of cell 
which may have the ability to induce Mx in response to IPNV. There is also the likelihood 
that different strains of IPNV have varying IFN antagonistic properties. The results 
presented in this thesis support McBeath et al., (2007) contention that induction of the IFN 
system by IPNV involves complex virus/host interactions and may play a role in 
determining states of resistance or susceptibility. With further work, it would be possible to 
characterise IPNVs IFN antagonism in more detail, and to confirm the stage of the IFN 
response that this virus blocks in order to suppress the antiviral response. A better 
understanding of the IFN antagonistic properties of viruses such as IPNV would be of great 
benefit for the rational design of novel live, attenuated viral vaccines and holds the promise 
of providing novel targets for development of antiviral compounds active against human 
and animal pathogens (Levy and Garcia-Sastre 2001).  
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Chapter 7 - General discussion 
7.1    Discussion  
7.1.1  Macrophage culture and real time RT-PCR assay development 
The overarching objective of this project was to study the effects of IPNV on the innate 
immune response of Atlantic salmon macrophages. The close relationship of IPNV to 
Atlantic salmon head kidney macrophages (Johansen and Sommer, 1995) made the 
macrophage a logical choice for in vitro experiments. Macrophages also play a major role in 
innate and adaptive immune response (Sørensen et al., 1997). IPNV can be detected within 
the macrophages of persistently infected carrier fish (Sadasiv, 1995). An understanding of 
host immune responses to IPNV is crucial for the development of effective vaccines to 
counter this virus. IPNV vaccines must not only protect against disease, but also prevent the 
development of infectious carriers.  
              Consequently, characterisation of the immune mechanisms involved in the 
generation and maintenance of the carrier-state are of great importance for the design of 
IPNV vaccines and ultimately for the control of IPN. Vaccines that simply reduce or 
eliminate mortalities will do little to solve the problem of IPN on a worldwide scale (Reno, 
1999). In the present study, a reproducible technique was developed for the in vitro culture 
of macrophages for up to 12 days post-isolation (chapter 2). In conjunction with this a 
reliable RNA extraction method was developed which facilitated quantitation of immune 
related gene expression by real time RT-PCR for IPNV, IFN and Mx relative to the 
“housekeeping gene” ELF-1 (Chapter 3). Limitations were imposed on this study by the 
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yields of macrophages obtained from salmon head kidneys, and the inability to maintain 
cultures in 96 well plates. This restricted the number of replicates that could be studied in 
IPNV infection experiments, and subsequently limited the statistical power of experiments. 
Ideally, greater numbers of replicates should be studied, but financial and logistical 
constraints prevented such an approach in the present study. However as the effects of many 
of the experimental manipulations were pronounced, this drawback did not negate the 
overall conclusions of the project. In future studies, a larger consumables budget and more 
manpower, would permit the use of experiments with more time points and the 
investigation into further mRNA targets.  
7.1.2  Innate immune responses in IPNV-infected Atlantic salmon head kidney 
macrophages. 
The effect of IFN on IPNV levels in infected macrophages was investigated in chapter 4. 
The efficacy of the IFN preparations was confirmed in a luciferase reporter assay. Since a 
relationship has been demonstrated between Mx expression and protection against IPNV 
(Nygaard et al., 2000) it was anticipated that IFN-treated macrophages would be more 
efficient in clearing the virus. The findings of this experiment would compliment the other 
findings of this thesis. It was demonstrated that stimulation of macrophages prior to 
infection helped reduce the viral levels in infected cells (section 5.3.6). As IPNV has 
evolved an ability to suppress the type I IFN system in Atlantic salmon macrophages there 
is a need to identify and develop therapeutic means of activating the macrophage’s type I 
IFN system prior to or in the presence of IPNV infection. The ability of immunostimulants 
to prevent infection or aid the clearance of IPNV from infected macrophages was therefore 
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investigated in the present study. Three immunostimulants, MAF, glucan and LPS, were 
tested for the ability to up-regulate the innate immune response of the Atlantic salmon 
macrophage (section 5.3.5). Immunostimulants increase resistance to infectious disease, not 
by enhancing specific immune responses, but by enhancing non-specific defence 
mechanisms (Sakai, 1999). All three treatments studied have been shown to be effective 
against bacterial diseases. However, in the present study, none were able to induce Mx 
expression, and thus they may not represent useful means of controlling IPNV. The inability 
to induce an Mx response may be due to the specificity of type I IFN signalling. If the 
immunostimulants were shown to have the ability to enhance virus clearance this could 
have potentially helped prevent the establishment of carrier status, which would 
consequently help to reduce the incidence of IPN in wild and farmed fish. The lack of 
published studies reporting successful use of immunostimulants to mitigate virus infections 
in aquaculture suggests that they may only have a limited use. 
7.1.3  IPNV levels in Atlantic salmon head kidney macrophages  
IPNV levels were investigated in macrophages following infection to ascertain if replication 
of the virus occurred within the cell. Following the development of a reproducible in vitro 
culture technique, it was demonstrated that Atlantic salmon head kidney macrophages can 
be successfully infected in vitro (section 5.4.1). There was a significant increase in the 
infected macrophage virus levels between the time 0 and 1 day post infection sample point. 
Infected macrophage virus levels were significantly greater than in uninfected cells at all 
time points. This result would suggest that IPNV has the ability to replicate in Atlantic 
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salmon head kidney macrophages during the early stages of infection.  Peak virus levels 
occurred between 3 and 5 days post infection (Figure 24).  
Whilst increases in the mean IPNV:ELF-1 ratios were observed in the infected 
macrophages, none of these increases were shown to be significant between 1 and 9 days 
post infection. Whilst the experiment demonstrates that IPNV infects macrophages in vitro, 
replication of the virus may occur at relatively low levels. IPNV levels declined between 5 
and 9 days post infection, but crucially the virus was not completely cleared, as levels at 9 
days post infection were still significantly greater than in uninfected cells. This observation 
is in agreement with the persistent infections reported elsewhere.  
The results of the present study are not in agreement with several studies that 
suggest that IPNV persists within macrophages without replicating (Nova et al., 1996, 
Munro et al., 2006, Collet et al., 2007). However, the present study does suggest that the 
macrophage is not the cell in which the bulk of virus replication occurs in IPN of Atlantic 
salmon, as originally proposed by Yu et al (1982). It should be emphasised that the 
experiments conducted in this thesis have focused on IPNV infection of macrophages in 
vitro infection, and thus it would be interesting to compare the results with in vivo studies of 
the IPNV infection.   
In IFN treated IPNV-infected macrophages, IPNV levels were significantly reduced 
during the course of the experiment, suggesting that IFN may represent a potential 
treatment for IPN (Figure 35). However, IPNV levels also declined in IPNV-infected 
untreated macrophages. Whilst the reduction in IPNV levels was not statistically significant, 
this result suggests that other components of the immune response may be responsible for 
the declining virus levels. However, as infected fish normally develop a life long 
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asymptomatic carrier state it is not likely, if there is any alternative antiviral response, that it 
is of great significance as it is not capable of clearing the virus entirely. Nevertheless, this 
again highlights the advantage of a larger number of genes or novel mRNA targets being 
investigated in order to give a more in depth picture of the relationship between IPNV and 
the head kidney macrophage. For a clearer insight into how IPNV replicates in head kidney 
macrophages, qRT-PCR utilising absolute quantification would provide more rigorous 
results than the relative quantification method used in the present study. Laminarin, V. 
anguillarum LPS and MAF were found to be incapable of inducing Mx, and therefore may 
be better suited to the control of bacterial diseases.   
The absence of IPNV in macrophage culture media assessed by infectivity assays in 
CHSE-214 cells suggests that any decline in IPNV levels is a result of the virus being 
broken down in macrophages rather than shed. However, it is possible that washing of the 
macrophage monolayers and replacing of the culture medium may have led to the removal 
of any virus shed by the cells.  
7.1.4  Suppression of type I IFN response in Atlantic salmon macrophages by IPNV 
In order to develop effective vaccines it is helpful to have an understanding of the host-
pathogen relationship. Many fish viral pathogens establish a persistent carrier state in the 
host; however little is known about the mechanisms involved in the establishment and 
maintenance of viral carrier states in fish and how viruses evade the hosts defences (Ellis, 
2001). As the innate immune system is the first line of defence against viral infections, and 
as the response of this system is primarily through induction of type I IFN’s and the 
activation of NK cells, viruses frequently act so as to subvert one or more of these 
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mechanisms to prolong survival (Rønneseth et al., 2006). The findings of the present study 
suggest that IPNV targets the type I IFN system, and this may facilitate the establishment of 
a carrier state. More specifically the results presented in Chapter 5 (section 6.3.1) 
demonstrate that IPNV has evolved the ability to block IFN production. No expression of 
IFN or Mx occurred in IPNV-infected macrophages in the experiments conducted in 
Chapter 4 (sections 5.3.4 and 5.3.5) and since Mx expression occurred in the Poly I:C 
treated macrophages (which serve as a positive control), it is probable that this was due to 
IPNV-mediated immunosuppression. Unfortunately, the sampling points in experiments 
conducted in chapter 4 were not optimal to detect IFN expression, and consequently no 
definite conclusions could be made concerning how IPNV suppresses the type 1 IFN 
response. However, through the use of sampling points positioned earlier in the course of 
infection, it was possible to demonstrate that IFN production was blocked by IPNV as 
opposed to IFN signalling (Figure 39). Further characterisation of the mechanism through 
which IPNV prevents IFN production would be of great benefit to the development of an 
IPNV vaccine, as it may be possible to generate attenuated viruses by altering specifically 
those gene(s) responsible for inhibition of IFN function (Goodbourn et al., 2000).  
 In summary, methods for the in vitro cultivation of macrophages and quantitative 
RT-PCR were used to characterise innate immune responses in IPNV-infected Atlantic 
salmon macrophages. The results of this research suggest that IPNV may block IFN 
production rather than IFN signalling. Three immunostimulants (MAF, LPS and glucan) 
were ineffective in boosting macrophage innate immune responses to IPNV. These results 
highlight potential means to control IPN through rational design of attenuated IPNV 
vaccines.  
Chapter 7: General Discussion 
 
165 
7.1.5  Relevance of findings to the current status of IPN in Scotland  
Persistent IPNV infection of Atlantic salmon poses a significant and costly threat to the 
aquaculture industry. Scottish salmon production in 2000 exceeded 130,000 tonnes and, at 
£400M, contributed up to 40% of Scottish food exports (Rae, 2002). According to Murray 
(2006 b) most of this production occurred in areas with few economic alternatives, therefore 
losses of salmon production due to IPN are of considerable importance. IPN is an example 
of a disease which is emerging in the aquaculture of finfish. This disease was first reported 
from trout hatcheries in North America in the 1950s (Wood et al., 1955) but has since 
spread to most countries with salmonid production. Hence, the results of the present study 
are particularly timely. Moreover, recent legislative changes have increased the requirement 
for effective means of controlling IPN. On commencement of this study IPN was 
categorised as a List III disease under Annex A of European Union (EU) council directive 
91/67. Therefore in Great Britain IPN was a notifiable disease under The Diseases of Fish 
Acts 1937 and 1983. A recent assessment has identified IPNV as an increasingly common 
pathogen in farmed Scottish Atlantic salmon; with over 80% of marine sites are now 
infected (Murray, 2006 a). As a result of this increase in prevalence, during the course of 
this study IPN was deregulated from a List III disease to a non notifiable disease rating. IPN 
is now so widespread, the threat of IPNV infection to Atlantic salmon is of great 
significance for the farmer, and subsequently increases the need for them to protect their 
fish. It is a widely held opinion that the only effective way to control virus infections in 
aquaculture is to prevent the exposure of fish to pathogenic viruses and especially to 
prevent movement of infected fish between farms (Blake et al., 1995; Williams et al., 1999; 
Milne, 2006 a). However, as the virus is so widespread there is little that can be done by the 
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farmer to prevent his stock coming into contact with the virus. A stark reality of this is the 
susceptibility to an outbreak of IPN in Atlantic salmon post-smolts shortly after seawater 
transfer (Rønneseth et al., 2006).  This therefore increases the importance of understanding 
the immunity of Atlantic salmon with respect to IPNV infection, and subsequently 
undertaking research into how the immune system can be enhanced. Possible steps to limit 
the consequences of IPN might involve the improvement of disease resistance through 
breeding programmes, and modulation of the immunity through vaccines, 
immunostimulants or other means.  
 To put the findings of this study in context with respect to the current status of IPN 
in Scotland, there are many areas of work that require attention. It is the opinion of Murray 
(2006 a) that in practice eradication of IPNV from Scotland now seems impractical. This 
study appears to be the first in the literature to demonstrate that IPNV specifically blocks 
the production of IFN within Atlantic salmon macrophages. Further characterisation of the 
mechanism of IFN inhibition by IPNV would assist with the development of control 
measures. In terms of making fish more resistant to IPNV the most obvious solution would 
be vaccination to make the post-smolts less susceptible to infection. According to the report 
of the Aquaculture Health Joint Working Group on Infectious Pancreatic Necrosis Virus in 
Scotland published by the Scottish Executive, several vaccines against IPNV are currently 
undergoing field trials in marine sites in Scotland, Norway and Chile. However, the efficacy 
of these vaccines in protecting against mortality in post-smolts is still uncertain because of 
the lack of reliable lethal challenge models. In addition, the development of vaccines 
against infectious diseases is time consuming and ultimately expensive (Randonic et al., 
2004).  It may also be difficult to administer vaccines to salmon at the fry life cycle stage. It 
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is hoped that results as presented in this thesis will increase the understanding of IPN, 
however there are still many more questions still to be answered concerning the persistence 
of IPNV within the fish. Moreover, since there are no effective treatments available against 
IPN more research is required. For example, further work is essential to characterise the 
Atlantic salmon innate immune response. Effective treatments against IPN are vital to 
enable economically viable culture of Atlantic salmon to continue in an area where 
eradication of the virus seems impractical. A number of potential approaches are discussed 
in the ensuing future work section.  
7.2    Future work  
In this thesis, a technique was developed for the culture of macrophages and the subsequent 
extraction of RNA for use in real time RT-PCR analyses of immune targets. This enables an 
opportunity for reproducible in vitro studies of macrophage immunity to IPNV. In the 
present study Mx and IFN have been investigated together with IPNV levels in infected 
macrophages. Other molecular biological methods could also be applied to the study of 
macrophage immunity to IPNV. For example, microarray technology provides a powerful 
tool for measuring the expression levels of large numbers of genes simultaneously and 
creates unparalleled opportunities to study complex physiological or pathological processes, 
including the development of disease, that are mediated by the co-ordinated action of 
multiple genes (Kerr et al., 2000). Detection of genes differentially expressed across 
experimental, biological, and/or clinical conditions is a major objective for microarray 
experiments (Tan et al., 2006). Microarray analyses of IPNV-infected macrophages and 
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controls would represent a powerful means of characterising the immune response to an 
important fish pathogenic virus. 
 The results of the present study were based entirely on in vitro experiments. As 
discussed above, the results of this thesis are in conflict with other studies, with respect to 
the ability of IPNV infected macrophages to express Mx. Whilst all attempts were made to 
provide the optimal culture conditions for the macrophages, an in vitro experiment can 
never fully reproduce in vivo conditions. Therefore it would be of interest to conduct an 
experiment where Atlantic salmon are challenged in vivo with IPNV, with head 
macrophages sampled over a time period post-infection. The expression of IFN and Mx 
within these macrophages could be compared to controls and also macrophages infected in 
vitro. This would reveal whether isolation and in vitro culture effect macrophage gene 
expression.  
 It would also be interesting to investigate the interaction between IPNV and other 
cell types. According to Rønneseth et al., (2006) the role of neutrophils and their regulation 
during infections in fish is poorly understood. These authors demonstrated that neutrophils 
are involved in virus clearance and are affected by IPNV for weeks after the 
commencement of infection. This again raises the important question, how well do in vitro 
studies represent what is happening within a fish? By building on the knowledge gained in 
this study regarding the innate immune response of Atlantic salmon head kidney 
macrophages in response to IPNV, it would be possible to investigate the IFN suppressing 
abilities of IPNV in other cell types. By identifying all the possible sites of virus 
persistence, it would enable a greater understanding of the carrier state.  
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 The most important area of work that requires further research as a consequence of 
the findings of this study concerns the ability of IPNV to block IFN production in Atlantic 
salmon head kidney macrophages. With further work, it would be possible to characterise 
more comprehensively the interaction between IPNV and host encoded proteins. One 
possible method of identifying which structure of IPNV is responsible for blocking the IFN- 
α/ß response in Atlantic salmon head kidney macrophages would be RNA interference 
(RNAi). In recent years, sequence-specific gene silencing has been an area of increasing 
focus, both because of its interesting biology and because of its power as an experimental 
tool (Denli and Hannon, 2003). In animals and protozoa gene-specific double-stranded 
RNA triggers the degradation of homologous cellular RNAs, the phenomenon of RNAi. 
RNAi has been shown to represent a novel paradigm in eukaryotic biology and a powerful 
method for studying gene function (Ullu et al., 2002). Target genes can be silenced by 
transfection of chemically or enzymatically synthesized small interfering RNAs (siRNA) or 
by DNA based-vector systems that encode short harirpin RNAs (shRNAs) that are further 
processed into siRNAs in the cytoplasm (Du et al., 2006).  Campagna et al., (2005) 
designed 19bp siRNAs to target the genome segment 11 of two strains of Rotavirus to 
demonstrate that NSP5 is an essential protein for the formation of viroplasms and for virus 
replication. Both siRNAs were entirely specific and they abolished the expression of NSP5 
through the knockdown of segment 11 RNA. It has been suggested that as RNAi has been 
shown to play a role in viral clearance studies (Kapadia et al., 2006; Yoon, 2004; Wang, 
2004), therapeutic induction of RNAi either alone or in combination with IFN treatment 
might represent an alternative approach for the treatment of chronic diseases (Kapadia et 
al., 2006). Inhibition of virus replication by means of induced RNAi have been reported for 
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numerous viruses, including several important human pathogens such as human 
immunodeficiency virus type 1, hepatitis C virus, hepatitis B virus, dengue virus, poliovirus 
and influenza virus A. Examples of these are reviewed in Joost Haasnoot et al., (2003). 
However, Krönke et al., (2004) have raised the important point that the error-prone 
replication of RNA viruses, which gives rise to the rapid evolution of escape mutants, may 
represent an obstacle for the development of siRNA-based gene therapies. For this reason, 
they suggest that RNA viruses and retroviruses will be especially difficult to eradicate. 
 Once the viral structure responsible for the blocking of the IFN- α/ß response is 
identified, it would be possible to examine the direct effect of the interaction between the 
antagonist and the various steps in the IFN pathway. Through doing this, the specific stage 
at which the virus blocks the production of IFN would be revealed. A commonly used 
technique that has been used to facilitate the study of protein-protein interactions is the 
yeast two-hybrid system (Fields and Song, 1989). The system is based on the ability to split 
a transcription factor (GAL4) into two separable functional domains: a DNA-binding 
domain and a transcriptional activation domain. Each one when expressed separately is 
unable to activate transcription. These domains are used to generate hybrid proteins to be 
tested for potential protein-protein interaction. Plasmids encoding two hybrid proteins one 
consisting of the GAL4 DNA-binding domain fused to the “bait” protein and the other 
consisting of the GAL4 activation domain fused to the “prey” protein are constructed and 
introduced into the yeast (Chien et al., 1991). Once “bait” protein - “prey” protein 
interaction is generated, it reconstitutes a functional transcription factor that can be readily 
monitored using reporter gene assays in yeast (Aronheim, 2000). However according to 
Shioda et al., (2000) some interactions of mammalian proteins may not occur in the yeast 
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milieu because of possible lack of associating factors, protein modifications (such as signal-
induced phosphorylation), or correct protein folding. As a result, Shoida et al., (2000) 
developed a mammalian cell two-hybrid screening system to identify interacting proteins 
that are difficult to detect by the yeast system. However, these methods are restricted in the 
fact that they do not cater for transcription factor interactions and will only indicate if 
protein interaction has occurred. As this method only identifies interactions between 
proteins it would therefore only be possible to investigate which proteins corresponding to 
the numerous stages of the IFN pathway the IPNV antagonistic structure interacts with. 
Subsequently one is only able to propose that IFN blocking may occur at this stage as the 
yeast 2 hybrid method does not demonstrate how this interaction affects the outcome of the 
pathway.  
As two-step real time RT-PCR has been implemented to analyse the expression of 
targets in this thesis from the extracted macrophage RNA, a library of cDNA which can be 
kept indefinitely (Bustin, 2000, Peters et al., 2004), is generated for each experiment. This 
is a considerable advantage as other mRNA targets can be quantified with relative ease 
when new and interesting targets are detected in fish. With investigation into further targets 
it would be possible look for alternative targets within the macrophage IFN system which 
are affected by IPNV infection, and subsequently this may be another way of highlighting 
the specific stage at which the virus blocks IFN production. Thus, the cDNA stocks 
produced in this project represent a useful resource for further study of macrophage 
immunobiology.    
  
172 
References 
 
Acosta, F., Lockhart, K., Gahlawat, S.K., Real, F. and Ellis, A.E. (2004). Mx expression in 
Atlantic salmon (Salmo salar L.) parr in response to Listonella anguillarum bacterin, 
lipopolysaccharide and chromosomal DNA. Fish and Shellfish Immunology, 17, 255-263.   
 
Ahmet, M.D. and Hannon, G.J. (2003). RNAi: an ever-growing puzzle. Trends in 
Biochemical Sciences, 28, 196-201.  
 
Ahne, W. and Negele, R.D. (1985). Studies on the transmission of infectious pancreatic 
necrosis virus via eyed eggs and sexual products of salmonid fish. In: Ellis, A.E., (Ed.) Fish 
and Shellfish Pathology, pp. 261-269. London: Academic Press. 
 
Ahne, W., Kelly, R.K. and Scholtfeldt, H.J. (1989). Factors affecting the transmission and 
outbreak of infectious pancreatic necrosis (IPN). In: Lillelund, K. and Rosenthal, H., (Eds.) 
Contributions to the Canadian-German cooperation programme: "Fish health protection 
studies", Hamberg. 
 
Akira, S. and Hemmi, H. (2003). Recognition of pathogen-associated molecular patterns by 
TLR family. Immunology Letters, 85, 85-95.  
 
  
173 
Alexopoulou, L., Holt, A.C., Medzhitov, R. and Flavell, R.A. (2001). Recognition of 
double-stranded RNA and activation of NF-қ B by Toll-like receptor 3. Nature, 413, 732-
738.  
 
Alonso, M., Rodriguez, S. and Prieto, S.I.P. (1999). Nested PCR improves detection of 
infectious hematopoietic necrosis virus in cells co infected with infectious pancreatic 
necrosis virus.  Journal of Virological Methods, 81, 1-9. 
 
Altmann, S.M., Mellon, M.T., Distel, D.L., Kim, C.H. (2003). Molecular and functional 
analysis of an interferon gene from the zebrafish, Danio rerio. Journal of Virology, 77, 
1992-2002.  
 
Anderson, D.P. (1992). Immunostimulants, adjuvants and vaccine carriers in fish: 
Applications to aquaculture. Annual Review of Fish Diseases, 2, 281-307.  
 
Anon. (2003). Final report of the Aquaculture Health Joint Working Group subgroup on 
infectious pancreatic necrosis in Scotland. Aberdeen: Fisheries Research Services. 90p.  
 
Ariel, E. and Olesen, N.J. (2002). Finfish in aquaculture and their diseases - A retrospective 
view on the European Community. Bulletin of the European Association of Fish 
Pathologists, 22, 72-85. 
 
  
174 
Aronheim, A. (2000). Protein Recruitment Systems for the Analysis of Protein-Protein 
Interactions, Biochemical Pharmacology, 60, 1009-1013.  
 
Barlic-Maganja, D., Strancar, M., Hostnik, P., Jencic, V. and Grom, J. (2002). Comparison 
of the efficiency and sensitivity of virus isolation and molecular methods for routine 
diagnosis of infectious haematopoietic necrosis virus and infectious pancreatic necrosis 
virus. Journal of Fish Diseases, 25, 73-80. 
 
Bebak, J., Mcallister, P.E. and Smith, G. (1998). Infectious pancreatic necrosis virus: 
transmission from infectious to susceptible rainbow trout fry. Journal of Aquatic Animal 
Health, 10, 287-293. 
 
Bergan, V. and Robertsen, B. (2004). Characterization of Atlantic halibut (Hippoglossus 
hippoglossus) Mx expression. Developmental and Comparative Immunology, 28, 1037-
1047.  
 
Bergan, V., Steinsvik, S., Xu, H., Kileng, Ø. and Robertsen, B. (2006). Promoters of type I 
interferon genes from Atlantic salmon contain two main regulatory regions. FEBS Journal, 
273, 3893-3906.  
 
Best, S.M., Morris, K.L., Shannon, J.G., Robertson, S.J., Mitzel, D.N., Park, G.S., Boer, E., 
Wolfinbarger, J.B. and Bloom, M.E. (2005). Inhibition of Interferon-Stimulated JAK-STAT 
  
175 
Signalling by a Tick-Borne Flavivirus and Identification of NS5 as an Interferon 
Antagonist, Journal of Virology, 79, 12828-12839.  
 
Biering, E. and Bergh, O. (1996). Experimental infection of Atlantic halibut, Hippoglossus 
hippoglossus L, yolk-sac larvae with infectious pancreatic necrosis virus: Detection of virus 
by immunohistochemistry and in situ hybridization. Journal of Fish Diseases, 19, 261-269. 
 
Biering, E. (1997) Immune response of the Atlantic halibut (Hippoglossus hippoglossus L) 
to infectious pancreatic necrosis virus (IPNV). Fish and Shellfish Immunology, 7, 137-149. 
 
Biering, E., Villong, S., Sommerset, I., Christie, K.E. (2005) Update on viral vaccines for 
fish. Developments in Biologicals, 121, 97-113. 
 
Bird, S., Zou, J., Savan, R., Kono, T., Sakai, M., Woo, J. and Secombes, C. (2005). 
Characterisation and expression analysis of an interleukin 6 homologue in the Japanese 
pufferfish, Fugu rubripes. Developmental and Comparative Immunology, 29, 775-789.  
 
Blake, S.L., Schill, W.B., Mcallister, P.E., Lee, M.K., Singer, J.T. and Nicholson, B.L. 
(1995). Detection and identification of aquatic birnaviruses by PCR assay. Journal of 
Clinical Microbiology, 33, 835-839.  
 
  
176 
Blake, S., Ma, J.Y., Caporale, D.A., Jairath, S. and Nicholson, B.L. (2001). Phylogenetic 
relationships of aquatic birnaviruses based on deduced amino acid sequences of genome 
segment A cDNA. Diseases of Aquatic Organisms, 45, 89-102. 
 
Bootland, L.M., Dobos, P. and Stevenson, R.M.W. (1991). The IPNV carrier state and 
demonstration of vertical transmission in experimentally infected brook trout. Diseases of 
Aquatic Organisms, 10, 13-21.  
 
Bootland, L.M., Dobos, P. and Stevenson, R.M.W. (1990). Fry age and size effects on 
immersion immunization of brook trout, Salvelinus-fontinalis mitchell, against infectious 
pancreatic necrosis virus. Journal of Fish Diseases 13, 113-125. 
 
Bootland, L.M., Dobos, P. and Stevenson, R.M.W. (1995). Immunization of adult brook 
trout, Salvelinus-fontinalis (mitchill), fails to prevent the infectious pancreatic necrosis virus 
(IPNV) carrier state. Journal of Fish Diseases, 18, 449-458. 
 
Boudinot, P., Massin, P., Blanco, M., Riffault, S. and Benmansour, A., (1999). vig-1, a new 
fish gene induced by the rhabdovirus glycoprotein, has a virus-induced homolgogue in 
humans and shares conserved motifs with the MoaA family. Journal of Virology, 73, 1846-
1852.  
 
  
177 
Bowden, T.J., Smail, D.A. and Ellis, A.E. (2002). Development of a reproducible infectious 
pancreatic necrosis virus challenge model for Atlantic salmon, Salmo salar L. Journal of 
Fish Diseases, 25, 555-563. 
 
Braun-Nesje, R., Bertheussen, K., Kaplan, G. and Seljelid, R. (1981). Salmonid 
macrophages: separation, in vitro culture and characterization. Journal of Fish Diseases, 4, 
141-151.  
 
Bricknell, I. and Dalmo, R.A. (2005). The use of immunostimulants in fish larval 
aquaculture. Fish and Shellfish Immunology, 19, 457-472.  
 
Bridle, A.R., Carter, C.G., Morrison, R.N., Nowak, B.F. (2005). The effect of ß-glucan 
administration on macrophage respiratory burst activity and Atlantic salmon, Salmo salar 
L., challenged with amoebic gill disease-evidence of inherent resistance. Journal of Fish 
Diseases, 28, 347-356.  
 
Bruslind, L.D. and Reno, P.W. (2000). Virulence comparison of three Buhl-Subtype 
isolates of infectious pancreatic necrosis virus in Brook trout fry, Journal of Aquatic Animal 
Health, 12, 301-315. 
 
Bustin, S.A. (2000). Absolute quantification of mRNA using real-time reverse transcription 
polymerase chain reaction assays. Journal of Molecular Endocrinology, 25, 169-193.  
 
  
178 
Bustin, S.A. and Nolan, T. (2004). Pitfalls of quantitative real-time reverse-transcription 
polymerase chain reaction. Journal of Biomolecular Techniques, 15:155-166.  
 
Bustin, S.A., Benes, V., Nolan, T. and Pfaffl, M.W. (2005). Quantitative real-time RT-PCR- 
a perspective. Journal of Molecular Endocrinology, 34, 597-601.  
 
Campagna, M., Eichwald, C., Vascotto, F. and Burrone, O.R. (2005). RNA interference of 
rotavirus segment 11 mRNA reveals the essential role of NSP5 in the virus replicative 
cycle, Journal of General Virology, 86, 1481-1487.  
 
Candan, A. (2002). First report on the diagnosis of infectious pancreatic necrosis (IPN) 
based on reverse transcription polymerase chain reaction (RTPCR) in Turkey. Bulletin of 
the European Association of Fish Pathologists, 22, 45-48. 
 
Cann, A.J. (2001). Principles of molecular virology, 3rd edn. San diego: Academic press. 
 
Chen, D. and Ainsworth, A.J. (1992). Glucan administration potentiates immune defence 
mechanisms of channel catfish, Ictalurus punctatus Rafinesque. Journal of Fish Diseases, 
15, 295-304.  
 
Chien, C-C., Bartel, P.L., Sternglanz, R. and Fields, S. (1991). The two-hybrid system: A 
method to identify and clone genes for proteins that interact with a protein of interest, Proc. 
Natl. Acad. Sci, 88, 9578-9582.   
  
179 
Chou, H.Y., Peng, T.Y., Chang, S.J., Hsu, Y.L. and Wu, J.L. (1999). Effect of heavy metal 
stressors and salinity shock on the susceptibility of grouper (Epinephelus sp.) to infectious 
pancreatic necrosis virus. Virus Research, 63, 121-129. 
 
Christie, K.E (1997). Immunization with viral antigens: Infectious pancreatic necrosis. In 
Gudding, R., Lillehaug, A., Midtlyng, P.J. and Brown, F., (Eds.) Fish vaccinology, pp. 191-
199. Karger. 
 
Collet, B. and Secombes, C.J. (2001). The rainbow trout (Oncorhynchus mykiss) Mx1 
promoter - Structural and functional characterization. European Journal of Biochemistry, 
268, 1577-1584. 
 
Collet, B. and Secombes, C.J. (2002). Type I-Interferon signalling in fish, Fish and 
Shellfish Immunology, 12, 389-397.  
 
Collet, B., Boudinot, P., Benmansour, A., Secombes, C.J. (2004) An Mx1 promoter-
reporter system to study interferon pathways in rainbow trout, Developmental and 
Comparative Immunology, 28, 793-801.  
 
Collet, B., Munro, E.S., Gahlawat, S., Acosta, F., Garcia, J., Roemelt, C., Zou, J., 
Secombes, C.J. and Ellis, A.E. (2007). Infectious pancreatic necrosis virus suppresses type I 
interferon signalling in rainbow trout gonad cell line but not in Atlantic salmon 
macrophages, Fish and Shellfish Immunology, 22, 44-56.    
  
180 
Cutrin, J.M., Olveira, J.G., Barja, J.L. and Dopazo, C.P. (2000). Diversity of infectious 
pancreatic necrosis virus strains isolated from fish, shellfish, and other reservoirs in 
northwestern Spain. Applied and Environmental Microbiology, 66, 839-843. 
 
Cutrin, J.M., Lopez-Vazquez, C., Olveira, J.G., Castro, S., Dopazo, C.P. and Bandin, I. 
(2005). Isolation in cell culture and detection by PCR-based technology of IPNV-like virus 
from leukocytes of carrier turbot, Scophthalmus maximus (L.). Journal of Fish Diseases, 28, 
713-722. 
 
Dalmo, R.A. and Seljeild, R. (1995). The immunomodulatory effect of LPS, laminaran and 
sulphated laminaran [ß (1,3)-D-glucan] on  Atlantic salmon, Salmo salar L., macrophages 
in vitro. Journal of Fish Diseases, 18, 175-185 
 
Dalmo, R.A., Bøgwald, J., Ingebrigtsen, K. and Seljelid, R. (1996). The immunomodulatory 
effect of laminaran [ß (1,3)-D-glucan] on Atlantic salmon, Salmo salar L., anterior kidney 
leucocytes after intraperitoneal, peroral and peranal administration. Journal of Fish 
Diseases, 19, 449-457.  
 
Dalmo, R.A., Ingebrigtsen, K. and Bøgwald, J. (1997). Non-specific defence mechanisms in 
fish, with particular reference to the reticuloendothelial system (RES). Journal of Fish 
Diseases, 20, 241-273.   
 
  
181 
Damsgard, B., Mortensen, A. and Sommer, A.-I. (1998). Effects of infectious pancreatic 
necrosis virus (IPNV) on appetite and growth in Atlantic salmon, Salmo salar L (1998) 
Aquaculture, 163, 185-193.  
 
De Sena, J. and Rio, G.J. (1975). Partial purification and Characterization of RTG-2 fish 
cell Interferon, Infection and Immunity, 11, 815-822.  
 
Dobos, P., Hill, B.J., Hallett, R., Kells, D.T.C., Becht, H. and Teninges, D. (1979) 
Biophysical and biochemical characterization of five animal viruses with bisegmented 
double-stranded RNA genomes. Journal of Virology, 32, 593-605. 
 
Dobos, P. (1995). The molecular biology of infectious pancreatic necrosis virus (IPNV). 
Annual Review of Fish Diseases, 5, 25-54. 
 
Dorson, M., Castric J. and Torchy, C. (1978). Infectious pancreatic necrosis virus and 
antigenic features of a pathogenic strain and of a non-pathogenic varient selected in RTG-2 
cells.  Journal of Fish Diseases, 1, 309-320. 
 
Dorson, M. (1988). Vaccination against infectious pancreatic necrosis. In: Ellis, A.E., (Ed.) 
Fish Vaccination, pp. 162-171. London: Academic Press.  
 
  
182 
Dorson, M., De Kinkelin, P. and Torchy, C. (1992). Interferon synthesis in rainbow trout 
fry following infection with infectious pancreatic necrosis virus. Fish and Shellfish 
Immunology, 2, 311-313 
 
Drolet, B.S., Chiou, P.P., Heidel, J. and Leong, J.A.C. (1995). Detection of truncated virus-
particles in a persistent RNA virus-infection in-vivo. Journal of Virology, 69, 2140-2147. 
 
Du, G, Yonekubo, J, Zeng, Y, Osisami, M and Frohman, M.A. (2006). Design of 
expression vectors for RNA interference based on miRNAs and RNA splicing, FEBS 
Journal, 273, 5421-5427.  
 
Duncan, R., Nagy, E., Krell, P.J., Dobos, P. (1987). Synthesis of the infectious pancreatic 
necrosis virus polyprotein, detection of virus-encoded protease, and fine structure mapping 
of genome segment A coding regions. Journal of Virology, 61, 3655-3664.  
 
Eggset, G., Mortensen, A., Johansen, L.H. and Sommer, A.I. (1997). Susceptibility to 
furunculosis, cold water vibriosis, and infectious pancreatic necrosis (IPN) in post-smolt 
Atlantic salmon (Salmo salar L.) as a function of smolt status by seawater transfer.  
Aquaculture, 158, 179-191. 
 
Einer-Jensen, K., Bjorklund, H., Oreshkova, S., Shchelkunov, I., Vesely, T. and Lorenzen, 
N. (2002). Detection and typing of fish viruses. Bulletin of the European Association of 
Fish Pathologists, 22, 158-165. 
  
183 
Ellermann-Eriksen, S. (2005) Macrophages and cytokines in the early in the early defence 
against herpes simplex virus, Virology Journal, 2, 59.  
 
Ellis, A.E. (1977). The leucocytes of fish: A review. Journal of Fish Biology, 11, 453-491.  
 
Ellis, A.E. (1988). Fish vaccination, London: Academic press. 
 
Ellis, A.E. (2001). Innate host defense mechanisms of fish against viruses and bacteria.  
Developmental and Comparative Immunology, 25, 827-839. 
 
Engstad, R.E. and Robertsen, B. (1993). Recognition of yeast cell wall glucan by Atlantic 
salmon (Salmo salar L.) macrophages. Developmental and Comparative Immunology, 17, 
319-330.  
 
Espinoza, J.C. and Kuznar, J. (2002). Rapid simultaneous detection and quantitation of 
infectious pancreatic necrosis virus (IPNV). Journal of Virological Methods, 105, 81-85. 
 
Estepa, A. and Coll, J.M. (1991). Infection of mitogen-stimulated trout leukocytes with 
salmonid viruses. Journal of Fish Diseases, 14, 555-562.  
 
Ferguson, H.W. (1989). Systematic pathology of fish: a text and atlas of comparitive tissue 
responses in diseases of teleosts, Ames: Iowa State University press.  
 
  
184 
Ferko, B., Stasakova, J., Romanova, J., Kittel, C., Sereinig, S., Katinger, H. and Egorov, A. 
(2004). Immunogenicity and Protection Efficacy of Replication-Deficient Influenza A 
Viruses with Altered NS1 Genes, Journal of Virology, 78, 13037-13045.  
 
Fields, S. and Song, O.K. (1989). A novel genetic system to detect protein-protein 
interactions. Nature, 340, 245-246.  
 
Freeman, W.M., Walker, S.J. and Vrana, K.E. (1999). Quantitative RT-PCR: Pitfalls and 
Potential. BioTechniques, 26, 112-125.  
 
Frost, P. and Ness, A. (1997). Vaccination of Atlantic salmon with recombinant VP2 of 
infectious pancreatic necrosis virus (IPNV), added to a multivalent vaccine, suppresses viral 
replication following IPNV challenge. Fish and Shellfish Immunology, 7, 609-619. 
 
Frucht, D.M., Fukao, T., Bogdan, C., Schindler, H., O’Shea, J.J. and Koyasu, S. (2001). 
IFN-γ production by antigen-presenting cells: mechanisms emerge, TRENDS in 
Immunology, 22, 556-560.  
 
Garcia, J., Urquhart, K. and Ellis, A.E. (2006). Infectious pancreatic necrosis virus 
establishes an asymtomptomatic carrier state in kidney leucocytes of juvenile Atlantic cod, 
Gadus morhua L. Journal of Fish Diseases, 29, 409-413.  
 
  
185 
Garcia-Sastre, A. (2002). Mechanisms of inhibition of the host interferon α/ß-mediated 
antiviral responses by viruses, Microbes and Infection, 4, 647-655.  
 
Gentle, A., Anastasopoulos, F. and McBrien, N.A. (2001). High-resolution semi-
quantitative real-time PCR without the use of a standard curve. BioTechniques, 31, 502-
508. 
 
Gessani, S. and Belardelli, F. (1998). IFN-γ Expression in Macrophages and its possible 
biological significance, Cytokine and Growth Factors Reviews, 9, 117-123.  
 
Ginzinger, D.G. (2002). Gene quantification using real-time quantitative PCR: An emerging 
technology hits the mainstream. Experimental Haematology, 30, 503-512.  
 
Goodbourn, S., Didcock, L. and Randall, R.E. (2000). Interferons: cell signalling, immune 
modulation, antiviral responses and viral countermeasures. Journal of General Virology, 81, 
2341-2364.  
 
Graham, S. and Secombes, C.J. (1990). Do fish lymphocytes secrete interferon? Journal of 
Fish Biology, 36, 563-573. 
 
Gratacap, R.M.L., Thompson, K.D., Bricknell, I.R. and Adams, A. (2006). 
Lipopolysaccharides extraction: Application of Butan-1-ol method to Vibrio anguillarum.  
  
186 
Fifth International Symposium on Aquatic Animal health. September 2-6, San Francisco, 
California.  
 
Guselle, N.F., Markham, R.J.F. and Speare, D.J. (2006). Intraperitoneal administration of ß-
1,3/1,6-glucan to rainbow trout, Oncorhynchus mykiss (Walbaum), protects against Loma 
salmonae. Journal of Fish Diseases, 29, 375-381.  
 
Halder, M. and Ahne, W. (1988). Freshwater crayfish Astacus astacus - a vector for 
infectious pancreatic necrosis virus (IPNV). Diseases of Aquatic Organisms, 4, 205-209. 
 
Haller, O., Kochs, G. and Friedemann W., (2006). The interferon response circuit: 
Induction and suppression by pathogenic viruses. Virology, 344, 119-130.  
 
Havarstein, L.S., Endresen, C., Hjeltnes, B., Christie, K.E. and Glette, J. (1990). Specific 
immunoglobulins in serum from Atlantic salmon, Salmo salar L, immunized with vibrio-
salmonicida and infectious pancreatic necrosis virus. Journal of Fish Diseases, 13, 101-111. 
 
Haynes, L.M., Moore, D.D., Kurt-Jones, E.A., Finberg, R.W., Anderson, L.J. and Tripp, 
R.A. (2001). Involvement of Toll-Like receptor 4 in Innate Immunity to Respiratory 
Syncytial Virus, Journal of Virology, 75, 10730-10737.  
 
  
187 
Hedrick, R.P. and Fryer, J.L. (1982). Persistent infections of salmonid cell lines with 
infectious pancreatic necrosis virus (IPNV): A model for the carrier state in trout. Fish 
Pathology, 16, 163-172. 
 
Heppell, J. and Davis, H.L. (2000). Application of DNA vaccine technology to aquaculture.  
Advanced Drug Delivery Reviews, 43, 29-43. 
 
Hierholzer, J.C. and Killington, R.A. (1996). Virus isolation and quantification. In: Mahy, 
B.W.J. and Kangro, H.O., (Eds.). Virology Methods Manual. Great Britian, Academic Press 
Limited pp. 25-46.  
 
Hill, B.J. (1982). Infectious pancreatic necrosis virus and its virulence. In: Roberts, R.J., 
(Ed.) Microbial diseases of fish, pp. 91-114. London: Academic Press 
 
Hill, B.J. and Way, K. (1995). Serological classification of infectious pancreatic necrosis 
(IPN) virus and other aquatic birnaviruses. Annual Review of Fish Diseases, 5, 55-77. 
 
Honda, K., Yanai, H., Takaoka, A. and Taniguchi, T. (2005). Regulation of the Type I IFN 
induction: a current view. International Immunology, 17, 1367-1378.  
 
Hong, J.R., Lin, T.L., Hsu, Y.L. and Wu, J.L. (1998a). Apoptosis precedes necrosis of fish 
cell line with infectious pancreatic necrosis virus infection. Virology, 250, 76-84. 
 
  
188 
Hong, J.R., Lin, T.L., Hsu, Y.L. and Wu, J.L. (1998b). Induction of apoptosis and 
secondary necrosis by infectious pancreatic necrosis virus in fish embryonic cells. Journal 
of Fish Diseases, 21, 463-467. 
 
Hong, J.R., Lin, T.L., Yang, J.Y., Hsu, Y.L. and Wu, J.L. (1999). Dynamics of nontypical 
apoptotic morphological changes visualized by green fluorescent protein in living cells with 
infectious pancreatic necrosis virus infection. Journal of Virology, 73, 5056-5063. 
 
Hong, J.R., Gong, H.Y. and Wu, J.L. (2002). IPNV VP5, a novel anti-apoptosis gene of the 
Bcl-2 family, regulates Mcl-1 and viral protein expression. Virology, 295, 217-229. 
 
Hoshino, K., Kaisho, T., Iwabe, T., Takeuchi, O. and Akira, S. (2002). Differential 
involvement of IFN-ß in Toll-like receptor-stimulated dendritic cell activation. 
International Immunology, 14, 1225-1231.  
 
Jarp, J., Gjevre, A.G., Olsen, A.B. and Bruheim, T. (1995). Risk-factors for furunculosis, 
infectious pancreatic necrosis and mortality in post-smolt of Atlantic salmon, Salmo-salar 
L. Journal of Fish Diseases, 18, 67-78. 
 
Jarp, J., Taksdal, T. and Torud, B. (1996). Infectious pancreatic necrosis in Atlantic salmon 
Salmo salar in relation to specific antibodies, smoltification, and infection with erythrocytic 
inclusion body syndrome (EIBS). Diseases of Aquatic Organisms, 27, 81-88. 
 
  
189 
Jashes, M., Gonzalez, M., Lopezlastra, M., Declercq, E. and Sandino, A. (1996). Inhibitors 
of infectious pancreatic necrosis virus (IPNV) replication. Antiviral Research, 29, 309-312. 
 
Jensen, I., and Robertsen B. (2000). Cloning of an Mx cDNA from Atlantic halibut 
(Hippolossus hippoglossus) and characterisation of Mx mRNA expression in response to 
double-stranded RNA of infectious pancreatic necrosis virus. Journal of Interferon and 
Cytokine Research, 20, 701-710.  
 
Jensen, I., Larsen, R. and Robertsen, B., (2002). An antiviral state induced in Chinhook 
salmon embryo cells (CHSE-214) by transfection with the double-stranded RNA poly I:C. 
Fish and Shellfish Immunology, 13, 367-378.  
 
Jensen, I. and Robertsen, B. (2002). Effect of double-stranded RNA and interferon on the 
antiviral activity of Atlantic salmon cells against infectious salmon anemia virus and 
infectious pancreatic necrosis virus. Fish and Shellfish Immunology, 13, 221-241. 
 
Jensen, I., Albuquerque, A., Sommer, A-I. and Robertsen, B. (2002). Effect of poly I:C on 
the expression of Mx proteins and resistance against infection by infectious salmon anaemia 
virus in Atlantic salmon. Fish and Shellfish Immunology, 13, 311-326.  
 
Johansen, L.H. and Sommer, A.I. (1995) Multiplication of infectious pancreatic necrosis 
virus (IPNV) in head kidney and blood leucocytes isolated from Atlantic salmon, Salmo 
salar L. Journal of Fish Diseases, 18, 147-156.  
  
190 
Johansen, L.H. and Sommer, A.I. (2001) Infectious pancreatic necrosis virus infection in 
Atlantic salmon Salmo salar post-smolts affects the outcome of secondary infections with 
infectious salmon anaemia virus or Vibrio salmonicida. Diseases of Aquatic Organisms, 47, 
109-117. 
 
Johansen, A., Collet, B., Sandaker, E., Secombes, C.J. and Jørgensen, J.B. (2004). 
Quantification of Atlantic salmon type-I interferon using an Mx promoter reporter gene 
assay. Fish and Shellfish Immunology, 16, 173-184. 
 
Joost Haasnoot, P.C., Cupac, D. and Berkhout, B. (2003). Inhibition of Virus Replication by 
RNA Interference, Journal of Biomedical Science, 10, 607-616.  
 
Jørgensen, J.B. and Robertsen, B. (1995). Yeast ß-glucan stimulates respiratory burst 
activity of Atlantic salmon (Salmo salar L.) macrophages. Developmental and Comparative 
Immunology, 19, 43-57.   
 
Jørgensen, J.B., Johansen, A., Stenersen, B. and Sommer, A.I. (2001). CpG 
oligodeoxynucleotides and plasmid DNA stimulate Atlantic salmon (Salmo salar L.) 
leucocytes to produce supernatants with antiviral activity. Developmental and Comparitive 
Immunology, 25, 313-321.  
 
  
191 
Jørgensen, J.B., Johansen, A., Sterio, K. and Johansen, A. (2003). CpG DNA induces 
protective antiviral immune responses in Atlantic salmon (Salmo salar L.). Journal of 
Virology, 77, 11471-11479.  
 
Jørgensen, S.M., Lyng-Syvertsen, B., Lukacs, M., Grimholt, U. and Gjøen, T (2006). 
Expression of MHC class I pathway genes in response to infectious salmon anaemia virus 
in Atlantic salmon (Salmon salar L.) cells. Fish and Shellfish Immunology, 21, 548-560.  
 
Kapadia, S.B., Brideau-Anderson, A. and Chisari, F.V. (2003). Interference of hepatitis C 
virus RNA replication by short interfering RNAs, Proceedings of the National Academy of 
Sciences of the United States of America, 100, 2014-2018.  
 
Kato, A., Homma, T., Batchelor, J., Hashimoto, N., Imai, S., Wakiguchi, H., Saito, H. and 
Matsumoto, K. (2003). Interferon-alpha/beta receptor-mediated selective induction of a 
gene cluster by CpG oligodeoxynucleotide 2006, BMC Immunology,4, 1-10 
 
Kaufmann, S.H.E. (1993). Immunity to intracellular bacteria. Annual Review of 
Immunology, 11, 129-163. 
 
Kent, M.L. and Poppe, T.T. (1998). Diseases of seawater netpen-reared salmonid fishes, 
Nanaimo, BC, Canada: Quadra Printers Ltd. 
 
  
192 
Kerr, M.K., Martin, M., and Churchill, G.A. (2000). Analysis of variance for gene 
expression microarray data, Journal of Computational Biology, 7, 819–839. 
 
Kim, C.H., Dummer, D.M., Chiou, P.P. and Leong, J.A.C. (1999). Truncated particles 
produced in fish surviving infectious hematopoietic necrosis virus infection: mediators of 
persistence?  Journal of Virology, 73, 843-849. 
 
Kim, C.H., Johnson, M.C., Drennan, J.D., Simon, B.E., Thomann, E. and Leong, J.A.C. 
(2000) DNA vaccines encoding viral glycoproteins induce nonspecific immunity and mx 
protein synthesis in fish. Journal of Virology, 74, 7048-7054. 
 
Knott, R.M., Munro, A.L. (1986). The persistence of infectious pancreatic necrosis virus in 
Atlantic salmon. Veterinary Immunology and Immunopathology, 12, 359-364.  
 
Krönke, J., Kittler, R., Buchholz, F., Windisch, M.P., Pietschmann, T., Bartenschlager, R. 
and Frese, M. (2004). Alternative Approaches for Efficient Inhibition of Hepatitis C Virus 
RNA Replication by Small Intefering RNAs, Journal of Virology, 78, 3436-3446.  
 
Kumari, J. and Sahoo, P.K. (2006). Dietary ß-1,3 glucan potentiates innate immunity and 
disease resistance of Asian catfish, Clarias batrachus (L.). Journal of Fish Diseases, 29, 
95-101.  
 
  
193 
Kuo, C.C., Kuo, C.W., Liang, C.M. and Liang, S.M. (2005) A transcriptomic and proteomic 
analysis of the effect of CpG-ODN on human THP-1 monocytic leukemia cells, Proteomics 
5, 894–906. 
 
Kutyavin, I.V., Afonina, I.A., Mills, A., Gorn, V.V. Lukhtanov, E.A. Belousov, E.S., 
Singer, M.J., Walburger, D.K., Lokhov, S.G., Gall, A.A., Dempcy, R., Reed, M.W., Meyer, 
R.B., & Hedgpeth, J. (2000). 3'-minor groove binder–DNA probes increase sequence 
specificity at PCR extension temperatures. Nucleic Acids Research, 28, 655–661.  
 
Labus, M.B., Breeman, S., Ellis, A.E., Smail, D.A., Kervick, M. and Melvin, W.T. (2001). 
Antigenic comparison of a truncated form of VP2 of infectious pancreatic necrosis (IPN) 
virus expressed in four different cell types. Fish and Shellfish Immunology, 11, 203-216. 
 
Laing, K.J. and Secombes, C.J. (2004). Chemokines, Developmental and Comparative 
Immunology, 28, 443-460.  
 
Lancaster, M.U., Hodgetts, S.I., Mackenzie, J.S. and Urosevic, N. (1998). Characterization 
of defective viral RNA produced during persistent infection of vero cells with Murray 
Valley encephalitis virus. Journal of Virology, 72, 2474-2482. 
 
Larsen, R., Røkenes, T. and Robertsen, B. (2004). Inhibition of Infectious Pancreatic 
Necrosis Virus Replication by Atlantic salmon Mx1 Protein, Journal of Virology, 78, 7938-
7944.  
  
194 
Lee, J.Y., Hirono, I. and Aoki, T. (2000). Cloning and analysis of expression of Mx cDNA 
in Japanese flounder, Paralichthys olivaceus.  Developmental and Comparative 
Immunology, 24, 407-415. 
 
Leong, J.A.C., Trobridge, G.D., Kim, C.H.Y., Johnson, M. and Simon, B. (1998). 
Interferon-inducible Mx proteins in fish. Immunological Reviews, 166, 349-363. 
 
Levy, D.E. & Garcia-Sastre, A. (2001). The virus battles: IFN induction of the antiviral 
state and mechanisms of viral evasion. Cytokine & Growth Factor Reviews, 12, 143-156. 
 
Livak, K. (1997). ABI Prism 7700 Sequence Detection System, User Bulletin 2. PE Applied 
Biosystems, Foster City, CA.  
 
Livak, K.J. and Schmittgen, T.D. (2001). Analysis of Relative Gene Expression Data Using 
Real-Time Quantitative PCR and the 2-∆∆ CT Method. Methods, 25, 402-408.  
 
Lockhart, K., McBeath, A.J.A., Collet, B. Snow, M and Ellis, A.E. (2006). Expression of 
Mx mRNA following infection with IPNV is greater in IPN-susceptible Atlantic salmon 
post-smolts than in IPN-resistant Atlantic salmon parr, Fish and Shellfish Immunology, 
22,151-156.  
 
  
195 
Long, S., Wilson, M., Bengten, E., Bryan, L., Clem, W., Miller, N.W. and Chinchar, V.G. 
(2004). Identification of a cDNA encoding channel catfish interferon. Developmental 
Comparative Immunology, 28, 97-111.  
 
Lopezlastra, M., Gonzalez, M., Jashes, M. and Sandino, A.M. (1994). A detection method 
for infectious pancreatic necrosis virus (IPNV) based on reverse transcription (RT)-
polymerase chain- reaction (PCR). Journal of Fish Diseases, 17, 269-282. 
 
Lui, W. and Saint, D.A. (2002). A new quantitative method of real time reverse 
transcription polymerase chain reaction assay based on simulation of polymerase chain 
reaction kinetics. Analytical Biochemistry, 302, 52-59.  
 
Machida, K., Cheng, K.T.H., Sung, V.M.-H., Levine, A.M., Foung, S. and Lai, M.M.C. 
(2006). Hepatitus C Virus induces Toll-like Receptor 4 Expression, leading to enhanced 
production of Beta Interferon and Interleukin-6, Journal of Virology, 80, 866-874.  
 
Magnadóttir, B. (2006). Innate immunity of fish (overview). Fish and Shellfish Immunology 
20, 137-151.  
 
Magyar, G., Chung, H.K. and Dobbs, P. (1998). Conversion of VP1 to VPg in cells infected 
by infectious pancreatic necrosis virus. Virology, 245, 142-150. 
 
  
196 
Manning, M.J. and Nakanashi, T. (1996). The Specific Immune System: Cellular defenses. 
In: The Fish Immune System: Organism, Pathogen, and Environment. (Iwama, G., 
Nakanishi, T. ed) pp.159-205. San Diego: Academic Press.  
 
Marié, I., Durbin, J.E. and Levy, D.E. (1998). Differential viral induction of distinct 
interferon-α genes by positive feedback through interferon regulatory factor-7, The EMBO 
Journal, 17, 6660-6669.  
 
Matsumoto, M., Kikkawa, S., Kohase, M., Miyake, K. and Seya, T. (2002). Establishment 
of a monoclonal antibody against human Toll-receptor 3 that blocks double-stranded RNA-
mediated signalling. Biochemical and Biophysical Research Communications, 293, 1364-
1369.  
 
Mcallister, P.E. and Owens, W.J. (1992) Recovery of infectious pancreatic necrosis virus 
from the feces of wild piscivorous birds. Aquaculture, 106, 227-232. 
 
Mcallister, P.E. and Bebak, J. (1997). Infectious pancreatic necrosis virus in the 
environment: Relationship to effluent from aquaculture facilities. Journal of Fish Diseases, 
20, 201-207. 
 
McBeath, A.J.A., Snow, M., Secombes, C.J., Ellis, A.E. and Collet, B. (2007). Expression 
kinetics of interferon and interferon-induced genes in Atlantic salmon (Salmo salar) 
  
197 
following infection with infectious pancreatic necrosis virus and infectious salmon anaemia 
virus. Fish and Shellfish Immunology, 22, 230-241.  
 
Melby, H.P., Caswell-Reno, P. and Falk, K. (1994). Antigenic analysis of Norwegian 
aquatic Birnavirus isolates using monoclonal antibodies with special reference to fish 
species, age and health status. Journal of Fish Diseases, 17, 85-91.  
 
Melroe, G.T., Deluca, N.A. and Knipe, D.M. (2004). Herpes simplex virus 1 has multiple 
mechanisms for blocking virus-induced interferon production. Journal of Virology, 78, 
8411-8420.  
 
Midtlyng, P.J., Storset, A., Michel, C., Slierendrecht, W.J. and Okamoto, N. (2002). 
Breeding for disease resistance in fish. Bulletin of the European Association of Fish 
Pathologists, 22, 166-172. 
 
Milne, S.A., Gallacher, S., Cash, P. and Porter, A.J.R. (2006). A reliable RT-PCR-ELISA 
method for the detection of infectious pancreatic necrosis virus (IPNV) in farmed rainbow 
trout. Journal of Virological Methods, 132, 92-96.  
 
Moody, C.E., Serreze, D.V. and Reno, P.W. (1985). Non-specific cyto-toxic activity of 
teleost leukocytes. Developmental and Comparative Immunology, 9, 51-64. 
 
  
198 
Mortensen, S.H. (1993). Passage of infectious pancreatic necrosis virus (IPNV) through 
invertebrates in an aquatic food-chain. Diseases of Aquatic Organisms, 16, 41-45. 
 
Moya, J., Pizarro, H., Jashes, M., De Clercq, E. and Sandino, A.M. (2000). In vivo effect of 
EICAR (5-ethynyl-1-beta-D- ribofuranosylimidazole-carboxamide) on experimental 
infected rainbow trout (Oncorhynchus mykiss) and coho salmon (Onchorhynchus kisutch) 
fry with infectious pancreatic necrosis virus. Antiviral Research, 48, 125-130. 
 
Mulero, V. and Mesenguer, J. (1998). Functional characterisation of a macrophage-
activiating factor produced by leucocytes of gilthead seabream (Sparus aurata L.)  Fish and 
Shellfish Immunology, 8, 143-156.  
 
Muller, P.Y., Janovjak, A., Miserez, A.R. and Dobbie, Z. (2002). Processing of gene 
expression data generated by quantitative real-time RT-PCR. BioTechniques, 32, 1372-
1379.  
 
Muñoz-Jordán, J.L., Sánchez-Burgos, G.G., Laurent-Rolle, M. and Garcia-Sastre, A. 
(2003). Inhibition of interferon signalling by dengue virus, Microbiology, 24, 14333-14338.  
 
Munro, E.S., Gahlawat, S.K. and Ellis, A.E. (2004). A sensitive non-destructive method for 
detecting IPNV carrier Atlantic salmon, Salmo salar L., by culture of virus from plastic 
adherent blood leucocytes. Journal of Fish Diseases, 27, 129-134.  
 
  
199 
Munro E.S., Gahlawat, S.K., Acosta, F. and Ellis A.E. (2006). In Infectious pancreatic 
necrosis virus carrier Atlantic salmon, Salmo salar L., post smolts, almost all kidney 
macrophages ex vivo contain a low level of non-replicating virus. Journal of Fish Diseases, 
29, 43-46.  
 
Munzo, J., Esteban, M.A. and Meseguer, J. (1999). In vitro culture requirements of sea bass 
(Dicentrarchus labrax L.) blood cells: Differential adhesion and phase contrast microscopic 
study. Fish and Shellfish Immunology, 9, 417-428.  
 
Murray, A.G., Busby, C.D. and Bruno, D.W. (2003) Infectious pancreatic necrosis virus in 
Scottish Atlantic salmon farms, 1996-2001. Emerging Infectious Diseases, 9, 455-460. 
 
Murray, A.G. (2006 a). A model of the emergence of infectious pancreatic necrosis virus in 
Scottish salmon farms 1996-2003. Ecological Modelling, 199, 64-72.  
 
Murray, A.G. (2006 b). Persistence of infectious pancreatic necrosis virus (IPNV) in 
Scottish salmon (Salmo salar L.) farms. Preventive Veterinary Medicine, 76, 97-108.  
 
Nakanishi, T., Fischer, U., Dijkstra, J.M., Hasegawa, S., Somamoto, T., Okamoto, N. and 
Ototake, M. (2002). Cytotoxic T cell function in fish. Developmental and Comparative 
Immunology, 26, 131-139. 
 
  
200 
Neumann, N.F., Fagan, D. and Belosevic, M. (1995). Macrophage activating factor(s) 
secreted by mitogen stimulated goldfish kidney leukocytes synergize with bacterial 
lipopolysaccharide to induce nitric oxide production in teleost macrophages. Developmental 
and Comparative Immunology, 19, 473-482.    
 
Noga, E.J. (2000) Fish disease: diagnosis and treatment, Ames, IA:  Iowa state university 
press. 
 
Novoa, B., Barja, J.L. and Figueras, A. (1995) Entry and sequential distribution of an 
aquatic birnavirus in turbot (Scophthalmus-maximus). Aquaculture, 131, 1-9. 
 
Nova, B., Figueras, A., Ashton, I. and Secombes, C.J. (1996). In vitro studies on the 
regulation of rainbow trout (Oncorhynchus mykiss) macrophage respiratory burst activity. 
Developmental and Comparative Immunology, 20, 207-216.  
 
Nova, B., Figueras, A., Ashton, I. and Secombes, C.J. (1996 b). Effects of in vitro addition 
of infectious pancreatic necrosis virus (IPNV) on rainbow trout Oncorhynchus mykiss 
leucocyte responses. Veterinary Immunology and Immunopathology, 51, 365-376.  
 
Nygaard, R., Husgard, S., Sommer, A.I., Leong, J.A.C. and Robertsen, B. (2000). Induction 
of Mx protein by interferon and double-stranded RNA in salmonid cells. Fish & Shellfish 
Immunology 10, 435-450. 
 
  
201 
Nyman, T.A., Matikainen, S., Sareneva, T., Julkunen, I., and Kalkkinen, N. (2000). 
Proteome analysis reveals ubiquitin-conjugating enzymes to be a new family of interferon-
α-regulated genes. European Journal of Biochemistry, 267, 4011-4019.  
 
O’Farrell, C., Vaghefi, N., Contonnet, M., Buteau, B., Boudinot, P. and Benmansour, A. 
(2002). Survey of transcript expression in rainbow trout leukocytes reveals a major 
contribution of interferon-responsive genes in the early response to a rhabdovirus infection. 
Journal of Virology, 76, 8040-8049.  
 
Okamoto, N., Shirakura, T., Nagakura, Y. and Sano, T. (1983). The mechanism of 
interference with fish viral infection in the RTG-2 cell line. Fish Pathology, 18, 7-12. 
 
Oldstone, M.B.A. (2006). Viral persistence: Parameters, mechanisms and future 
predictions. Virology, 344, 111-118.  
 
Oye, A.K. and Rimstad, E. (2001). Inactivation of infectious salmon anaemia virus, viral 
haemorrhagic septicaemia virus and infectious pancreatic necrosis virus in water using 
UVC irradiation. Diseases of Aquatic Organisms, 48, 1-5. 
 
Park, J.W. and Jeong, G.J. (1996). Identification of VP3 as an important neutralising 
epitope from DRT strain, a Korean isolate of infectious pancreatic necrosis virus (IPNV). 
Fish & Shellfish Immunology, 6, 207-219. 
 
  
202 
Paulsen, S.M., Lunde, H., Engstad, R.E. and Robertsen, B. (2003). In vivo effects of ß-
glucan and LPS on regulation of lysozyme activity and mRNA expression in Atlantic 
salmon (Salmo salar L.). Fish and Shellfish Immunology, 14, 39-54.  
 
Peat, S., Whelan, W.J. and Lawley, H.G. (1958). The structure of laminarin. Part I. The 
main polymeric linkage. Journal of the Chemical Society, 724-728.   
 
Peters, I.R., Helps, C.R., Hall, E.J. and Day, M.J. (2004). Real-time RT-PCR: 
considerations for efficient and sensitive assay design. Journal of Immunological Methods, 
286, 203-217.  
 
Pettersen, E.F., Ulvenes, M., Melingem, G.O. and Wergeland, H.I. (2003). Peripheral blood 
and head kidney leucocyte populations during out-of-season (0+) parr-smolt transformation 
and seawater transfer of Atlantic salmon (Salmo salar L.) Fish and Shellfish Immunology, 
15, 373-385.  
 
Pettersen, E.F., Bjørløw, I., Hagland, T.J. and Wergeland, H.I. (2005). Effect of seawater 
temperature on leucocyte populations in Atlantic salmon post-smolts. Vet. Immunological 
Immounopathology, 15, 65-76 
 
Pfaffl, M.W. (2001). A new mathematical model for relative quantification in real-time RT-
PCR. Nucleic Acids Research, 29, 2002-2007. 
 
  
203 
Pfaffl, M.W., Horgan, G.W. and Dempfle, L. (2002) Relative expression software tool 
(REST©) for group-wise comparison and statistical analysis of relative expression results in 
real-time PCR. Nucleic Acids Research, 30, 1-10.  
 
Pierson, S.N., Butler, J.N. and Foster, R.G. (2003). Experimental validation of novel and 
conventional approaches to quantitative real-time PCR data analysis. Nucleic Acids 
Research, 31, e73. 
 
Plouffe, D.A, Hanington, P.C., Walsh, J.C., Wilson, E.C. and Belosevic, M. (2005). 
Comparison of select innate immune mechanisms of fish and mammals. 
Xenotransplantation, 12, 266-277.  
 
Post, G. (1987). Textbook of fish health, 2nd edn. Ascot: T.F.H. Publications. 
 
Rae, G. (2002). Sea lice control is Scotland, past and present. Pest Management Science, 
58, 515-520. 
 
Randonic, A., Thulke, S., Mackay, I.M., Landt, O., Siegert, W. and Nitsche, A. (2004). 
Guideline to reference gene selection for quantitative real-time PCR. Biochemical and 
Biophysical Research Communications, 313, 856-862.  
 
  
204 
Reno, P.W. (1999). Infectious pancreatic necrosis and associated aquatic birnaviruses. In: 
Woo, P.T.K. and Bruno, D.W., (Eds.) Fish diseases and disorders: volume 3: viral, 
bacterial and fungal infection, pp. 1-55. Oxon:  CAB International 
 
Rise, M.L., Jones, S.R.M., Brown, G.D., Von Schalburg, K.R., Davidson, W.S. and Koop, 
B.F. (2004). Microarray analyses identify molecular biomarkers of Atlantic salmon 
macrophage and haematopoietic kidney response to Piscirickettsia salmonis infection. 
Pysiol Genomics, 20, 21-35.  
 
Robersten, B. (2006). The interferon system of teleost fish. Fish & Shellfish Immunology, 
20,172-191.  
 
Roberts, R.J. (1989). Fish pathology, 2nd edn. London: Baillere tindall. 
 
Roberts, R.J. and Shepherd, C.J. (1997). Handbook of trout and salmon diseases, 3rd edn.  
Farnham: Fishing news books. 
 
Robertsen, B., Trobridge, G. and Leong, J.A. (1997). Molecular cloning of double-stranded 
RNA inducible MX genes from Atlantic salmon (Salmo salar L.). Developmental and 
Comparative Immunology 21, 397-412. 
 
  
205 
Robertsen, B., Rorstad, G., Engstad, R. and Raa, J. (1990). Enhancement of non-specific 
disease resistance in Atlantic salmon, Salmo salar L., by a glucan from Saccharomyces 
cerevisiae cell walls. Journal of Fish diseases, 13, 391-400.  
 
Robertsen, B. (1999). Modulation of the non-specific defence of fish by structurally 
conserved microbial polymers. Fish and Shellfish Immunology, 9, 269-290.  
 
Robertsen, B., Bergen, V., Røkenes, T., Larsen, R. and Albuquerque, A. (2003). Atlantic 
salmon interferon genes: cloning, sequence analysis, expression and biological activity. 
Journal of Interferon Cytokine Research, 23, 601-612.  
 
Rønneseth, A., Pettersen, E.F. and Wergeland, H.I. (2006). Neutrophils and B-cells in blood 
and head kidney of Atlantic salmon (Salmo salar L.) challenged with infectious pancreatic 
necrosis virus (IPNV). Fish and Shellfish Immunology, 20, 610-620.  
 
Sadasiv, E.C. (1995). Immunological and pathological responses of salmonids to infectious 
pancreatic necrosis virus (IPNV). Annual Review of Fish Diseases 5, 209-223. 
 
Saint-Jean, S.R. and Pérez-Prietom, S.I. (2006). Interferon mediated antiviral activity 
against salmonid fish viruses in BF-2 and other cell lines, Veterinary Immunology and 
Immunopathology, 110, 1-10.  
 
Sakai, M. (1999). Current research of fish immunostimulants. Aquaculture, 172, 63-92.  
  
206 
Salinas, I., Lockhart, K., Bowden, T.J., Collet, B, Secombes, C.J. and Ellis, A.E. (2004). An 
assessment of immunostimulants as Mx inducers in Atlantic salmon (Salmo salar L.) parr 
and the effect of temperature on the kinetics of Mx responses, Fish & Shellfish 
Immunology, 17, 159-170.  
 
Samuel, C.E. (2001). Antiviral Actions of Interferons. Clinical Microbiology Reviews, 14, 
778-809.  
 
Sangrador-Vegas, A., Martin, S.A.M., O’Dea, P.G. and Smith, T.J. (2000). Cloning and 
characterization of the Rainbow trout (Oncorhynchus mykiss) type II interleukin-1 receptor 
cDNA. European Journal of Biochemistry, 267: 7031-7037. 
 
Santi, N., Vakharia, V.N., and Evensen Ø. (2004) Identification of putative motifs involved 
in the virulence of infectious pancreatic necrosis virus. Virology, 322, 31-40.  
 
Santi, N., Song, H., Vakharia, V.N. and Evensen, Ø. (2005). Infectious pancreatic necrosis 
virus VP5 is dispensable for virulence and persistence. Journal of Virology, 79, 9206-9216.  
 
Sarmento, A., Marques, F., Ellis, A.E. and Afonso, A. (2004). Modulation of the activity of 
sea bass (Dicentrarchus labrax) head-kidney macrophages by macrophage activating 
factor(s) and lipopolysaccharide. Fish and Shellfish Immunology, 16, 79-92.  
 
  
207 
Sato, M., Suemori, H., Hata, N., Asagiri, M., Ogasawara, K., Nakao, K., Nakaya, T., 
Katsuki, M., Noguchi, S., Tanaka, N. and Taniguchi, T. (2000). Distinct and essential roles 
of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene 
induction, Immunity, 13, 539-548.  
 
Savan, M. and Dobos, P. (1980). Effect of virazole on rainbow trout Salmo gairdneri 
richardson fry infected with infectious pancreatic necrosis virus. Journal of Fish Diseases, 
3, 437-440. 
 
Schmitz, F., Mages, J., Heit, A., Lang, R., and Wagner, H. (2004). Transcriptional 
activation induced in macrophages by Toll-like receptor (TLR) ligands: from expression 
profiling to a model of TLR signaling, European Journal of Immunology, 34, 2863–2873.  
 
Secombes, C.J. (1990). Isolation of salmonid macrophages and analysis of their killing 
activity. In: Techniques in Fish Immunology (ed. By J.S. Stolen, D.P. Fletcher, B.S. 
Anderson & W.B. van Muiswinkel), pp.137-154. SOS Publications, Fair Haven, NJ, USA.  
 
Secombes, C.J. (1994). The phylogeny of cytokines. In: The Cytokine Handbook, 2nd 
edition (A.W. Thompson, ed.) pp.567-594. London: Academic Press.   
 
Sen, G.C. (2001). Viruses and Interferons, Annual review of microbiology, 55, 255-281.  
 
  
208 
Shioda, T., Andriole, S., Yahata, T. and Isselbacher, K.J. (2000). A green fluorescent 
protein-reporter mammalian two-hybrid system with extrachromosomal maintenance of a 
prey expression plasmid:Application to interaction screening. Proceedings of the National 
Academy of Sciences of the United States of America, 97, 5220-5224.  
 
Shivappa, R.B., Song, H., Yao, K., Aas-Eng, A., Evensen, Ø. and Vakharia, V.N. (2004). 
Molecular characterization of Sp serotype strains of infectious pancreatic necrosis virus 
exhibiting differences in virulence. Diseases of Aquatic Organisms, 61, 23-32.  
 
Smail, D.A., Bruno, D.W., Dear, G., McFarlane, L.A. and Ross, K. (1992). Infectious 
pancreatic necrosis (IPN) virus Sp serotype in farmed Atlantic salmon, Salmo salar L., 
post-smolts associated with mortality and clinical diseases. Journal of Fish Diseases, 15, 
77-83. 
 
Smail, D.A., Huntly, P.J. and Munro, A.L.S. (1993a). Fate of 4 fish pathogens after 
exposure to fish silage containing fish farm mortalities and conditions for the inactivation of 
infectious pancreatic necrosis virus. Aquaculture, 113, 173-181. 
 
Smail, D.A., Irwin, N., Harrison, D. and Munro, A.L.S. (1993b). Passage and survival of 
infectious pancreatic necrosis (IPN) virus in the cows gut after feeding a silage mixture 
containing IPN virus. Aquaculture, 113, 183-187. 
 
  
209 
Smail, D.A., Mcfarlane, L., Bruno, D.W. and Mcvicar, A.H. (1995). The pathology of an 
IPN-Sp sub-type (Sh) in farmed Atlantic salmon, Salmo salar L, post-smolts in the Shetland 
Isles, Scotland. Journal of Fish Diseases, 18, 631-638. 
 
Solem, S.T., Jørgensen, J.B. and Robertsen, B. (1995). Stimulation of respiratory burst and 
phagocytic activity in Atlantic salmon (Salmo salar L.) macrophages by lipopolysaccharide. 
Fish and Shellfish Immunology, 5, 475-491.  
 
Somamoto, T., Nakanishi, T. and Okamoto, N. (2000). Specific cell-mediated cytotoxicity 
against a virus-infected syngeneic cell line in isogeneic ginbuna crucian carp. 
Developmental and Comparative Immunology, 24, 633-640. 
 
Song, H., Santi, N., Evensen, Ø. and Vakharia, V.N. (2005). Molecular determinants of 
infectious pancreatic necrosis virus virulence and cell culture adaptation. Journal of 
Virology, 79, 10289-10299.  
 
Sørensen, K K., Sveinbjørnsson, B., Dalmo, R A., Smedsrød, B., and Bertheussen, K. 
(1997). Isolation, cultivation and characterization of head kidney macrophages from 
Atlantic cod, Gadus morhua L, Journal of Fish Diseases, 20,  93-107. 
 
Steuerwald, N., Cohen, J., Herrera, R.J. and Brenner, C.A. (1999). Analysis of gene 
expression in single oocytes and embryos by real-time rapid cycle fluorescence monitored 
RT-PCR. Molecular Human Reproduction, 5, 1034-1039. 
  
210 
Stoskopf, M.K. (1993). Fish medicine, Philadelphia: W.B. Saunders Company. 
 
Swanson, R.N. and Gillespie, J.H. (1981). An indirect fluorescent-antibody test for the rapid 
detection of infectious pancreatic necrosis virus in tissues. Journal of Fish Diseases, 4, 309-
315. 
 
Swanson, R.N. and Gillespie, J.H. (1982). Isolation of infectious pancreatic necrosis virus 
from the blood and blood components of experimentally infected trout. Canadian Journal 
of Fisheries and Aquatic Sciences, 39, 225-228. 
 
Taffala, C., Nova, B. (2000) Requirements for nitric oxide production by turbot 
(Scophthalmus maximus) head kidney macrophages. Developmental and Comparative 
Immunology, 24, 623-631.  
 
Tafalla, C., Coll, J. and Secombes, C.J. (2005). Expression of genes related to the early 
immune response in rainbow trout (Oncorhynchus mykiss) after viral haemorrhagic 
septicaemia virus (VHSV) infection. Developmental Comparative Immunology, 29, 615-
626.  
 
Taksdal, T., Poppe, T., Sivertsen, T. and Ferguson, H.W. (1995). Low-levels of vitamin-e in 
plasma from atlantic salmon Salmo- salar with acute infectious pancreatic necrosis (IPN). 
Diseases of Aquatic Organisms, 22, 33-37. 
 
  
211 
Taksdal, T., Ramstad, A., Stangeland, K. and Dannevig, B.H. (1998). Induction of 
infectious pancreatic necrosis (IPN) in covertly infected Atlantic salmon, Salmo salar L., 
post smolts by stress exposure, by injection of IPN virus (IPNV) and by cohabitation. 
Journal of Fish Diseases, 21, 193-204. 
 
Taksdal, D. (1999). Infectious pancreatic necrosis (IPN) in Atlantic salmon: Infection trials, 
pathogenesis and diagnostic methods. PhD thesis. Norwegian college of veterinary 
medicine. Oslo, ISBN 82-90550-3. 
 
Taksdal, T., Dannevig, B.H. and Rimstad, E. (2001). Detection of infectious pancreatic 
necrosis (IPN)-virus in experimentally infected Atlantic salmon parr by RT-PCR and cell 
culture isolation. Bulletin of the European Association of Fish Pathologists, 21, 214-219. 
 
Tan, Y-D., Fornage, M. and Fu, Y.U. (2006). Ranking analysis of microarray data: A 
powerful method for identifying differentially expressed genes. Genomics, 88, 846-854.  
 
Taniguchi, T. and Takaoka, A. (2002). The interferon- α/ß system in antiviral responses: a 
multimodal machinery of gene regulation by the IRF family of transcription factors, 
Current Opinion in Immunology, 14, 111-116.  
 
Tosi, M.F. (2005). Innate immune responses to infection, Journal of Allergy and Clinical 
Immunology, 116, 241-249.  
 
  
212 
Trobridge, G.D., Chiou, P.P. and Leong, J.A.C. (1997). Cloning of the rainbow trout 
(Oncorhynchus mykiss) Mx2 and Mx3 cDNAs and characterization of trout Mx protein 
expression in salmon cells. Journal of Virology, 71, 5304-5311. 
 
Trobridge, G.D., Chiou, P.P., Kim, C.H. and Leong, J.A.C. (1997). Induction of the Mx 
protein of rainbow trout Oncorhynchus mykiss in vitro and in vivo with poly I:C dsRNA and 
infectious hematopoietic necrosis virus. Diseases of Aquatic Organisms, 30, 91-98 
 
Ullu, E., Djikeng, A., Shi, H. and Tschudi, C. (2002). RNAi interference: advances and 
questions. Philosophical transactions of the Royal society B: Biological sciences, 357, 65-
70.  
 
Valarcher, J-F., Furze, J., Wyld, S., Cook, R., Conzelmann, K-K. and Taylor, G. (2003). 
Role of Alpha/Beta Interferons in the Attenuation and Immunogenicity of Recombinant 
Bovine Respiratory Syncytical Viruses Lacking NS Proteins. Journal of Virology, 77, 8426-
8349.  
 
Wang, A.M., Doyle, M.V. and Mark, D.F. (1989). Quantitation of mRNA by the 
polymerase chain reaction. Proceedings of the National Academy of Sciences, 86, 9717-
9721.  
 
  
213 
Wang, Z., Ren, L., Zhao, X., Hung, T., Meng, A., Wang, J. and Chen, Y-G. (2004). 
Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs 
in mammalian cells, Journal of Virology, 78, 7523-7527.  
 
Weber, S., Fichtner, D., Mettenleiter, T.C. and Mundt, E. (2001). Expression of VP5 of 
infectious pancreatic necrosis virus strain VR299 is initiated at the second in-frame start 
codon. Journal of General Virology, 82, 805-812. 
 
Wergeland, H.I. and Aakre Johansen, R. (2001). A salmonid cell line (TO) for production 
of infectious salmon anaemia virus (ISAV). Diseases of Aquatic Organisms, 44, 183-190.  
 
Williams, K., Blake, S., Sweeney, A., Singer J. T., and Nicholson B. L. (1999). Multiplex 
Reverse Transcriptase PCR Assay for Simultaneous Detection of Three Fish Viruses. 
Journal of Clinical Microbiology, 37, 4139-4141.  
 
Wolf, K. (1988). Fish viruses and fish viral diseases, 1st edition. New York: Cornell 
University press. 
 
Wong, M.L. and Mendrano, J.F. (2005). Real-time PCR for mRNA quantitation. 
Biotechniques, 39, 1-11.  
 
  
214 
Yabu, T., Hirose, H., Hirono, I., Katagiri, T., Aoki, T. and Yamamoto, E. (1998). Molecular 
cloning of a novel interferon regulatory factor in Japanese flounder, Paralichthys olivaceus, 
Molecular Marine Biology and Biotechnology, 7, 138-144.  
 
Yamamoto, T. (1975). Infectious pancreatic necrosis (IPN) virus carriers and antibody 
production in a population of rainbow trout (salmo gairdneri). Candian Journal of 
Microbiology, 21, 1343-1347. 
 
Yoon, J-B., Kim, S-H., Shin, M-C., Lee, D-G., Hong, S-K., Jung, Y-T., Khang, I-G., Shin, 
W-S, Kim, C-C. and Paik, S-Y. (2004). Inhibition of Herpesvirus-6B RNA Replication by 
Short Interference RNAs, Journal of Biochemistry and Molecular Biology, 37, 383-385. 
 
Yoshiura, Y., Kiryu, I., Fujiwara, A., Suetake, H., Suzuki, Y., Nakanishi, T. and Ototake, 
M. (2003). Identification and characterization of Fugu orthologues of mammalian 
interleukin-12 subunits. Immunogenetics, 55, 296-306.  
 
Yu, K. K-Y., MacDonald, R.D. and Moore, A.R. (1982). Replication of infectious 
pancreatic necrosis virus in trout leucocytes and detection of the carrier state. Journal of 
Fish Diseases, 5, 401-410.  
 
Zhang, Y.B., Hu C.Y., Zhang J., Huang G.P., Wei L.H., Zhang, Q.Y. and Gui, J.F. (2003). 
Molecular cloning and characterization of crucian carp (Carassius auratus L.) interferon 
regulatory factor 7, Fish and Shellfish Immunology, 15, 453-466.  
  
215 
Zhang, Z., Ding, L. and Sandford, A.J. (2005). Selection of reference genes for gene 
expression studies in human neutrophils by real-time PCR. BCM Molecular Biology, 6, 1-7.  
 
Zou, J., Carrington, A., Collet, B., Dijkstra, J.M., Yoshiura, Y., Bols, N. and Secombes, C. 
(2005). Identification and Bioactivities of IFN-γ in Rainbow Trout Oncorhynchus mykiss: 
The First Th1-Type Cytokine Characterized Functionally in Fish, The Journal of 
Immunology, 175, 2484-2494.  
 
Zou, J., Wang, T., Hirono I., Aoki, T., Inagawa, H. and Honda, T. (2002). Differential 
Expression of two tumor necrosis factor genes in rainbow trout, Oncorhynchus mykiss, 
Developmental and  Comparative Immunology, 26, 161-172.  
 
